id	sid	tid	token	lemma	pos
finefocus-3492	1	1	54	54	NUM
finefocus-3492	1	2	|	|	ADV
finefocus-3492	1	3	fine	fine	ADJ
finefocus-3492	1	4	focus	focus	VERB
finefocus-3492	1	5	anti	anti	ADJ
finefocus-3492	1	6	-	-	NOUN
finefocus-3492	1	7	proliferation	proliferation	NOUN
finefocus-3492	1	8	of	of	ADP
finefocus-3492	1	9	melanoma	melanoma	NOUN
finefocus-3492	1	10	cells	cell	NOUN
finefocus-3492	1	11	and	and	CCONJ
finefocus-3492	1	12	immune	immune	ADJ
finefocus-3492	1	13	stimulation	stimulation	NOUN
finefocus-3492	1	14	by	by	ADP
finefocus-3492	1	15	the	the	DET
finefocus-3492	1	16	cyanobacterial	cyanobacterial	ADJ
finefocus-3492	1	17	indole	indole	NOUN
finefocus-3492	1	18	-	-	PUNCT
finefocus-3492	1	19	alkaloid	alkaloid	NOUN
finefocus-3492	1	20	scytonemin	scytonemin	PROPN
finefocus-3492	1	21	jadon	jadon	PROPN
finefocus-3492	1	22	evans	evans	PROPN
finefocus-3492	1	23	(	(	PUNCT
finefocus-3492	1	24	evanjm05@pfw.edu	evanjm05@pfw.edu	PROPN
finefocus-3492	1	25	)	)	PUNCT
finefocus-3492	1	26	aaron	aaron	PROPN
finefocus-3492	1	27	jones	jones	PROPN
finefocus-3492	1	28	(	(	PUNCT
finefocus-3492	1	29	joneaa@iu.edu	joneaa@iu.edu	PROPN
finefocus-3492	1	30	)	)	PUNCT
finefocus-3492	1	31	elliott	elliott	PROPN
finefocus-3492	1	32	blumenthal	blumenthal	PROPN
finefocus-3492	1	33	(	(	PUNCT
finefocus-3492	1	34	blumenth@pfw.edu	blumenth@pfw.edu	PROPN
finefocus-3492	1	35	)	)	PUNCT
finefocus-3492	1	36	*	*	PUNCT
finefocus-3492	1	37	tanya	tanya	PROPN
finefocus-3492	1	38	soule	soule	PROPN
finefocus-3492	1	39	(	(	PUNCT
finefocus-3492	1	40	soulet@pfw.edu	soulet@pfw.edu	PROPN
finefocus-3492	1	41	)	)	PUNCT
finefocus-3492	1	42	department	department	NOUN
finefocus-3492	1	43	of	of	ADP
finefocus-3492	1	44	biology	biology	NOUN
finefocus-3492	1	45	,	,	PUNCT
finefocus-3492	1	46	purdue	purdue	PROPN
finefocus-3492	1	47	university	university	PROPN
finefocus-3492	1	48	fort	fort	PROPN
finefocus-3492	1	49	wayne	wayne	PROPN
finefocus-3492	1	50	*	*	PUNCT
finefocus-3492	1	51	corresponding	correspond	VERB
finefocus-3492	1	52	author	author	NOUN
finefocus-3492	1	53	department	department	PROPN
finefocus-3492	1	54	of	of	ADP
finefocus-3492	1	55	biology	biology	NOUN
finefocus-3492	1	56	,	,	PUNCT
finefocus-3492	1	57	purdue	purdue	PROPN
finefocus-3492	1	58	university	university	PROPN
finefocus-3492	1	59	fort	fort	PROPN
finefocus-3492	1	60	wayne	wayne	PROPN
finefocus-3492	1	61	,	,	PUNCT
finefocus-3492	1	62	2101	2101	NUM
finefocus-3492	1	63	e	e	PROPN
finefocus-3492	1	64	coliseum	coliseum	NOUN
finefocus-3492	1	65	blvd	blvd	NOUN
finefocus-3492	1	66	.	.	PUNCT
finefocus-3492	1	67	,	,	PUNCT
finefocus-3492	1	68	fort	fort	PROPN
finefocus-3492	1	69	wayne	wayne	PROPN
finefocus-3492	1	70	,	,	PUNCT
finefocus-3492	1	71	indiana	indiana	PROPN
finefocus-3492	1	72	46845	46845	NUM
finefocus-3492	1	73	manuscript	manuscript	NOUN
finefocus-3492	1	74	received	receive	VERB
finefocus-3492	1	75	29	29	NUM
finefocus-3492	1	76	january	january	PROPN
finefocus-3492	1	77	,	,	PUNCT
finefocus-3492	1	78	2021	2021	NUM
finefocus-3492	1	79	;	;	PUNCT
finefocus-3492	1	80	accepted	accept	VERB
finefocus-3492	1	81	15	15	NUM
finefocus-3492	1	82	june	june	NOUN
finefocus-3492	1	83	,	,	PUNCT
finefocus-3492	1	84	2021	2021	NUM
finefocus-3492	1	85	keywords	keyword	NOUN
finefocus-3492	1	86	:	:	PUNCT
finefocus-3492	1	87	scytonemin	scytonemin	NOUN
finefocus-3492	1	88	,	,	PUNCT
finefocus-3492	1	89	melanoma	melanoma	NOUN
finefocus-3492	1	90	,	,	PUNCT
finefocus-3492	1	91	spleen	spleen	NOUN
finefocus-3492	1	92	cells	cell	NOUN
finefocus-3492	1	93	,	,	PUNCT
finefocus-3492	1	94	anti	anti	ADJ
finefocus-3492	1	95	-	-	ADJ
finefocus-3492	1	96	proliferative	proliferative	ADJ
finefocus-3492	1	97	,	,	PUNCT
finefocus-3492	1	98	natural	natural	ADJ
finefocus-3492	1	99	products	product	NOUN
finefocus-3492	1	100	volume	volume	NOUN
finefocus-3492	1	101	seven	seven	NUM
finefocus-3492	1	102	|	|	ADV
finefocus-3492	1	103	55	55	NUM
finefocus-3492	1	104	abstract	abstract	NOUN
finefocus-3492	1	105	under	under	ADP
finefocus-3492	1	106	the	the	DET
finefocus-3492	1	107	stress	stress	NOUN
finefocus-3492	1	108	of	of	ADP
finefocus-3492	1	109	ultraviolet	ultraviolet	ADJ
finefocus-3492	1	110	radiation	radiation	NOUN
finefocus-3492	1	111	some	some	DET
finefocus-3492	1	112	cyanobacteria	cyanobacteria	NOUN
finefocus-3492	1	113	synthesize	synthesize	NOUN
finefocus-3492	1	114	scytonemin	scytonemin	PROPN
finefocus-3492	1	115	,	,	PUNCT
finefocus-3492	1	116	a	a	DET
finefocus-3492	1	117	protective	protective	ADJ
finefocus-3492	1	118	pigment	pigment	NOUN
finefocus-3492	1	119	against	against	ADP
finefocus-3492	1	120	dna	dna	PROPN
finefocus-3492	1	121	photodamage	photodamage	NOUN
finefocus-3492	1	122	.	.	PUNCT
finefocus-3492	2	1	in	in	ADP
finefocus-3492	2	2	addition	addition	NOUN
finefocus-3492	2	3	to	to	ADP
finefocus-3492	2	4	photoprotection	photoprotection	NOUN
finefocus-3492	2	5	,	,	PUNCT
finefocus-3492	2	6	scytonemin	scytonemin	NOUN
finefocus-3492	2	7	has	have	AUX
finefocus-3492	2	8	been	be	AUX
finefocus-3492	2	9	shown	show	VERB
finefocus-3492	2	10	to	to	PART
finefocus-3492	2	11	have	have	VERB
finefocus-3492	2	12	an	an	DET
finefocus-3492	2	13	anti	anti	ADJ
finefocus-3492	2	14	-	-	ADJ
finefocus-3492	2	15	proliferative	proliferative	ADJ
finefocus-3492	2	16	effect	effect	NOUN
finefocus-3492	2	17	on	on	ADP
finefocus-3492	2	18	various	various	ADJ
finefocus-3492	2	19	types	type	NOUN
finefocus-3492	2	20	of	of	ADP
finefocus-3492	2	21	malignant	malignant	ADJ
finefocus-3492	2	22	cells	cell	NOUN
finefocus-3492	2	23	.	.	PUNCT
finefocus-3492	3	1	in	in	ADP
finefocus-3492	3	2	this	this	DET
finefocus-3492	3	3	study	study	NOUN
finefocus-3492	3	4	the	the	DET
finefocus-3492	3	5	effect	effect	NOUN
finefocus-3492	3	6	of	of	ADP
finefocus-3492	3	7	scytonemin	scytonemin	NOUN
finefocus-3492	3	8	on	on	ADP
finefocus-3492	3	9	melanoma	melanoma	NOUN
finefocus-3492	3	10	and	and	CCONJ
finefocus-3492	3	11	spleen	spleen	NOUN
finefocus-3492	3	12	cells	cell	NOUN
finefocus-3492	3	13	was	be	AUX
finefocus-3492	3	14	assessed	assess	VERB
finefocus-3492	3	15	both	both	CCONJ
finefocus-3492	3	16	in	in	ADP
finefocus-3492	3	17	vitro	vitro	X
finefocus-3492	3	18	using	use	VERB
finefocus-3492	3	19	tissue	tissue	NOUN
finefocus-3492	3	20	cultures	culture	NOUN
finefocus-3492	3	21	and	and	CCONJ
finefocus-3492	3	22	in	in	ADP
finefocus-3492	3	23	vivo	vivo	NOUN
finefocus-3492	3	24	in	in	ADP
finefocus-3492	3	25	mice	mouse	NOUN
finefocus-3492	3	26	models	model	NOUN
finefocus-3492	3	27	.	.	PUNCT
finefocus-3492	4	1	melanoma	melanoma	NOUN
finefocus-3492	4	2	and	and	CCONJ
finefocus-3492	4	3	spleen	spleen	PROPN
finefocus-3492	4	4	cells	cell	NOUN
finefocus-3492	4	5	were	be	AUX
finefocus-3492	4	6	exposed	expose	VERB
finefocus-3492	4	7	to	to	ADP
finefocus-3492	4	8	0.08	0.08	NUM
finefocus-3492	4	9	to	to	PART
finefocus-3492	4	10	10	10	NUM
finefocus-3492	4	11	µm	µm	NOUN
finefocus-3492	4	12	of	of	ADP
finefocus-3492	4	13	scytonemin	scytonemin	NOUN
finefocus-3492	4	14	,	,	PUNCT
finefocus-3492	4	15	and	and	CCONJ
finefocus-3492	4	16	cell	cell	NOUN
finefocus-3492	4	17	proliferation	proliferation	NOUN
finefocus-3492	4	18	was	be	AUX
finefocus-3492	4	19	measured	measure	VERB
finefocus-3492	4	20	using	use	VERB
finefocus-3492	4	21	tritiated	tritiate	VERB
finefocus-3492	4	22	thymidine	thymidine	NOUN
finefocus-3492	4	23	uptake	uptake	NOUN
finefocus-3492	4	24	.	.	PUNCT
finefocus-3492	5	1	the	the	DET
finefocus-3492	5	2	data	datum	NOUN
finefocus-3492	5	3	suggest	suggest	VERB
finefocus-3492	5	4	that	that	SCONJ
finefocus-3492	5	5	scytonemin	scytonemin	NOUN
finefocus-3492	5	6	acts	act	VERB
finefocus-3492	5	7	as	as	ADP
finefocus-3492	5	8	an	an	DET
finefocus-3492	5	9	inhibitor	inhibitor	NOUN
finefocus-3492	5	10	for	for	ADP
finefocus-3492	5	11	melanoma	melanoma	NOUN
finefocus-3492	5	12	cells	cell	NOUN
finefocus-3492	5	13	in	in	ADP
finefocus-3492	5	14	a	a	DET
finefocus-3492	5	15	concentration	concentration	NOUN
finefocus-3492	5	16	-	-	PUNCT
finefocus-3492	5	17	dependent	dependent	ADJ
finefocus-3492	5	18	manner	manner	NOUN
finefocus-3492	5	19	while	while	SCONJ
finefocus-3492	5	20	enhancing	enhance	VERB
finefocus-3492	5	21	the	the	DET
finefocus-3492	5	22	proliferation	proliferation	NOUN
finefocus-3492	5	23	of	of	ADP
finefocus-3492	5	24	spleen	spleen	NOUN
finefocus-3492	5	25	cells	cell	NOUN
finefocus-3492	5	26	,	,	PUNCT
finefocus-3492	5	27	suggesting	suggest	VERB
finefocus-3492	5	28	that	that	SCONJ
finefocus-3492	5	29	it	it	PRON
finefocus-3492	5	30	can	can	AUX
finefocus-3492	5	31	potentially	potentially	ADV
finefocus-3492	5	32	augment	augment	VERB
finefocus-3492	5	33	the	the	DET
finefocus-3492	5	34	immune	immune	ADJ
finefocus-3492	5	35	response	response	NOUN
finefocus-3492	5	36	.	.	PUNCT
finefocus-3492	6	1	furthermore	furthermore	ADV
finefocus-3492	6	2	,	,	PUNCT
finefocus-3492	6	3	mice	mouse	NOUN
finefocus-3492	6	4	injected	inject	VERB
finefocus-3492	6	5	with	with	ADP
finefocus-3492	6	6	melanoma	melanoma	NOUN
finefocus-3492	6	7	cells	cell	NOUN
finefocus-3492	6	8	and	and	CCONJ
finefocus-3492	6	9	scytonemin	scytonemin	NOUN
finefocus-3492	6	10	produced	produce	VERB
finefocus-3492	6	11	fewer	few	ADJ
finefocus-3492	6	12	tumors	tumor	NOUN
finefocus-3492	6	13	than	than	ADP
finefocus-3492	6	14	mice	mouse	NOUN
finefocus-3492	6	15	that	that	PRON
finefocus-3492	6	16	did	do	AUX
finefocus-3492	6	17	not	not	PART
finefocus-3492	6	18	receive	receive	VERB
finefocus-3492	6	19	scytonemin	scytonemin	NOUN
finefocus-3492	6	20	,	,	PUNCT
finefocus-3492	6	21	although	although	SCONJ
finefocus-3492	6	22	the	the	DET
finefocus-3492	6	23	data	datum	NOUN
finefocus-3492	6	24	were	be	AUX
finefocus-3492	6	25	not	not	PART
finefocus-3492	6	26	significant	significant	ADJ
finefocus-3492	6	27	.	.	PUNCT
finefocus-3492	7	1	this	this	DET
finefocus-3492	7	2	study	study	NOUN
finefocus-3492	7	3	adds	add	VERB
finefocus-3492	7	4	to	to	ADP
finefocus-3492	7	5	the	the	DET
finefocus-3492	7	6	growing	grow	VERB
finefocus-3492	7	7	body	body	NOUN
finefocus-3492	7	8	of	of	ADP
finefocus-3492	7	9	research	research	NOUN
finefocus-3492	7	10	that	that	SCONJ
finefocus-3492	7	11	scytonemin	scytonemin	NOUN
finefocus-3492	7	12	may	may	AUX
finefocus-3492	7	13	be	be	AUX
finefocus-3492	7	14	beneficial	beneficial	ADJ
finefocus-3492	7	15	as	as	ADP
finefocus-3492	7	16	a	a	DET
finefocus-3492	7	17	future	future	ADJ
finefocus-3492	7	18	anticancer	anticancer	NOUN
finefocus-3492	7	19	agent	agent	NOUN
finefocus-3492	7	20	to	to	PART
finefocus-3492	7	21	prevent	prevent	VERB
finefocus-3492	7	22	tumor	tumor	NOUN
finefocus-3492	7	23	cell	cell	NOUN
finefocus-3492	7	24	growth	growth	NOUN
finefocus-3492	7	25	.	.	PUNCT
finefocus-3492	8	1	56	56	NUM
finefocus-3492	8	2	|	|	CCONJ
finefocus-3492	8	3	fine	fine	ADJ
finefocus-3492	8	4	focus	focus	NOUN
finefocus-3492	8	5	introduction	introduction	NOUN
finefocus-3492	8	6	according	accord	VERB
finefocus-3492	8	7	to	to	ADP
finefocus-3492	8	8	the	the	DET
finefocus-3492	8	9	centers	center	NOUN
finefocus-3492	8	10	for	for	ADP
finefocus-3492	8	11	disease	disease	NOUN
finefocus-3492	8	12	control	control	NOUN
finefocus-3492	8	13	,	,	PUNCT
finefocus-3492	8	14	skin	skin	NOUN
finefocus-3492	8	15	cancer	cancer	NOUN
finefocus-3492	8	16	is	be	AUX
finefocus-3492	8	17	the	the	DET
finefocus-3492	8	18	most	most	ADV
finefocus-3492	8	19	common	common	ADJ
finefocus-3492	8	20	type	type	NOUN
finefocus-3492	8	21	of	of	ADP
finefocus-3492	8	22	cancer	cancer	NOUN
finefocus-3492	8	23	in	in	ADP
finefocus-3492	8	24	the	the	DET
finefocus-3492	8	25	world	world	NOUN
finefocus-3492	8	26	,	,	PUNCT
finefocus-3492	8	27	with	with	ADP
finefocus-3492	8	28	85,868	85,868	NUM
finefocus-3492	8	29	people	people	NOUN
finefocus-3492	8	30	in	in	ADP
finefocus-3492	8	31	the	the	DET
finefocus-3492	8	32	united	united	PROPN
finefocus-3492	8	33	states	states	PROPN
finefocus-3492	8	34	diagnosed	diagnose	VERB
finefocus-3492	8	35	with	with	ADP
finefocus-3492	8	36	melanomas	melanoma	NOUN
finefocus-3492	8	37	of	of	ADP
finefocus-3492	8	38	the	the	DET
finefocus-3492	8	39	skin	skin	NOUN
finefocus-3492	8	40	in	in	ADP
finefocus-3492	8	41	2017	2017	NUM
finefocus-3492	8	42	(	(	PUNCT
finefocus-3492	8	43	3	3	NUM
finefocus-3492	8	44	)	)	PUNCT
finefocus-3492	8	45	.	.	PUNCT
finefocus-3492	9	1	consequently	consequently	ADV
finefocus-3492	9	2	,	,	PUNCT
finefocus-3492	9	3	the	the	DET
finefocus-3492	9	4	demand	demand	NOUN
finefocus-3492	9	5	for	for	ADP
finefocus-3492	9	6	a	a	DET
finefocus-3492	9	7	product	product	NOUN
finefocus-3492	9	8	that	that	PRON
finefocus-3492	9	9	is	be	AUX
finefocus-3492	9	10	both	both	CCONJ
finefocus-3492	9	11	effective	effective	ADJ
finefocus-3492	9	12	in	in	ADP
finefocus-3492	9	13	killing	kill	VERB
finefocus-3492	9	14	tumor	tumor	NOUN
finefocus-3492	9	15	cells	cell	NOUN
finefocus-3492	9	16	and	and	CCONJ
finefocus-3492	9	17	safe	safe	ADJ
finefocus-3492	9	18	for	for	SCONJ
finefocus-3492	9	19	an	an	DET
finefocus-3492	9	20	individual	individual	NOUN
finefocus-3492	9	21	to	to	PART
finefocus-3492	9	22	take	take	VERB
finefocus-3492	9	23	is	be	AUX
finefocus-3492	9	24	as	as	ADV
finefocus-3492	9	25	great	great	ADJ
finefocus-3492	9	26	as	as	SCONJ
finefocus-3492	9	27	it	it	PRON
finefocus-3492	9	28	has	have	AUX
finefocus-3492	9	29	ever	ever	ADV
finefocus-3492	9	30	been	be	AUX
finefocus-3492	9	31	.	.	PUNCT
finefocus-3492	10	1	since	since	SCONJ
finefocus-3492	10	2	ultraviolet	ultraviolet	ADJ
finefocus-3492	10	3	radiation	radiation	NOUN
finefocus-3492	10	4	(	(	PUNCT
finefocus-3492	10	5	uvr	uvr	NOUN
finefocus-3492	10	6	)	)	PUNCT
finefocus-3492	10	7	plays	play	VERB
finefocus-3492	10	8	a	a	DET
finefocus-3492	10	9	major	major	ADJ
finefocus-3492	10	10	role	role	NOUN
finefocus-3492	10	11	in	in	ADP
finefocus-3492	10	12	skin	skin	NOUN
finefocus-3492	10	13	cancer	cancer	NOUN
finefocus-3492	10	14	,	,	PUNCT
finefocus-3492	10	15	potential	potential	ADJ
finefocus-3492	10	16	treatments	treatment	NOUN
finefocus-3492	10	17	could	could	AUX
finefocus-3492	10	18	explore	explore	VERB
finefocus-3492	10	19	photoprotective	photoprotective	ADJ
finefocus-3492	10	20	effects	effect	NOUN
finefocus-3492	10	21	of	of	ADP
finefocus-3492	10	22	various	various	ADJ
finefocus-3492	10	23	compounds	compound	NOUN
finefocus-3492	10	24	against	against	ADP
finefocus-3492	10	25	solar	solar	ADJ
finefocus-3492	10	26	uvr	uvr	NOUN
finefocus-3492	10	27	.	.	PUNCT
finefocus-3492	11	1	longwavelength	longwavelength	NOUN
finefocus-3492	11	2	(	(	PUNCT
finefocus-3492	11	3	uva	uva	PROPN
finefocus-3492	11	4	)	)	PUNCT
finefocus-3492	11	5	in	in	ADP
finefocus-3492	11	6	the	the	DET
finefocus-3492	11	7	range	range	NOUN
finefocus-3492	11	8	of	of	ADP
finefocus-3492	11	9	320	320	NUM
finefocus-3492	11	10	-	-	SYM
finefocus-3492	11	11	400	400	NUM
finefocus-3492	11	12	nm	nm	NOUN
finefocus-3492	11	13	,	,	PUNCT
finefocus-3492	11	14	plays	play	VERB
finefocus-3492	11	15	a	a	DET
finefocus-3492	11	16	role	role	NOUN
finefocus-3492	11	17	in	in	ADP
finefocus-3492	11	18	longterm	longterm	ADJ
finefocus-3492	11	19	skin	skin	NOUN
finefocus-3492	11	20	damage	damage	NOUN
finefocus-3492	11	21	contributing	contribute	VERB
finefocus-3492	11	22	to	to	ADP
finefocus-3492	11	23	aging	age	VERB
finefocus-3492	11	24	skin	skin	NOUN
finefocus-3492	11	25	due	due	ADP
finefocus-3492	11	26	to	to	ADP
finefocus-3492	11	27	its	its	PRON
finefocus-3492	11	28	deep	deep	ADJ
finefocus-3492	11	29	penetration	penetration	NOUN
finefocus-3492	11	30	of	of	ADP
finefocus-3492	11	31	the	the	DET
finefocus-3492	11	32	epidermis	epidermis	NOUN
finefocus-3492	11	33	and	and	CCONJ
finefocus-3492	11	34	dermis	dermis	NOUN
finefocus-3492	11	35	.	.	PUNCT
finefocus-3492	12	1	uva	uva	PROPN
finefocus-3492	12	2	is	be	AUX
finefocus-3492	12	3	known	know	VERB
finefocus-3492	12	4	to	to	ADP
finefocus-3492	12	5	damage	damage	NOUN
finefocus-3492	12	6	keratinocytes	keratinocyte	NOUN
finefocus-3492	12	7	,	,	PUNCT
finefocus-3492	12	8	which	which	PRON
finefocus-3492	12	9	are	be	AUX
finefocus-3492	12	10	found	find	VERB
finefocus-3492	12	11	in	in	ADP
finefocus-3492	12	12	the	the	DET
finefocus-3492	12	13	basal	basal	ADJ
finefocus-3492	12	14	layer	layer	NOUN
finefocus-3492	12	15	of	of	ADP
finefocus-3492	12	16	the	the	DET
finefocus-3492	12	17	epidermis	epidermis	NOUN
finefocus-3492	12	18	where	where	SCONJ
finefocus-3492	12	19	most	most	ADJ
finefocus-3492	12	20	skin	skin	NOUN
finefocus-3492	12	21	cancers	cancer	NOUN
finefocus-3492	12	22	occur	occur	VERB
finefocus-3492	12	23	(	(	PUNCT
finefocus-3492	12	24	8)	8)	NUM
finefocus-3492	12	25	.	.	PUNCT
finefocus-3492	12	26	shortwavelength	shortwavelength	NOUN
finefocus-3492	12	27	uvb	uvb	ADJ
finefocus-3492	12	28	in	in	ADP
finefocus-3492	12	29	the	the	DET
finefocus-3492	12	30	range	range	NOUN
finefocus-3492	12	31	of	of	ADP
finefocus-3492	12	32	280320	280320	NUM
finefocus-3492	12	33	nm	nm	NOUN
finefocus-3492	12	34	is	be	AUX
finefocus-3492	12	35	the	the	DET
finefocus-3492	12	36	major	major	ADJ
finefocus-3492	12	37	contributor	contributor	NOUN
finefocus-3492	12	38	in	in	ADP
finefocus-3492	12	39	sunburns	sunburn	NOUN
finefocus-3492	12	40	and	and	CCONJ
finefocus-3492	12	41	contributes	contribute	VERB
finefocus-3492	12	42	to	to	ADP
finefocus-3492	12	43	skin	skin	NOUN
finefocus-3492	12	44	cancer	cancer	NOUN
finefocus-3492	12	45	alongside	alongside	ADP
finefocus-3492	12	46	uva	uva	PROPN
finefocus-3492	12	47	by	by	ADP
finefocus-3492	12	48	directly	directly	ADV
finefocus-3492	12	49	damaging	damage	VERB
finefocus-3492	12	50	dna	dna	NOUN
finefocus-3492	12	51	and	and	CCONJ
finefocus-3492	12	52	proteins	protein	NOUN
finefocus-3492	12	53	(	(	PUNCT
finefocus-3492	12	54	17	17	NUM
finefocus-3492	12	55	)	)	PUNCT
finefocus-3492	12	56	.	.	PUNCT
finefocus-3492	13	1	all	all	DET
finefocus-3492	13	2	living	live	VERB
finefocus-3492	13	3	cells	cell	NOUN
finefocus-3492	13	4	,	,	PUNCT
finefocus-3492	13	5	including	include	VERB
finefocus-3492	13	6	bacteria	bacteria	NOUN
finefocus-3492	13	7	,	,	PUNCT
finefocus-3492	13	8	can	can	AUX
finefocus-3492	13	9	be	be	AUX
finefocus-3492	13	10	harmed	harm	VERB
finefocus-3492	13	11	by	by	ADP
finefocus-3492	13	12	uvr	uvr	PROPN
finefocus-3492	13	13	(	(	PUNCT
finefocus-3492	13	14	8)	8)	NUM
finefocus-3492	13	15	.	.	PUNCT
finefocus-3492	14	1	as	as	ADP
finefocus-3492	14	2	photosynthetic	photosynthetic	ADJ
finefocus-3492	14	3	bacteria	bacteria	NOUN
finefocus-3492	14	4	regularly	regularly	ADV
finefocus-3492	14	5	exposed	expose	VERB
finefocus-3492	14	6	to	to	ADP
finefocus-3492	14	7	uvr	uvr	PROPN
finefocus-3492	14	8	,	,	PUNCT
finefocus-3492	14	9	cyanobacteria	cyanobacteria	PROPN
finefocus-3492	14	10	have	have	AUX
finefocus-3492	14	11	developed	develop	VERB
finefocus-3492	14	12	several	several	ADJ
finefocus-3492	14	13	mechanisms	mechanism	NOUN
finefocus-3492	14	14	to	to	PART
finefocus-3492	14	15	defend	defend	VERB
finefocus-3492	14	16	themselves	themselves	PRON
finefocus-3492	14	17	against	against	ADP
finefocus-3492	14	18	its	its	PRON
finefocus-3492	14	19	harmful	harmful	ADJ
finefocus-3492	14	20	effects	effect	NOUN
finefocus-3492	14	21	.	.	PUNCT
finefocus-3492	15	1	these	these	PRON
finefocus-3492	15	2	include	include	VERB
finefocus-3492	15	3	physical	physical	ADJ
finefocus-3492	15	4	migration	migration	NOUN
finefocus-3492	15	5	away	away	ADV
finefocus-3492	15	6	from	from	ADP
finefocus-3492	15	7	uvr	uvr	PROPN
finefocus-3492	15	8	(	(	PUNCT
finefocus-3492	15	9	1	1	NUM
finefocus-3492	15	10	)	)	PUNCT
finefocus-3492	15	11	,	,	PUNCT
finefocus-3492	15	12	synthesis	synthesis	NOUN
finefocus-3492	15	13	of	of	ADP
finefocus-3492	15	14	uv	uv	NOUN
finefocus-3492	15	15	shock	shock	NOUN
finefocus-3492	15	16	proteins	protein	NOUN
finefocus-3492	15	17	(	(	PUNCT
finefocus-3492	15	18	4	4	NUM
finefocus-3492	15	19	)	)	PUNCT
finefocus-3492	15	20	,	,	PUNCT
finefocus-3492	15	21	up	up	ADP
finefocus-3492	15	22	-	-	PUNCT
finefocus-3492	15	23	regulation	regulation	NOUN
finefocus-3492	15	24	of	of	ADP
finefocus-3492	15	25	antioxidant	antioxidant	ADJ
finefocus-3492	15	26	defenses	defense	NOUN
finefocus-3492	15	27	(	(	PUNCT
finefocus-3492	15	28	14	14	NUM
finefocus-3492	15	29	)	)	PUNCT
finefocus-3492	15	30	,	,	PUNCT
finefocus-3492	15	31	and	and	CCONJ
finefocus-3492	15	32	down	down	ADP
finefocus-3492	15	33	-	-	PUNCT
finefocus-3492	15	34	regulation	regulation	NOUN
finefocus-3492	15	35	of	of	ADP
finefocus-3492	15	36	uvrsensitive	uvrsensitive	ADJ
finefocus-3492	15	37	proteins	protein	NOUN
finefocus-3492	15	38	(	(	PUNCT
finefocus-3492	15	39	7	7	NUM
finefocus-3492	15	40	)	)	PUNCT
finefocus-3492	15	41	.	.	PUNCT
finefocus-3492	16	1	of	of	ADP
finefocus-3492	16	2	particular	particular	ADJ
finefocus-3492	16	3	interest	interest	NOUN
finefocus-3492	16	4	is	be	AUX
finefocus-3492	16	5	the	the	DET
finefocus-3492	16	6	ability	ability	NOUN
finefocus-3492	16	7	of	of	ADP
finefocus-3492	16	8	some	some	DET
finefocus-3492	16	9	cyanobacteria	cyanobacteria	NOUN
finefocus-3492	16	10	to	to	PART
finefocus-3492	16	11	synthesize	synthesize	VERB
finefocus-3492	16	12	scytonemin	scytonemin	NOUN
finefocus-3492	16	13	,	,	PUNCT
finefocus-3492	16	14	a	a	DET
finefocus-3492	16	15	photoprotective	photoprotective	ADJ
finefocus-3492	16	16	sheath	sheath	NOUN
finefocus-3492	16	17	pigment	pigment	NOUN
finefocus-3492	16	18	that	that	PRON
finefocus-3492	16	19	protects	protect	VERB
finefocus-3492	16	20	primarily	primarily	ADV
finefocus-3492	16	21	against	against	ADP
finefocus-3492	16	22	uva	uva	PROPN
finefocus-3492	16	23	radiation	radiation	NOUN
finefocus-3492	16	24	(	(	PUNCT
finefocus-3492	16	25	5	5	NUM
finefocus-3492	16	26	)	)	PUNCT
finefocus-3492	16	27	.	.	PUNCT
finefocus-3492	17	1	scytonemin	scytonemin	NOUN
finefocus-3492	17	2	is	be	AUX
finefocus-3492	17	3	a	a	DET
finefocus-3492	17	4	lipophilic	lipophilic	ADJ
finefocus-3492	17	5	,	,	PUNCT
finefocus-3492	17	6	yellow	yellow	ADJ
finefocus-3492	17	7	-	-	PUNCT
finefocus-3492	17	8	brown	brown	ADJ
finefocus-3492	17	9	,	,	PUNCT
finefocus-3492	17	10	indole	indole	ADJ
finefocus-3492	17	11	-	-	PUNCT
finefocus-3492	17	12	alkaloid	alkaloid	NOUN
finefocus-3492	17	13	pigment	pigment	NOUN
finefocus-3492	17	14	(	(	PUNCT
finefocus-3492	17	15	fig	fig	NOUN
finefocus-3492	17	16	.	.	NOUN
finefocus-3492	18	1	1	1	NUM
finefocus-3492	18	2	)	)	PUNCT
finefocus-3492	18	3	(	(	PUNCT
finefocus-3492	18	4	10	10	NUM
finefocus-3492	18	5	)	)	PUNCT
finefocus-3492	18	6	that	that	PRON
finefocus-3492	18	7	efficiently	efficiently	ADV
finefocus-3492	18	8	absorbs	absorb	VERB
finefocus-3492	18	9	uva	uva	PROPN
finefocus-3492	18	10	in	in	ADP
finefocus-3492	18	11	vivo	vivo	NOUN
finefocus-3492	18	12	at	at	ADP
finefocus-3492	18	13	370	370	NUM
finefocus-3492	18	14	nm	nm	NOUN
finefocus-3492	18	15	(	(	PUNCT
finefocus-3492	18	16	6	6	NUM
finefocus-3492	18	17	)	)	PUNCT
finefocus-3492	18	18	.	.	PUNCT
finefocus-3492	19	1	it	it	PRON
finefocus-3492	19	2	is	be	AUX
finefocus-3492	19	3	produced	produce	VERB
finefocus-3492	19	4	by	by	ADP
finefocus-3492	19	5	certain	certain	ADJ
finefocus-3492	19	6	species	specie	NOUN
finefocus-3492	19	7	of	of	ADP
finefocus-3492	19	8	cyanobacteria	cyanobacteria	NOUN
finefocus-3492	19	9	where	where	SCONJ
finefocus-3492	19	10	it	it	PRON
finefocus-3492	19	11	is	be	AUX
finefocus-3492	19	12	induced	induce	VERB
finefocus-3492	19	13	upon	upon	SCONJ
finefocus-3492	19	14	exposure	exposure	NOUN
finefocus-3492	19	15	to	to	ADP
finefocus-3492	19	16	uva	uva	PROPN
finefocus-3492	19	17	,	,	PUNCT
finefocus-3492	19	18	and	and	CCONJ
finefocus-3492	19	19	is	be	AUX
finefocus-3492	19	20	then	then	ADV
finefocus-3492	19	21	deposited	deposit	VERB
finefocus-3492	19	22	into	into	ADP
finefocus-3492	19	23	the	the	DET
finefocus-3492	19	24	sheath	sheath	NOUN
finefocus-3492	19	25	surrounding	surround	VERB
finefocus-3492	19	26	the	the	DET
finefocus-3492	19	27	cells	cell	NOUN
finefocus-3492	19	28	(	(	PUNCT
finefocus-3492	19	29	5	5	NUM
finefocus-3492	19	30	)	)	PUNCT
finefocus-3492	19	31	.	.	PUNCT
finefocus-3492	20	1	in	in	ADP
finefocus-3492	20	2	addition	addition	NOUN
finefocus-3492	20	3	to	to	ADP
finefocus-3492	20	4	its	its	PRON
finefocus-3492	20	5	photoprotective	photoprotective	ADJ
finefocus-3492	20	6	properties	property	NOUN
finefocus-3492	20	7	,	,	PUNCT
finefocus-3492	20	8	scytonemin	scytonemin	NOUN
finefocus-3492	20	9	demonstrates	demonstrate	VERB
finefocus-3492	20	10	antiinflammatory	antiinflammatory	NOUN
finefocus-3492	20	11	and	and	CCONJ
finefocus-3492	20	12	anti	anti	ADJ
finefocus-3492	20	13	-	-	ADJ
finefocus-3492	20	14	proliferative	proliferative	ADJ
finefocus-3492	20	15	qualities	quality	NOUN
finefocus-3492	20	16	.	.	PUNCT
finefocus-3492	21	1	tissue	tissue	NOUN
finefocus-3492	21	2	hyperplasia	hyperplasia	NOUN
finefocus-3492	21	3	is	be	AUX
finefocus-3492	21	4	a	a	DET
finefocus-3492	21	5	hallmark	hallmark	ADJ
finefocus-3492	21	6	feature	feature	NOUN
finefocus-3492	21	7	of	of	ADP
finefocus-3492	21	8	hyperproliferative	hyperproliferative	ADJ
finefocus-3492	21	9	and	and	CCONJ
finefocus-3492	21	10	inflammatory	inflammatory	ADJ
finefocus-3492	21	11	pathologies	pathology	NOUN
finefocus-3492	21	12	,	,	PUNCT
finefocus-3492	21	13	such	such	ADJ
finefocus-3492	21	14	as	as	ADP
finefocus-3492	21	15	rheumatoid	rheumatoid	NOUN
finefocus-3492	21	16	arthritis	arthritis	NOUN
finefocus-3492	21	17	,	,	PUNCT
finefocus-3492	21	18	psoriasis	psoriasis	NOUN
finefocus-3492	21	19	,	,	PUNCT
finefocus-3492	21	20	asthma	asthma	NOUN
finefocus-3492	21	21	,	,	PUNCT
finefocus-3492	21	22	and	and	CCONJ
finefocus-3492	21	23	cancer	cancer	NOUN
finefocus-3492	21	24	(	(	PUNCT
finefocus-3492	21	25	15	15	NUM
finefocus-3492	21	26	)	)	PUNCT
finefocus-3492	21	27	.	.	PUNCT
finefocus-3492	22	1	scytonemin	scytonemin	NOUN
finefocus-3492	22	2	has	have	AUX
finefocus-3492	22	3	been	be	AUX
finefocus-3492	22	4	shown	show	VERB
finefocus-3492	22	5	to	to	PART
finefocus-3492	22	6	exhibit	exhibit	VERB
finefocus-3492	22	7	anti	anti	ADJ
finefocus-3492	22	8	-	-	ADJ
finefocus-3492	22	9	inflammatory	inflammatory	ADJ
finefocus-3492	22	10	properties	property	NOUN
finefocus-3492	22	11	that	that	PRON
finefocus-3492	22	12	could	could	AUX
finefocus-3492	22	13	potentially	potentially	ADV
finefocus-3492	22	14	treat	treat	VERB
finefocus-3492	22	15	these	these	DET
finefocus-3492	22	16	diseases	disease	NOUN
finefocus-3492	22	17	(	(	PUNCT
finefocus-3492	22	18	11	11	NUM
finefocus-3492	22	19	,	,	PUNCT
finefocus-3492	22	20	15	15	NUM
finefocus-3492	22	21	,	,	PUNCT
finefocus-3492	22	22	16	16	NUM
finefocus-3492	22	23	)	)	PUNCT
finefocus-3492	22	24	.	.	PUNCT
finefocus-3492	23	1	for	for	ADP
finefocus-3492	23	2	example	example	NOUN
finefocus-3492	23	3	,	,	PUNCT
finefocus-3492	23	4	the	the	DET
finefocus-3492	23	5	topical	topical	ADJ
finefocus-3492	23	6	application	application	NOUN
finefocus-3492	23	7	of	of	ADP
finefocus-3492	23	8	scytonemin	scytonemin	NOUN
finefocus-3492	23	9	on	on	ADP
finefocus-3492	23	10	mouse	mouse	PROPN
finefocus-3492	23	11	ear	ear	NOUN
finefocus-3492	23	12	edema	edema	PROPN
finefocus-3492	23	13	reduced	reduce	VERB
finefocus-3492	23	14	swelling	swell	VERB
finefocus-3492	23	15	compared	compare	VERB
finefocus-3492	23	16	to	to	ADP
finefocus-3492	23	17	mice	mouse	NOUN
finefocus-3492	23	18	receiving	receive	VERB
finefocus-3492	23	19	no	no	DET
finefocus-3492	23	20	treatment	treatment	NOUN
finefocus-3492	23	21	(	(	PUNCT
finefocus-3492	23	22	16	16	NUM
finefocus-3492	23	23	)	)	PUNCT
finefocus-3492	23	24	.	.	PUNCT
finefocus-3492	24	1	furthermore	furthermore	ADV
finefocus-3492	24	2	,	,	PUNCT
finefocus-3492	24	3	several	several	ADJ
finefocus-3492	24	4	studies	study	NOUN
finefocus-3492	24	5	argue	argue	VERB
finefocus-3492	24	6	that	that	SCONJ
finefocus-3492	24	7	scytonemin	scytonemin	PROPN
finefocus-3492	24	8	inhibits	inhibit	VERB
finefocus-3492	24	9	cell	cell	NOUN
finefocus-3492	24	10	proliferation	proliferation	NOUN
finefocus-3492	24	11	through	through	ADP
finefocus-3492	24	12	mechanisms	mechanism	NOUN
finefocus-3492	24	13	of	of	ADP
finefocus-3492	24	14	cell	cell	NOUN
finefocus-3492	24	15	cycle	cycle	NOUN
finefocus-3492	24	16	arrest	arrest	NOUN
finefocus-3492	24	17	(	(	PUNCT
finefocus-3492	24	18	15	15	NUM
finefocus-3492	24	19	,	,	PUNCT
finefocus-3492	24	20	16	16	NUM
finefocus-3492	24	21	,	,	PUNCT
finefocus-3492	24	22	18	18	NUM
finefocus-3492	24	23	,	,	PUNCT
finefocus-3492	24	24	19	19	NUM
finefocus-3492	24	25	)	)	PUNCT
finefocus-3492	24	26	.	.	PUNCT
finefocus-3492	25	1	scytonemin	scytonemin	NOUN
finefocus-3492	25	2	has	have	AUX
finefocus-3492	25	3	also	also	ADV
finefocus-3492	25	4	been	be	AUX
finefocus-3492	25	5	shown	show	VERB
finefocus-3492	25	6	to	to	PART
finefocus-3492	25	7	interrupt	interrupt	VERB
finefocus-3492	25	8	hyperproliferation	hyperproliferation	NOUN
finefocus-3492	25	9	of	of	ADP
finefocus-3492	25	10	renal	renal	ADJ
finefocus-3492	25	11	cancer	cancer	NOUN
finefocus-3492	25	12	cells	cell	NOUN
finefocus-3492	25	13	(	(	PUNCT
finefocus-3492	25	14	18	18	NUM
finefocus-3492	25	15	)	)	PUNCT
finefocus-3492	25	16	and	and	CCONJ
finefocus-3492	25	17	slow	slow	VERB
finefocus-3492	25	18	the	the	DET
finefocus-3492	25	19	proliferation	proliferation	NOUN
finefocus-3492	25	20	of	of	ADP
finefocus-3492	25	21	multiple	multiple	ADJ
finefocus-3492	25	22	myeloma	myeloma	NOUN
finefocus-3492	25	23	cells	cell	NOUN
finefocus-3492	25	24	(	(	PUNCT
finefocus-3492	25	25	19	19	NUM
finefocus-3492	25	26	)	)	PUNCT
finefocus-3492	25	27	.	.	PUNCT
finefocus-3492	26	1	possibly	possibly	ADV
finefocus-3492	26	2	the	the	DET
finefocus-3492	26	3	most	most	ADV
finefocus-3492	26	4	thorough	thorough	ADJ
finefocus-3492	26	5	study	study	NOUN
finefocus-3492	26	6	on	on	ADP
finefocus-3492	26	7	the	the	DET
finefocus-3492	26	8	anti	anti	ADJ
finefocus-3492	26	9	-	-	ADJ
finefocus-3492	26	10	proliferative	proliferative	ADJ
finefocus-3492	26	11	properties	property	NOUN
finefocus-3492	26	12	of	of	ADP
finefocus-3492	26	13	scytonemin	scytonemin	NOUN
finefocus-3492	26	14	was	be	AUX
finefocus-3492	26	15	that	that	SCONJ
finefocus-3492	26	16	it	it	PRON
finefocus-3492	26	17	could	could	AUX
finefocus-3492	26	18	hinder	hinder	VERB
finefocus-3492	26	19	actively	actively	ADV
finefocus-3492	26	20	proliferating	proliferate	VERB
finefocus-3492	26	21	cells	cell	NOUN
finefocus-3492	26	22	,	,	PUNCT
finefocus-3492	26	23	including	include	VERB
finefocus-3492	26	24	malignant	malignant	ADJ
finefocus-3492	26	25	jurkat	jurkat	PROPN
finefocus-3492	26	26	t	t	PROPN
finefocus-3492	26	27	cells	cell	NOUN
finefocus-3492	26	28	,	,	PUNCT
finefocus-3492	26	29	rheumatoid	rheumatoid	ADJ
finefocus-3492	26	30	synovial	synovial	ADJ
finefocus-3492	26	31	fibroblasts	fibroblast	NOUN
finefocus-3492	26	32	implicated	implicate	VERB
finefocus-3492	26	33	in	in	ADP
finefocus-3492	26	34	arthritis	arthritis	NOUN
finefocus-3492	26	35	,	,	PUNCT
finefocus-3492	26	36	human	human	ADJ
finefocus-3492	26	37	lung	lung	NOUN
finefocus-3492	26	38	fibroblasts	fibroblast	NOUN
finefocus-3492	26	39	,	,	PUNCT
finefocus-3492	26	40	and	and	CCONJ
finefocus-3492	26	41	human	human	ADJ
finefocus-3492	26	42	umbilical	umbilical	ADJ
finefocus-3492	26	43	vein	vein	ADJ
finefocus-3492	26	44	endothelial	endothelial	ADJ
finefocus-3492	26	45	cells	cell	NOUN
finefocus-3492	26	46	.	.	PUNCT
finefocus-3492	27	1	this	this	DET
finefocus-3492	27	2	study	study	NOUN
finefocus-3492	27	3	also	also	ADV
finefocus-3492	27	4	demonstrated	demonstrate	VERB
finefocus-3492	27	5	that	that	SCONJ
finefocus-3492	27	6	scytonemin	scytonemin	NOUN
finefocus-3492	27	7	was	be	AUX
finefocus-3492	27	8	not	not	PART
finefocus-3492	27	9	cytotoxic	cytotoxic	ADJ
finefocus-3492	27	10	towards	towards	ADP
finefocus-3492	27	11	non	non	ADJ
finefocus-3492	27	12	-	-	ADJ
finefocus-3492	27	13	proliferative	proliferative	ADJ
finefocus-3492	27	14	human	human	ADJ
finefocus-3492	27	15	monocytes	monocyte	NOUN
finefocus-3492	27	16	(	(	PUNCT
finefocus-3492	27	17	15	15	NUM
finefocus-3492	27	18	)	)	PUNCT
finefocus-3492	27	19	.	.	PUNCT
finefocus-3492	28	1	these	these	DET
finefocus-3492	28	2	results	result	NOUN
finefocus-3492	28	3	convey	convey	VERB
finefocus-3492	28	4	the	the	DET
finefocus-3492	28	5	possibility	possibility	NOUN
finefocus-3492	28	6	for	for	SCONJ
finefocus-3492	28	7	scytonemin	scytonemin	NOUN
finefocus-3492	28	8	to	to	PART
finefocus-3492	28	9	halt	halt	VERB
finefocus-3492	28	10	malignant	malignant	ADJ
finefocus-3492	28	11	cell	cell	NOUN
finefocus-3492	28	12	growth	growth	NOUN
finefocus-3492	28	13	without	without	ADP
finefocus-3492	28	14	harming	harm	VERB
finefocus-3492	28	15	other	other	ADJ
finefocus-3492	28	16	body	body	NOUN
finefocus-3492	28	17	cells	cell	NOUN
finefocus-3492	28	18	,	,	PUNCT
finefocus-3492	28	19	which	which	PRON
finefocus-3492	28	20	is	be	AUX
finefocus-3492	28	21	a	a	DET
finefocus-3492	28	22	quality	quality	NOUN
finefocus-3492	28	23	particularly	particularly	ADV
finefocus-3492	28	24	sought	seek	VERB
finefocus-3492	28	25	after	after	ADV
finefocus-3492	28	26	in	in	ADP
finefocus-3492	28	27	cancer	cancer	NOUN
finefocus-3492	28	28	treatment	treatment	NOUN
finefocus-3492	28	29	research	research	NOUN
finefocus-3492	28	30	.	.	PUNCT
finefocus-3492	29	1	figure	figure	NOUN
finefocus-3492	29	2	1	1	NUM
finefocus-3492	29	3	.	.	PUNCT
finefocus-3492	29	4	figure	figure	NOUN
finefocus-3492	29	5	1	1	NUM
finefocus-3492	29	6	.	.	PUNCT
finefocus-3492	30	1	structure	structure	NOUN
finefocus-3492	30	2	of	of	ADP
finefocus-3492	30	3	scytonemin	scytonemin	NOUN
finefocus-3492	30	4	(	(	PUNCT
finefocus-3492	30	5	proteau	proteau	NOUN
finefocus-3492	30	6	et	et	PROPN
finefocus-3492	30	7	.	.	PUNCT
finefocus-3492	31	1	al	al	PROPN
finefocus-3492	31	2	.	.	PROPN
finefocus-3492	31	3	1993	1993	NUM
finefocus-3492	31	4	)	)	PUNCT
finefocus-3492	31	5	.	.	PUNCT
finefocus-3492	32	1	volume	volume	NOUN
finefocus-3492	32	2	seven	seven	NUM
finefocus-3492	33	1	|	|	ADV
finefocus-3492	33	2	57	57	NUM
finefocus-3492	33	3	since	since	SCONJ
finefocus-3492	33	4	the	the	DET
finefocus-3492	33	5	literature	literature	NOUN
finefocus-3492	33	6	suggests	suggest	VERB
finefocus-3492	33	7	that	that	SCONJ
finefocus-3492	33	8	the	the	DET
finefocus-3492	33	9	uvprotective	uvprotective	ADJ
finefocus-3492	33	10	agent	agent	NOUN
finefocus-3492	33	11	scytonemin	scytonemin	NOUN
finefocus-3492	33	12	is	be	AUX
finefocus-3492	33	13	implicated	implicate	VERB
finefocus-3492	33	14	in	in	ADP
finefocus-3492	33	15	cell	cell	NOUN
finefocus-3492	33	16	cycle	cycle	NOUN
finefocus-3492	33	17	arrest	arrest	NOUN
finefocus-3492	33	18	,	,	PUNCT
finefocus-3492	33	19	this	this	DET
finefocus-3492	33	20	study	study	NOUN
finefocus-3492	33	21	seeks	seek	VERB
finefocus-3492	33	22	to	to	PART
finefocus-3492	33	23	determine	determine	VERB
finefocus-3492	33	24	whether	whether	SCONJ
finefocus-3492	33	25	scytonemin	scytonemin	NOUN
finefocus-3492	33	26	will	will	AUX
finefocus-3492	33	27	have	have	VERB
finefocus-3492	33	28	anti	anti	ADJ
finefocus-3492	33	29	-	-	ADJ
finefocus-3492	33	30	proliferative	proliferative	ADJ
finefocus-3492	33	31	effects	effect	NOUN
finefocus-3492	33	32	against	against	ADP
finefocus-3492	33	33	melanoma	melanoma	NOUN
finefocus-3492	33	34	cell	cell	NOUN
finefocus-3492	33	35	growth	growth	NOUN
finefocus-3492	33	36	in	in	ADP
finefocus-3492	33	37	animals	animal	NOUN
finefocus-3492	33	38	.	.	PUNCT
finefocus-3492	34	1	therefore	therefore	ADV
finefocus-3492	34	2	,	,	PUNCT
finefocus-3492	34	3	the	the	DET
finefocus-3492	34	4	objectives	objective	NOUN
finefocus-3492	34	5	of	of	ADP
finefocus-3492	34	6	this	this	DET
finefocus-3492	34	7	study	study	NOUN
finefocus-3492	34	8	were	be	AUX
finefocus-3492	34	9	to	to	PART
finefocus-3492	34	10	examine	examine	VERB
finefocus-3492	34	11	both	both	DET
finefocus-3492	34	12	the	the	DET
finefocus-3492	34	13	in	in	ADV
finefocus-3492	34	14	vitro	vitro	X
finefocus-3492	34	15	melanoma	melanoma	NOUN
finefocus-3492	34	16	and	and	CCONJ
finefocus-3492	34	17	spleen	spleen	NOUN
finefocus-3492	34	18	cell	cell	NOUN
finefocus-3492	34	19	proliferation	proliferation	NOUN
finefocus-3492	34	20	in	in	ADP
finefocus-3492	34	21	the	the	DET
finefocus-3492	34	22	presence	presence	NOUN
finefocus-3492	34	23	of	of	ADP
finefocus-3492	34	24	different	different	ADJ
finefocus-3492	34	25	concentrations	concentration	NOUN
finefocus-3492	34	26	of	of	ADP
finefocus-3492	34	27	scytonemin	scytonemin	NOUN
finefocus-3492	34	28	,	,	PUNCT
finefocus-3492	34	29	as	as	ADV
finefocus-3492	34	30	well	well	ADV
finefocus-3492	34	31	as	as	ADP
finefocus-3492	34	32	the	the	DET
finefocus-3492	34	33	in	in	ADP
finefocus-3492	34	34	vivo	vivo	ADJ
finefocus-3492	34	35	effect	effect	NOUN
finefocus-3492	34	36	of	of	ADP
finefocus-3492	34	37	scytonemin	scytonemin	NOUN
finefocus-3492	34	38	on	on	ADP
finefocus-3492	34	39	tumor	tumor	NOUN
finefocus-3492	34	40	growth	growth	NOUN
finefocus-3492	34	41	in	in	ADP
finefocus-3492	34	42	mice	mouse	NOUN
finefocus-3492	34	43	.	.	PUNCT
finefocus-3492	35	1	if	if	SCONJ
finefocus-3492	35	2	scytonemin	scytonemin	NOUN
finefocus-3492	35	3	inhibits	inhibit	VERB
finefocus-3492	35	4	melanoma	melanoma	NOUN
finefocus-3492	35	5	cell	cell	NOUN
finefocus-3492	35	6	proliferation	proliferation	NOUN
finefocus-3492	35	7	without	without	ADP
finefocus-3492	35	8	equally	equally	ADV
finefocus-3492	35	9	inhibiting	inhibit	VERB
finefocus-3492	35	10	spleen	spleen	NOUN
finefocus-3492	35	11	cell	cell	NOUN
finefocus-3492	35	12	proliferation	proliferation	NOUN
finefocus-3492	35	13	,	,	PUNCT
finefocus-3492	35	14	then	then	ADV
finefocus-3492	35	15	it	it	PRON
finefocus-3492	35	16	has	have	VERB
finefocus-3492	35	17	potential	potential	ADJ
finefocus-3492	35	18	as	as	ADP
finefocus-3492	35	19	a	a	DET
finefocus-3492	35	20	future	future	ADJ
finefocus-3492	35	21	therapy	therapy	NOUN
finefocus-3492	35	22	for	for	ADP
finefocus-3492	35	23	malignant	malignant	ADJ
finefocus-3492	35	24	cells	cell	NOUN
finefocus-3492	35	25	and	and	CCONJ
finefocus-3492	35	26	should	should	AUX
finefocus-3492	35	27	be	be	AUX
finefocus-3492	35	28	further	far	ADV
finefocus-3492	35	29	explored	explore	VERB
finefocus-3492	35	30	as	as	ADP
finefocus-3492	35	31	an	an	DET
finefocus-3492	35	32	anti	anti	ADJ
finefocus-3492	35	33	-	-	ADJ
finefocus-3492	35	34	tumor	tumor	ADJ
finefocus-3492	35	35	therapy	therapy	NOUN
finefocus-3492	35	36	.	.	PUNCT
finefocus-3492	36	1	however	however	ADV
finefocus-3492	36	2	,	,	PUNCT
finefocus-3492	36	3	if	if	SCONJ
finefocus-3492	36	4	scytonemin	scytonemin	NOUN
finefocus-3492	36	5	affects	affect	VERB
finefocus-3492	36	6	melanoma	melanoma	NOUN
finefocus-3492	36	7	and	and	CCONJ
finefocus-3492	36	8	spleen	spleen	NOUN
finefocus-3492	36	9	cells	cell	NOUN
finefocus-3492	36	10	alike	alike	ADV
finefocus-3492	36	11	,	,	PUNCT
finefocus-3492	36	12	then	then	ADV
finefocus-3492	36	13	it	it	PRON
finefocus-3492	36	14	could	could	AUX
finefocus-3492	36	15	potentially	potentially	ADV
finefocus-3492	36	16	harm	harm	VERB
finefocus-3492	36	17	tissue	tissue	NOUN
finefocus-3492	36	18	and	and	CCONJ
finefocus-3492	36	19	might	might	AUX
finefocus-3492	36	20	not	not	PART
finefocus-3492	36	21	result	result	VERB
finefocus-3492	36	22	in	in	ADP
finefocus-3492	36	23	the	the	DET
finefocus-3492	36	24	production	production	NOUN
finefocus-3492	36	25	of	of	ADP
finefocus-3492	36	26	an	an	DET
finefocus-3492	36	27	effective	effective	ADJ
finefocus-3492	36	28	therapy	therapy	NOUN
finefocus-3492	36	29	.	.	PUNCT
finefocus-3492	37	1	while	while	SCONJ
finefocus-3492	37	2	the	the	DET
finefocus-3492	37	3	findings	finding	NOUN
finefocus-3492	37	4	of	of	ADP
finefocus-3492	37	5	other	other	ADJ
finefocus-3492	37	6	studies	study	NOUN
finefocus-3492	37	7	already	already	ADV
finefocus-3492	37	8	indicate	indicate	VERB
finefocus-3492	37	9	that	that	SCONJ
finefocus-3492	37	10	scytonemin	scytonemin	NOUN
finefocus-3492	37	11	slows	slow	VERB
finefocus-3492	37	12	malignant	malignant	ADJ
finefocus-3492	37	13	proliferation	proliferation	NOUN
finefocus-3492	37	14	(	(	PUNCT
finefocus-3492	37	15	15	15	NUM
finefocus-3492	37	16	,	,	PUNCT
finefocus-3492	37	17	16	16	NUM
finefocus-3492	37	18	,	,	PUNCT
finefocus-3492	37	19	18	18	NUM
finefocus-3492	37	20	,	,	PUNCT
finefocus-3492	37	21	19	19	NUM
finefocus-3492	37	22	)	)	PUNCT
finefocus-3492	37	23	,	,	PUNCT
finefocus-3492	37	24	this	this	DET
finefocus-3492	37	25	study	study	NOUN
finefocus-3492	37	26	takes	take	VERB
finefocus-3492	37	27	a	a	DET
finefocus-3492	37	28	slightly	slightly	ADV
finefocus-3492	37	29	different	different	ADJ
finefocus-3492	37	30	angle	angle	NOUN
finefocus-3492	37	31	by	by	ADP
finefocus-3492	37	32	comparing	compare	VERB
finefocus-3492	37	33	the	the	DET
finefocus-3492	37	34	effects	effect	NOUN
finefocus-3492	37	35	of	of	ADP
finefocus-3492	37	36	scytonemin	scytonemin	NOUN
finefocus-3492	37	37	on	on	ADP
finefocus-3492	37	38	cancerous	cancerous	ADJ
finefocus-3492	37	39	cell	cell	NOUN
finefocus-3492	37	40	proliferation	proliferation	NOUN
finefocus-3492	37	41	(	(	PUNCT
finefocus-3492	37	42	i.e.	i.e.	X
finefocus-3492	37	43	,	,	PUNCT
finefocus-3492	37	44	melanomas	melanoma	NOUN
finefocus-3492	37	45	)	)	PUNCT
finefocus-3492	37	46	to	to	ADP
finefocus-3492	37	47	healthy	healthy	ADJ
finefocus-3492	37	48	noncancerous	noncancerous	ADJ
finefocus-3492	37	49	cell	cell	NOUN
finefocus-3492	37	50	growth	growth	NOUN
finefocus-3492	37	51	(	(	PUNCT
finefocus-3492	37	52	i.e.	i.e.	X
finefocus-3492	37	53	,	,	PUNCT
finefocus-3492	37	54	spleen	spleen	NOUN
finefocus-3492	37	55	cells	cell	NOUN
finefocus-3492	37	56	)	)	PUNCT
finefocus-3492	37	57	from	from	ADP
finefocus-3492	37	58	other	other	ADJ
finefocus-3492	37	59	tissues	tissue	NOUN
finefocus-3492	37	60	in	in	ADP
finefocus-3492	37	61	the	the	DET
finefocus-3492	37	62	same	same	ADJ
finefocus-3492	37	63	organism	organism	NOUN
finefocus-3492	37	64	.	.	PUNCT
finefocus-3492	38	1	spleen	spleen	NOUN
finefocus-3492	38	2	cells	cell	NOUN
finefocus-3492	38	3	were	be	AUX
finefocus-3492	38	4	chosen	choose	VERB
finefocus-3492	38	5	over	over	ADP
finefocus-3492	38	6	skin	skin	NOUN
finefocus-3492	38	7	cells	cell	NOUN
finefocus-3492	38	8	,	,	PUNCT
finefocus-3492	38	9	for	for	ADP
finefocus-3492	38	10	example	example	NOUN
finefocus-3492	38	11	,	,	PUNCT
finefocus-3492	38	12	as	as	ADP
finefocus-3492	38	13	the	the	DET
finefocus-3492	38	14	healthy	healthy	ADJ
finefocus-3492	38	15	non	non	ADJ
finefocus-3492	38	16	-	-	ADJ
finefocus-3492	38	17	cancerous	cancerous	ADJ
finefocus-3492	38	18	control	control	NOUN
finefocus-3492	38	19	cells	cell	NOUN
finefocus-3492	38	20	because	because	SCONJ
finefocus-3492	38	21	they	they	PRON
finefocus-3492	38	22	are	be	AUX
finefocus-3492	38	23	more	more	ADV
finefocus-3492	38	24	likely	likely	ADJ
finefocus-3492	38	25	to	to	PART
finefocus-3492	38	26	interact	interact	VERB
finefocus-3492	38	27	with	with	ADP
finefocus-3492	38	28	a	a	DET
finefocus-3492	38	29	therapeutic	therapeutic	ADJ
finefocus-3492	38	30	agent	agent	NOUN
finefocus-3492	38	31	that	that	PRON
finefocus-3492	38	32	enters	enter	VERB
finefocus-3492	38	33	the	the	DET
finefocus-3492	38	34	bloodstream	bloodstream	NOUN
finefocus-3492	38	35	.	.	PUNCT
finefocus-3492	39	1	furthermore	furthermore	ADV
finefocus-3492	39	2	,	,	PUNCT
finefocus-3492	39	3	the	the	DET
finefocus-3492	39	4	spleen	spleen	NOUN
finefocus-3492	39	5	plays	play	VERB
finefocus-3492	39	6	a	a	DET
finefocus-3492	39	7	critical	critical	ADJ
finefocus-3492	39	8	role	role	NOUN
finefocus-3492	39	9	in	in	ADP
finefocus-3492	39	10	activating	activate	VERB
finefocus-3492	39	11	immune	immune	ADJ
finefocus-3492	39	12	cells	cell	NOUN
finefocus-3492	39	13	in	in	ADP
finefocus-3492	39	14	response	response	NOUN
finefocus-3492	39	15	to	to	ADP
finefocus-3492	39	16	bloodborne	bloodborne	ADJ
finefocus-3492	39	17	antigens	antigen	NOUN
finefocus-3492	39	18	.	.	PUNCT
finefocus-3492	40	1	therefore	therefore	ADV
finefocus-3492	40	2	,	,	PUNCT
finefocus-3492	40	3	the	the	DET
finefocus-3492	40	4	hypothesis	hypothesis	NOUN
finefocus-3492	40	5	of	of	ADP
finefocus-3492	40	6	this	this	DET
finefocus-3492	40	7	study	study	NOUN
finefocus-3492	40	8	is	be	AUX
finefocus-3492	40	9	that	that	SCONJ
finefocus-3492	40	10	in	in	ADP
finefocus-3492	40	11	the	the	DET
finefocus-3492	40	12	presence	presence	NOUN
finefocus-3492	40	13	of	of	ADP
finefocus-3492	40	14	scytonemin	scytonemin	NOUN
finefocus-3492	40	15	,	,	PUNCT
finefocus-3492	40	16	melanoma	melanoma	NOUN
finefocus-3492	40	17	growth	growth	NOUN
finefocus-3492	40	18	will	will	AUX
finefocus-3492	40	19	decrease	decrease	VERB
finefocus-3492	40	20	in	in	ADP
finefocus-3492	40	21	tissues	tissue	NOUN
finefocus-3492	40	22	and	and	CCONJ
finefocus-3492	40	23	animals	animal	NOUN
finefocus-3492	40	24	while	while	SCONJ
finefocus-3492	40	25	spleen	spleen	NOUN
finefocus-3492	40	26	cell	cell	NOUN
finefocus-3492	40	27	proliferation	proliferation	NOUN
finefocus-3492	40	28	will	will	AUX
finefocus-3492	40	29	increase	increase	VERB
finefocus-3492	40	30	.	.	PUNCT
finefocus-3492	41	1	methods	method	NOUN
finefocus-3492	41	2	melanoma	melanoma	VERB
finefocus-3492	41	3	and	and	CCONJ
finefocus-3492	41	4	spleen	spleen	NOUN
finefocus-3492	41	5	cell	cell	NOUN
finefocus-3492	41	6	assays	assay	NOUN
finefocus-3492	41	7	b16	b16	NOUN
finefocus-3492	41	8	-	-	PUNCT
finefocus-3492	41	9	f1	f1	NOUN
finefocus-3492	41	10	melanoma	melanoma	NOUN
finefocus-3492	41	11	cells	cell	NOUN
finefocus-3492	41	12	were	be	AUX
finefocus-3492	41	13	purchased	purchase	VERB
finefocus-3492	41	14	from	from	ADP
finefocus-3492	41	15	the	the	DET
finefocus-3492	41	16	american	american	ADJ
finefocus-3492	41	17	type	type	NOUN
finefocus-3492	41	18	culture	culture	NOUN
finefocus-3492	41	19	collection	collection	NOUN
finefocus-3492	41	20	(	(	PUNCT
finefocus-3492	41	21	atcc	atcc	NOUN
finefocus-3492	41	22	©	©	PROPN
finefocus-3492	41	23	crl-6323	crl-6323	NOUN
finefocus-3492	41	24	)	)	PUNCT
finefocus-3492	42	1	(	(	PUNCT
finefocus-3492	42	2	2	2	NUM
finefocus-3492	42	3	)	)	PUNCT
finefocus-3492	42	4	.	.	PUNCT
finefocus-3492	43	1	spleen	spleen	NOUN
finefocus-3492	43	2	cells	cell	NOUN
finefocus-3492	43	3	were	be	AUX
finefocus-3492	43	4	extracted	extract	VERB
finefocus-3492	43	5	from	from	ADP
finefocus-3492	43	6	male	male	ADJ
finefocus-3492	43	7	c57bl/6	c57bl/6	NOUN
finefocus-3492	43	8	mice	mouse	NOUN
finefocus-3492	43	9	obtained	obtain	VERB
finefocus-3492	43	10	from	from	ADP
finefocus-3492	43	11	charles	charles	PROPN
finefocus-3492	43	12	river	river	PROPN
finefocus-3492	43	13	labs	lab	NOUN
finefocus-3492	43	14	that	that	PRON
finefocus-3492	43	15	were	be	AUX
finefocus-3492	43	16	4	4	NUM
finefocus-3492	43	17	-	-	SYM
finefocus-3492	43	18	6	6	NUM
finefocus-3492	43	19	months	month	NOUN
finefocus-3492	43	20	old	old	ADJ
finefocus-3492	43	21	at	at	ADP
finefocus-3492	43	22	the	the	DET
finefocus-3492	43	23	time	time	NOUN
finefocus-3492	43	24	of	of	ADP
finefocus-3492	43	25	extraction	extraction	NOUN
finefocus-3492	43	26	.	.	PUNCT
finefocus-3492	44	1	for	for	ADP
finefocus-3492	44	2	each	each	DET
finefocus-3492	44	3	assay	assay	NOUN
finefocus-3492	44	4	,	,	PUNCT
finefocus-3492	44	5	a	a	DET
finefocus-3492	44	6	final	final	ADJ
finefocus-3492	44	7	concentration	concentration	NOUN
finefocus-3492	44	8	of	of	ADP
finefocus-3492	44	9	5	5	NUM
finefocus-3492	44	10	x	x	SYM
finefocus-3492	44	11	104	104	NUM
finefocus-3492	44	12	melanoma	melanoma	NOUN
finefocus-3492	44	13	or	or	CCONJ
finefocus-3492	44	14	1	1	NUM
finefocus-3492	44	15	x	x	SYM
finefocus-3492	44	16	106	106	NUM
finefocus-3492	44	17	spleen	spleen	NOUN
finefocus-3492	44	18	cells	cell	NOUN
finefocus-3492	44	19	were	be	AUX
finefocus-3492	44	20	placed	place	VERB
finefocus-3492	44	21	in	in	ADP
finefocus-3492	44	22	each	each	DET
finefocus-3492	44	23	well	well	NOUN
finefocus-3492	44	24	of	of	ADP
finefocus-3492	44	25	a	a	DET
finefocus-3492	44	26	96	96	NUM
finefocus-3492	44	27	-	-	PUNCT
finefocus-3492	44	28	well	well	NOUN
finefocus-3492	44	29	plate	plate	NOUN
finefocus-3492	44	30	and	and	CCONJ
finefocus-3492	44	31	assayed	assayed	ADJ
finefocus-3492	44	32	in	in	ADP
finefocus-3492	44	33	triplicate	triplicate	NOUN
finefocus-3492	44	34	for	for	ADP
finefocus-3492	44	35	each	each	DET
finefocus-3492	44	36	condition	condition	NOUN
finefocus-3492	44	37	.	.	PUNCT
finefocus-3492	45	1	samples	sample	NOUN
finefocus-3492	45	2	treated	treat	VERB
finefocus-3492	45	3	with	with	ADP
finefocus-3492	45	4	scytonemin	scytonemin	NOUN
finefocus-3492	45	5	received	receive	VERB
finefocus-3492	45	6	10	10	NUM
finefocus-3492	45	7	μl	μl	ADP
finefocus-3492	45	8	hplcpurified	hplcpurifie	VERB
finefocus-3492	45	9	scytonemin	scytonemin	NOUN
finefocus-3492	45	10	(	(	PUNCT
finefocus-3492	45	11	a	a	DET
finefocus-3492	45	12	gift	gift	NOUN
finefocus-3492	45	13	from	from	ADP
finefocus-3492	45	14	benjamin	benjamin	PROPN
finefocus-3492	45	15	philmus	philmus	PROPN
finefocus-3492	45	16	,	,	PUNCT
finefocus-3492	45	17	oregon	oregon	PROPN
finefocus-3492	45	18	state	state	PROPN
finefocus-3492	45	19	university	university	PROPN
finefocus-3492	45	20	)	)	PUNCT
finefocus-3492	45	21	diluted	dilute	VERB
finefocus-3492	45	22	in	in	ADP
finefocus-3492	45	23	dmso	dmso	NOUN
finefocus-3492	45	24	with	with	ADP
finefocus-3492	45	25	final	final	ADJ
finefocus-3492	45	26	concentrations	concentration	NOUN
finefocus-3492	45	27	of	of	ADP
finefocus-3492	45	28	10	10	NUM
finefocus-3492	45	29	to	to	PART
finefocus-3492	45	30	0.08	0.08	NUM
finefocus-3492	45	31	µm	µm	NOUN
finefocus-3492	45	32	.	.	PUNCT
finefocus-3492	46	1	to	to	PART
finefocus-3492	46	2	better	well	ADV
finefocus-3492	46	3	determine	determine	VERB
finefocus-3492	46	4	the	the	DET
finefocus-3492	46	5	effect	effect	NOUN
finefocus-3492	46	6	of	of	ADP
finefocus-3492	46	7	scytonemin	scytonemin	NOUN
finefocus-3492	46	8	on	on	ADP
finefocus-3492	46	9	spleen	spleen	NOUN
finefocus-3492	46	10	cell	cell	NOUN
finefocus-3492	46	11	growth	growth	NOUN
finefocus-3492	46	12	,	,	PUNCT
finefocus-3492	46	13	the	the	DET
finefocus-3492	46	14	mitogen	mitogen	PROPN
finefocus-3492	46	15	concanavalin	concanavalin	PROPN
finefocus-3492	46	16	a	a	PROPN
finefocus-3492	46	17	(	(	PUNCT
finefocus-3492	46	18	con	con	PROPN
finefocus-3492	46	19	a	a	PROPN
finefocus-3492	46	20	)	)	PUNCT
finefocus-3492	46	21	,	,	PUNCT
finefocus-3492	46	22	which	which	PRON
finefocus-3492	46	23	stimulates	stimulate	VERB
finefocus-3492	46	24	t	t	PROPN
finefocus-3492	46	25	lymphocyte	lymphocyte	ADJ
finefocus-3492	46	26	proliferation	proliferation	NOUN
finefocus-3492	46	27	,	,	PUNCT
finefocus-3492	46	28	was	be	AUX
finefocus-3492	46	29	added	add	VERB
finefocus-3492	46	30	at	at	ADP
finefocus-3492	46	31	a	a	DET
finefocus-3492	46	32	concentration	concentration	NOUN
finefocus-3492	46	33	of	of	ADP
finefocus-3492	46	34	0.1	0.1	NUM
finefocus-3492	46	35	µg	µg	NOUN
finefocus-3492	46	36	per	per	ADV
finefocus-3492	46	37	well	well	ADV
finefocus-3492	46	38	in	in	ADP
finefocus-3492	46	39	a	a	DET
finefocus-3492	46	40	volume	volume	NOUN
finefocus-3492	46	41	of	of	ADP
finefocus-3492	46	42	200	200	NUM
finefocus-3492	46	43	ul	ul	NOUN
finefocus-3492	46	44	of	of	ADP
finefocus-3492	46	45	rpmi-1640	rpmi-1640	ADJ
finefocus-3492	46	46	media	medium	NOUN
finefocus-3492	46	47	plus	plus	CCONJ
finefocus-3492	46	48	10	10	NUM
finefocus-3492	46	49	%	%	NOUN
finefocus-3492	46	50	fbs	fb	NOUN
finefocus-3492	46	51	,	,	PUNCT
finefocus-3492	46	52	to	to	PART
finefocus-3492	46	53	determine	determine	VERB
finefocus-3492	46	54	whether	whether	SCONJ
finefocus-3492	46	55	scytonemin	scytonemin	NOUN
finefocus-3492	46	56	inhibited	inhibited	AUX
finefocus-3492	46	57	rapidly	rapidly	ADV
finefocus-3492	46	58	proliferating	proliferate	VERB
finefocus-3492	46	59	spleen	spleen	NOUN
finefocus-3492	46	60	cells	cell	NOUN
finefocus-3492	46	61	(	(	PUNCT
finefocus-3492	46	62	12	12	NUM
finefocus-3492	46	63	)	)	PUNCT
finefocus-3492	46	64	.	.	PUNCT
finefocus-3492	47	1	spleen	spleen	PROPN
finefocus-3492	47	2	cell	cell	NOUN
finefocus-3492	47	3	plates	plate	NOUN
finefocus-3492	47	4	were	be	AUX
finefocus-3492	47	5	incubated	incubate	VERB
finefocus-3492	47	6	for	for	ADP
finefocus-3492	47	7	48	48	NUM
finefocus-3492	47	8	hours	hour	NOUN
finefocus-3492	47	9	,	,	PUNCT
finefocus-3492	47	10	then	then	ADV
finefocus-3492	47	11	3h	3h	NUM
finefocus-3492	47	12	-	-	PUNCT
finefocus-3492	47	13	thymidine	thymidine	NOUN
finefocus-3492	47	14	was	be	AUX
finefocus-3492	47	15	added	added	AUX
finefocus-3492	47	16	followed	follow	VERB
finefocus-3492	47	17	by	by	ADP
finefocus-3492	47	18	a	a	DET
finefocus-3492	47	19	second	second	ADJ
finefocus-3492	47	20	incubation	incubation	NOUN
finefocus-3492	47	21	for	for	ADP
finefocus-3492	47	22	24	24	NUM
finefocus-3492	47	23	hours	hour	NOUN
finefocus-3492	47	24	,	,	PUNCT
finefocus-3492	47	25	all	all	PRON
finefocus-3492	47	26	of	of	ADP
finefocus-3492	47	27	which	which	PRON
finefocus-3492	47	28	took	take	VERB
finefocus-3492	47	29	place	place	NOUN
finefocus-3492	47	30	at	at	ADP
finefocus-3492	47	31	37	37	NUM
finefocus-3492	47	32	°	°	NOUN
finefocus-3492	47	33	c	c	NOUN
finefocus-3492	47	34	under	under	ADP
finefocus-3492	47	35	10	10	NUM
finefocus-3492	47	36	%	%	NOUN
finefocus-3492	47	37	co2	co2	NOUN
finefocus-3492	47	38	.	.	PUNCT
finefocus-3492	48	1	a	a	DET
finefocus-3492	48	2	cell	cell	NOUN
finefocus-3492	48	3	harvester	harvester	NOUN
finefocus-3492	48	4	was	be	AUX
finefocus-3492	48	5	then	then	ADV
finefocus-3492	48	6	used	use	VERB
finefocus-3492	48	7	to	to	PART
finefocus-3492	48	8	transfer	transfer	VERB
finefocus-3492	48	9	the	the	DET
finefocus-3492	48	10	cells	cell	NOUN
finefocus-3492	48	11	onto	onto	ADP
finefocus-3492	48	12	filters	filter	NOUN
finefocus-3492	48	13	,	,	PUNCT
finefocus-3492	48	14	which	which	PRON
finefocus-3492	48	15	were	be	AUX
finefocus-3492	48	16	washed	wash	VERB
finefocus-3492	48	17	approximately	approximately	ADV
finefocus-3492	48	18	ten	ten	NUM
finefocus-3492	48	19	times	time	NOUN
finefocus-3492	48	20	using	use	VERB
finefocus-3492	48	21	phosphate	phosphate	ADJ
finefocus-3492	48	22	buffered	buffer	VERB
finefocus-3492	48	23	saline	saline	NOUN
finefocus-3492	48	24	(	(	PUNCT
finefocus-3492	48	25	pbs	pbs	PROPN
finefocus-3492	48	26	)	)	PUNCT
finefocus-3492	48	27	.	.	PUNCT
finefocus-3492	49	1	filters	filter	NOUN
finefocus-3492	49	2	were	be	AUX
finefocus-3492	49	3	then	then	ADV
finefocus-3492	49	4	placed	place	VERB
finefocus-3492	49	5	into	into	ADP
finefocus-3492	49	6	counting	count	VERB
finefocus-3492	49	7	tubes	tube	NOUN
finefocus-3492	49	8	with	with	ADP
finefocus-3492	49	9	ecolume	ecolume	NOUN
finefocus-3492	49	10	™	™	ADJ
finefocus-3492	49	11	scintillation	scintillation	NOUN
finefocus-3492	49	12	cocktail	cocktail	NOUN
finefocus-3492	49	13	(	(	PUNCT
finefocus-3492	49	14	mp	mp	NOUN
finefocus-3492	49	15	biomedicals	biomedical	NOUN
finefocus-3492	49	16	,	,	PUNCT
finefocus-3492	49	17	solon	solon	PROPN
finefocus-3492	49	18	,	,	PUNCT
finefocus-3492	49	19	ohio	ohio	PROPN
finefocus-3492	49	20	)	)	PUNCT
finefocus-3492	49	21	to	to	PART
finefocus-3492	49	22	count	count	VERB
finefocus-3492	49	23	the	the	DET
finefocus-3492	49	24	incorporated	incorporate	VERB
finefocus-3492	49	25	h3	h3	NOUN
finefocus-3492	49	26	-	-	PUNCT
finefocus-3492	49	27	thymidine	thymidine	NOUN
finefocus-3492	49	28	using	use	VERB
finefocus-3492	49	29	a	a	DET
finefocus-3492	49	30	beckman	beckman	PROPN
finefocus-3492	49	31	scintillation	scintillation	PROPN
finefocus-3492	49	32	counter	counter	PROPN
finefocus-3492	49	33	.	.	PUNCT
finefocus-3492	50	1	all	all	DET
finefocus-3492	50	2	assays	assay	NOUN
finefocus-3492	50	3	were	be	AUX
finefocus-3492	50	4	done	do	VERB
finefocus-3492	50	5	in	in	ADP
finefocus-3492	50	6	triplicate	triplicate	NOUN
finefocus-3492	50	7	and	and	CCONJ
finefocus-3492	50	8	controls	control	NOUN
finefocus-3492	50	9	received	receive	VERB
finefocus-3492	50	10	no	no	DET
finefocus-3492	50	11	scytonemin	scytonemin	NOUN
finefocus-3492	50	12	or	or	CCONJ
finefocus-3492	50	13	dmso	dmso	ADJ
finefocus-3492	50	14	treatment	treatment	NOUN
finefocus-3492	50	15	.	.	PUNCT
finefocus-3492	51	1	previous	previous	ADJ
finefocus-3492	51	2	experiments	experiment	NOUN
finefocus-3492	51	3	in	in	ADP
finefocus-3492	51	4	our	our	PRON
finefocus-3492	51	5	lab	lab	NOUN
finefocus-3492	51	6	have	have	AUX
finefocus-3492	51	7	demonstrated	demonstrate	VERB
finefocus-3492	51	8	that	that	SCONJ
finefocus-3492	51	9	dmso	dmso	NOUN
finefocus-3492	51	10	does	do	AUX
finefocus-3492	51	11	not	not	PART
finefocus-3492	51	12	have	have	VERB
finefocus-3492	51	13	an	an	DET
finefocus-3492	51	14	inhibitory	inhibitory	ADJ
finefocus-3492	51	15	effect	effect	NOUN
finefocus-3492	51	16	on	on	ADP
finefocus-3492	51	17	melanoma	melanoma	NOUN
finefocus-3492	51	18	cell	cell	NOUN
finefocus-3492	51	19	proliferation	proliferation	NOUN
finefocus-3492	51	20	(	(	PUNCT
finefocus-3492	51	21	unpublished	unpublished	ADJ
finefocus-3492	51	22	data	datum	NOUN
finefocus-3492	51	23	)	)	PUNCT
finefocus-3492	51	24	.	.	PUNCT
finefocus-3492	52	1	cell	cell	NOUN
finefocus-3492	52	2	counts	count	NOUN
finefocus-3492	52	3	were	be	AUX
finefocus-3492	52	4	averaged	average	VERB
finefocus-3492	52	5	and	and	CCONJ
finefocus-3492	52	6	compared	compare	VERB
finefocus-3492	52	7	to	to	AUX
finefocus-3492	52	8	control	control	VERB
finefocus-3492	52	9	groups	group	NOUN
finefocus-3492	52	10	to	to	PART
finefocus-3492	52	11	determine	determine	VERB
finefocus-3492	52	12	the	the	DET
finefocus-3492	52	13	percent	percent	NOUN
finefocus-3492	52	14	proliferation	proliferation	NOUN
finefocus-3492	52	15	relative	relative	ADJ
finefocus-3492	52	16	to	to	ADP
finefocus-3492	52	17	the	the	DET
finefocus-3492	52	18	control	control	NOUN
finefocus-3492	52	19	groups	group	NOUN
finefocus-3492	52	20	.	.	PUNCT
finefocus-3492	53	1	all	all	DET
finefocus-3492	53	2	statistical	statistical	ADJ
finefocus-3492	53	3	tests	test	NOUN
finefocus-3492	53	4	were	be	AUX
finefocus-3492	53	5	done	do	VERB
finefocus-3492	53	6	using	use	VERB
finefocus-3492	53	7	anova	anova	PROPN
finefocus-3492	53	8	and	and	CCONJ
finefocus-3492	53	9	tukeyhsd	tukeyhsd	VERB
finefocus-3492	53	10	post	post	ADJ
finefocus-3492	53	11	-	-	ADJ
finefocus-3492	53	12	hoc	hoc	ADJ
finefocus-3492	53	13	comparisons	comparison	NOUN
finefocus-3492	53	14	in	in	ADP
finefocus-3492	53	15	r	r	NOUN
finefocus-3492	53	16	studio	studio	NOUN
finefocus-3492	53	17	v1.2.1335	v1.2.1335	NOUN
finefocus-3492	53	18	(	(	PUNCT
finefocus-3492	53	19	13	13	NUM
finefocus-3492	53	20	)	)	PUNCT
finefocus-3492	53	21	.	.	PUNCT
finefocus-3492	54	1	in	in	ADP
finefocus-3492	54	2	vivo	vivo	ADJ
finefocus-3492	54	3	assays	assay	NOUN
finefocus-3492	54	4	for	for	ADP
finefocus-3492	54	5	in	in	ADP
finefocus-3492	54	6	vivo	vivo	ADJ
finefocus-3492	54	7	scytonemin	scytonemin	NOUN
finefocus-3492	54	8	experiments	experiment	NOUN
finefocus-3492	54	9	against	against	ADP
finefocus-3492	54	10	melanoma	melanoma	NOUN
finefocus-3492	54	11	tumor	tumor	NOUN
finefocus-3492	54	12	cells	cell	NOUN
finefocus-3492	54	13	,	,	PUNCT
finefocus-3492	54	14	18	18	NUM
finefocus-3492	54	15	male	male	NOUN
finefocus-3492	54	16	c57	c57	NOUN
finefocus-3492	54	17	/	/	SYM
finefocus-3492	54	18	bl6	bl6	NOUN
finefocus-3492	54	19	mice	mouse	NOUN
finefocus-3492	54	20	were	be	AUX
finefocus-3492	54	21	obtained	obtain	VERB
finefocus-3492	54	22	from	from	ADP
finefocus-3492	54	23	charles	charles	PROPN
finefocus-3492	54	24	river	river	PROPN
finefocus-3492	54	25	labs	lab	NOUN
finefocus-3492	54	26	that	that	PRON
finefocus-3492	54	27	were	be	AUX
finefocus-3492	54	28	approximately	approximately	ADV
finefocus-3492	54	29	14	14	NUM
finefocus-3492	54	30	weeks	week	NOUN
finefocus-3492	54	31	old	old	ADJ
finefocus-3492	54	32	at	at	ADP
finefocus-3492	54	33	the	the	DET
finefocus-3492	54	34	time	time	NOUN
finefocus-3492	54	35	of	of	ADP
finefocus-3492	54	36	experimentation	experimentation	NOUN
finefocus-3492	54	37	.	.	PUNCT
finefocus-3492	55	1	each	each	DET
finefocus-3492	55	2	mouse	mouse	NOUN
finefocus-3492	55	3	was	be	AUX
finefocus-3492	55	4	weighed	weigh	VERB
finefocus-3492	55	5	before	before	ADP
finefocus-3492	55	6	the	the	DET
finefocus-3492	55	7	initial	initial	ADJ
finefocus-3492	55	8	intraperitoneal	intraperitoneal	NOUN
finefocus-3492	55	9	(	(	PUNCT
finefocus-3492	55	10	ip	ip	NOUN
finefocus-3492	55	11	)	)	PUNCT
finefocus-3492	55	12	injection	injection	NOUN
finefocus-3492	55	13	of	of	ADP
finefocus-3492	55	14	scytonemin	scytonemin	NOUN
finefocus-3492	55	15	diluted	dilute	VERB
finefocus-3492	55	16	in	in	ADP
finefocus-3492	55	17	dmso	dmso	NOUN
finefocus-3492	55	18	to	to	ADP
finefocus-3492	55	19	a	a	DET
finefocus-3492	55	20	final	final	ADJ
finefocus-3492	55	21	concentration	concentration	NOUN
finefocus-3492	55	22	of	of	ADP
finefocus-3492	55	23	3.5	3.5	NUM
finefocus-3492	55	24	µm	µm	ADP
finefocus-3492	55	25	g-1	g-1	PROPN
finefocus-3492	55	26	.	.	PUNCT
finefocus-3492	56	1	scytonemin	scytonemin	PROPN
finefocus-3492	56	2	was	be	AUX
finefocus-3492	56	3	then	then	ADV
finefocus-3492	56	4	administered	administer	VERB
finefocus-3492	56	5	at	at	ADP
finefocus-3492	56	6	3.5	3.5	NUM
finefocus-3492	56	7	µm	µm	ADP
finefocus-3492	56	8	g-1	g-1	PROPN
finefocus-3492	56	9	daily	daily	ADV
finefocus-3492	56	10	for	for	ADP
finefocus-3492	56	11	two	two	NUM
finefocus-3492	56	12	weeks	week	NOUN
finefocus-3492	56	13	through	through	ADP
finefocus-3492	56	14	ip	ip	DET
finefocus-3492	56	15	injections	injection	NOUN
finefocus-3492	56	16	into	into	ADP
finefocus-3492	56	17	nine	nine	NUM
finefocus-3492	56	18	treated	treat	VERB
finefocus-3492	56	19	mice	mouse	NOUN
finefocus-3492	56	20	,	,	PUNCT
finefocus-3492	56	21	and	and	CCONJ
finefocus-3492	56	22	the	the	DET
finefocus-3492	56	23	other	other	ADJ
finefocus-3492	56	24	nine	nine	NUM
finefocus-3492	56	25	mice	mouse	NOUN
finefocus-3492	56	26	received	receive	VERB
finefocus-3492	56	27	the	the	DET
finefocus-3492	56	28	same	same	ADJ
finefocus-3492	56	29	volume	volume	NOUN
finefocus-3492	56	30	of	of	ADP
finefocus-3492	56	31	sterile	sterile	ADJ
finefocus-3492	56	32	saline	saline	NOUN
finefocus-3492	56	33	that	that	PRON
finefocus-3492	56	34	had	have	VERB
finefocus-3492	56	35	an	an	DET
finefocus-3492	56	36	equal	equal	ADJ
finefocus-3492	56	37	concentration	concentration	NOUN
finefocus-3492	56	38	of	of	ADP
finefocus-3492	56	39	dmso	dmso	NOUN
finefocus-3492	56	40	as	as	SCONJ
finefocus-3492	56	41	the	the	DET
finefocus-3492	56	42	scytonemin	scytonemin	NOUN
finefocus-3492	56	43	treated	treat	VERB
finefocus-3492	56	44	animals	animal	NOUN
finefocus-3492	56	45	.	.	PUNCT
finefocus-3492	57	1	after	after	ADP
finefocus-3492	57	2	two	two	NUM
finefocus-3492	57	3	weeks	week	NOUN
finefocus-3492	57	4	a	a	DET
finefocus-3492	57	5	single	single	ADJ
finefocus-3492	57	6	tail	tail	NOUN
finefocus-3492	57	7	vein	vein	VERB
finefocus-3492	57	8	injection	injection	NOUN
finefocus-3492	57	9	of	of	ADP
finefocus-3492	57	10	melanoma	melanoma	NOUN
finefocus-3492	57	11	cells	cell	NOUN
finefocus-3492	57	12	was	be	AUX
finefocus-3492	57	13	performed	perform	VERB
finefocus-3492	57	14	.	.	PUNCT
finefocus-3492	58	1	melanoma	melanoma	NOUN
finefocus-3492	58	2	cells	cell	NOUN
finefocus-3492	58	3	were	be	AUX
finefocus-3492	58	4	diluted	dilute	VERB
finefocus-3492	58	5	to	to	ADP
finefocus-3492	58	6	5	5	NUM
finefocus-3492	58	7	x	x	SYM
finefocus-3492	58	8	106	106	NUM
finefocus-3492	58	9	melanoma	melanoma	NOUN
finefocus-3492	58	10	cells	cell	NOUN
finefocus-3492	58	11	ml-1	ml-1	ADV
finefocus-3492	58	12	in	in	ADP
finefocus-3492	58	13	sterile	sterile	ADJ
finefocus-3492	58	14	saline	saline	NOUN
finefocus-3492	58	15	,	,	PUNCT
finefocus-3492	58	16	and	and	CCONJ
finefocus-3492	58	17	0.1	0.1	NUM
finefocus-3492	58	18	ml	ml	NOUN
finefocus-3492	58	19	of	of	ADP
finefocus-3492	58	20	this	this	DET
finefocus-3492	58	21	preparation	preparation	NOUN
finefocus-3492	58	22	was	be	AUX
finefocus-3492	58	23	injected	inject	VERB
finefocus-3492	58	24	into	into	ADP
finefocus-3492	58	25	the	the	DET
finefocus-3492	58	26	tail	tail	NOUN
finefocus-3492	58	27	vein	vein	NOUN
finefocus-3492	58	28	of	of	ADP
finefocus-3492	58	29	all	all	DET
finefocus-3492	58	30	18	18	NUM
finefocus-3492	58	31	mice	mouse	NOUN
finefocus-3492	58	32	.	.	PUNCT
finefocus-3492	59	1	ip	ip	PRON
finefocus-3492	59	2	injections	injection	NOUN
finefocus-3492	59	3	of	of	ADP
finefocus-3492	59	4	scytonemin	scytonemin	NOUN
finefocus-3492	59	5	were	be	AUX
finefocus-3492	59	6	continued	continue	VERB
finefocus-3492	59	7	for	for	ADP
finefocus-3492	59	8	an	an	DET
finefocus-3492	59	9	additional	additional	ADJ
finefocus-3492	59	10	week	week	NOUN
finefocus-3492	59	11	and	and	CCONJ
finefocus-3492	59	12	the	the	DET
finefocus-3492	59	13	mice	mouse	NOUN
finefocus-3492	59	14	were	be	AUX
finefocus-3492	59	15	monitored	monitor	VERB
finefocus-3492	59	16	for	for	ADP
finefocus-3492	59	17	any	any	DET
finefocus-3492	59	18	health	health	NOUN
finefocus-3492	59	19	changes	change	VERB
finefocus-3492	59	20	58	58	NUM
finefocus-3492	59	21	|	|	ADV
finefocus-3492	59	22	fine	fine	ADJ
finefocus-3492	59	23	focus	focus	NOUN
finefocus-3492	59	24	for	for	ADP
finefocus-3492	59	25	two	two	NUM
finefocus-3492	59	26	additional	additional	ADJ
finefocus-3492	59	27	weeks	week	NOUN
finefocus-3492	59	28	while	while	SCONJ
finefocus-3492	59	29	the	the	DET
finefocus-3492	59	30	tumors	tumor	NOUN
finefocus-3492	59	31	grew	grow	VERB
finefocus-3492	59	32	.	.	PUNCT
finefocus-3492	60	1	after	after	ADP
finefocus-3492	60	2	two	two	NUM
finefocus-3492	60	3	weeks	week	NOUN
finefocus-3492	60	4	of	of	ADP
finefocus-3492	60	5	no	no	DET
finefocus-3492	60	6	injections	injection	NOUN
finefocus-3492	60	7	eight	eight	NUM
finefocus-3492	60	8	mice	mouse	NOUN
finefocus-3492	60	9	in	in	ADP
finefocus-3492	60	10	each	each	DET
finefocus-3492	60	11	group	group	NOUN
finefocus-3492	60	12	survived	survive	VERB
finefocus-3492	60	13	and	and	CCONJ
finefocus-3492	60	14	were	be	AUX
finefocus-3492	60	15	weighed	weigh	VERB
finefocus-3492	60	16	once	once	ADV
finefocus-3492	60	17	more	more	ADV
finefocus-3492	60	18	and	and	CCONJ
finefocus-3492	60	19	sacrified	sacrifie	VERB
finefocus-3492	60	20	.	.	PUNCT
finefocus-3492	61	1	when	when	SCONJ
finefocus-3492	61	2	injected	inject	VERB
finefocus-3492	61	3	into	into	ADP
finefocus-3492	61	4	the	the	DET
finefocus-3492	61	5	tail	tail	NOUN
finefocus-3492	61	6	vein	vein	NOUN
finefocus-3492	61	7	of	of	ADP
finefocus-3492	61	8	syngeneic	syngeneic	NOUN
finefocus-3492	61	9	mice	mouse	NOUN
finefocus-3492	61	10	,	,	PUNCT
finefocus-3492	61	11	melanoma	melanoma	NOUN
finefocus-3492	61	12	cells	cell	NOUN
finefocus-3492	61	13	migrate	migrate	VERB
finefocus-3492	61	14	to	to	ADP
finefocus-3492	61	15	the	the	DET
finefocus-3492	61	16	lungs	lung	NOUN
finefocus-3492	61	17	and	and	CCONJ
finefocus-3492	61	18	produce	produce	VERB
finefocus-3492	61	19	dark	dark	ADJ
finefocus-3492	61	20	colonies	colony	NOUN
finefocus-3492	61	21	.	.	PUNCT
finefocus-3492	62	1	upon	upon	SCONJ
finefocus-3492	62	2	sacrifice	sacrifice	VERB
finefocus-3492	62	3	the	the	DET
finefocus-3492	62	4	lungs	lung	NOUN
finefocus-3492	62	5	were	be	AUX
finefocus-3492	62	6	teased	tease	VERB
finefocus-3492	62	7	apart	apart	ADV
finefocus-3492	62	8	and	and	CCONJ
finefocus-3492	62	9	the	the	DET
finefocus-3492	62	10	melanoma	melanoma	NOUN
finefocus-3492	62	11	tumor	tumor	NOUN
finefocus-3492	62	12	cell	cell	NOUN
finefocus-3492	62	13	colonies	colony	NOUN
finefocus-3492	62	14	were	be	AUX
finefocus-3492	62	15	counted	count	VERB
finefocus-3492	62	16	on	on	ADP
finefocus-3492	62	17	and	and	CCONJ
finefocus-3492	62	18	within	within	ADP
finefocus-3492	62	19	the	the	DET
finefocus-3492	62	20	lung	lung	NOUN
finefocus-3492	62	21	tissue	tissue	NOUN
finefocus-3492	62	22	and	and	CCONJ
finefocus-3492	62	23	the	the	DET
finefocus-3492	62	24	counts	count	NOUN
finefocus-3492	62	25	were	be	AUX
finefocus-3492	62	26	compared	compare	VERB
finefocus-3492	62	27	against	against	ADP
finefocus-3492	62	28	the	the	DET
finefocus-3492	62	29	control	control	NOUN
finefocus-3492	62	30	mice	mouse	NOUN
finefocus-3492	62	31	that	that	PRON
finefocus-3492	62	32	did	do	AUX
finefocus-3492	62	33	not	not	PART
finefocus-3492	62	34	receive	receive	VERB
finefocus-3492	62	35	scytonemin	scytonemin	NOUN
finefocus-3492	62	36	using	use	VERB
finefocus-3492	62	37	an	an	DET
finefocus-3492	62	38	anova	anova	PROPN
finefocus-3492	62	39	with	with	ADP
finefocus-3492	62	40	tukeyhsd	tukeyhsd	NOUN
finefocus-3492	62	41	post	post	ADJ
finefocus-3492	62	42	-	-	ADJ
finefocus-3492	62	43	hoc	hoc	ADJ
finefocus-3492	62	44	analysis	analysis	NOUN
finefocus-3492	62	45	.	.	PUNCT
finefocus-3492	63	1	all	all	DET
finefocus-3492	63	2	animal	animal	NOUN
finefocus-3492	63	3	experiments	experiment	NOUN
finefocus-3492	63	4	were	be	AUX
finefocus-3492	63	5	performed	perform	VERB
finefocus-3492	63	6	according	accord	VERB
finefocus-3492	63	7	to	to	ADP
finefocus-3492	63	8	iacuc	iacuc	PROPN
finefocus-3492	63	9	protocol	protocol	NOUN
finefocus-3492	63	10	#	#	SYM
finefocus-3492	63	11	1111000244	1111000244	NUM
finefocus-3492	63	12	.	.	PUNCT
finefocus-3492	64	1	results	result	VERB
finefocus-3492	64	2	melanoma	melanoma	NOUN
finefocus-3492	64	3	and	and	CCONJ
finefocus-3492	64	4	spleen	spleen	NOUN
finefocus-3492	64	5	cell	cell	NOUN
finefocus-3492	64	6	assays	assay	VERB
finefocus-3492	64	7	the	the	DET
finefocus-3492	64	8	melanoma	melanoma	NOUN
finefocus-3492	64	9	cell	cell	NOUN
finefocus-3492	64	10	assays	assay	NOUN
finefocus-3492	64	11	showed	show	VERB
finefocus-3492	64	12	that	that	SCONJ
finefocus-3492	64	13	in	in	ADP
finefocus-3492	64	14	the	the	DET
finefocus-3492	64	15	presence	presence	NOUN
finefocus-3492	64	16	of	of	ADP
finefocus-3492	64	17	10	10	NUM
finefocus-3492	64	18	μm	μm	NOUN
finefocus-3492	64	19	scytonemin	scytonemin	NOUN
finefocus-3492	64	20	,	,	PUNCT
finefocus-3492	64	21	the	the	DET
finefocus-3492	64	22	percent	percent	NOUN
finefocus-3492	64	23	inhibition	inhibition	NOUN
finefocus-3492	64	24	compared	compare	VERB
finefocus-3492	64	25	to	to	ADP
finefocus-3492	64	26	the	the	DET
finefocus-3492	64	27	control	control	NOUN
finefocus-3492	64	28	was	be	AUX
finefocus-3492	64	29	highest	high	ADJ
finefocus-3492	64	30	at	at	ADP
finefocus-3492	64	31	87.60	87.60	NUM
finefocus-3492	64	32	%	%	NOUN
finefocus-3492	64	33	±	±	NUM
finefocus-3492	64	34	1.86	1.86	NUM
finefocus-3492	64	35	while	while	NOUN
finefocus-3492	64	36	in	in	ADP
finefocus-3492	64	37	the	the	DET
finefocus-3492	64	38	presence	presence	NOUN
finefocus-3492	64	39	of	of	ADP
finefocus-3492	64	40	2	2	NUM
finefocus-3492	64	41	μm	μm	NOUN
finefocus-3492	64	42	scytonemin	scytonemin	NOUN
finefocus-3492	64	43	,	,	PUNCT
finefocus-3492	64	44	the	the	DET
finefocus-3492	64	45	inhibition	inhibition	NOUN
finefocus-3492	64	46	decreased	decrease	VERB
finefocus-3492	64	47	to	to	ADP
finefocus-3492	64	48	52.03	52.03	NUM
finefocus-3492	64	49	%	%	NOUN
finefocus-3492	64	50	±	±	NUM
finefocus-3492	64	51	1.76	1.76	NUM
finefocus-3492	64	52	(	(	PUNCT
finefocus-3492	64	53	fig	fig	NOUN
finefocus-3492	64	54	.	.	PUNCT
finefocus-3492	65	1	2	2	NUM
finefocus-3492	65	2	)	)	PUNCT
finefocus-3492	65	3	.	.	PUNCT
finefocus-3492	66	1	the	the	DET
finefocus-3492	66	2	percent	percent	NOUN
finefocus-3492	66	3	inhibition	inhibition	NOUN
finefocus-3492	66	4	compared	compare	VERB
finefocus-3492	66	5	to	to	ADP
finefocus-3492	66	6	the	the	DET
finefocus-3492	66	7	control	control	NOUN
finefocus-3492	66	8	was	be	AUX
finefocus-3492	66	9	significant	significant	ADJ
finefocus-3492	66	10	only	only	ADV
finefocus-3492	66	11	at	at	ADP
finefocus-3492	66	12	10	10	NUM
finefocus-3492	66	13	μm	μm	NUM
finefocus-3492	66	14	and	and	CCONJ
finefocus-3492	66	15	2	2	NUM
finefocus-3492	66	16	μm	μm	NOUN
finefocus-3492	66	17	scytonemin	scytonemin	NOUN
finefocus-3492	66	18	(	(	PUNCT
finefocus-3492	66	19	p	p	X
finefocus-3492	66	20	<	<	X
finefocus-3492	66	21	0.0001	0.0001	NUM
finefocus-3492	66	22	)	)	PUNCT
finefocus-3492	66	23	.	.	PUNCT
finefocus-3492	67	1	the	the	DET
finefocus-3492	67	2	percent	percent	NOUN
finefocus-3492	67	3	inhibition	inhibition	NOUN
finefocus-3492	67	4	generally	generally	ADV
finefocus-3492	67	5	increased	increase	VERB
finefocus-3492	67	6	as	as	SCONJ
finefocus-3492	67	7	the	the	DET
finefocus-3492	67	8	concentration	concentration	NOUN
finefocus-3492	67	9	of	of	ADP
finefocus-3492	67	10	scytonemin	scytonemin	NOUN
finefocus-3492	67	11	increased	increase	VERB
finefocus-3492	67	12	,	,	PUNCT
finefocus-3492	67	13	indicating	indicate	VERB
finefocus-3492	67	14	a	a	DET
finefocus-3492	67	15	positive	positive	ADJ
finefocus-3492	67	16	relationship	relationship	NOUN
finefocus-3492	67	17	among	among	ADP
finefocus-3492	67	18	these	these	DET
finefocus-3492	67	19	variables	variable	NOUN
finefocus-3492	67	20	.	.	PUNCT
finefocus-3492	68	1	for	for	ADP
finefocus-3492	68	2	the	the	DET
finefocus-3492	68	3	spleen	spleen	NOUN
finefocus-3492	68	4	cell	cell	NOUN
finefocus-3492	68	5	assays	assay	NOUN
finefocus-3492	68	6	,	,	PUNCT
finefocus-3492	68	7	in	in	ADP
finefocus-3492	68	8	all	all	DET
finefocus-3492	68	9	treatments	treatment	NOUN
finefocus-3492	68	10	except	except	SCONJ
finefocus-3492	68	11	the	the	DET
finefocus-3492	68	12	10	10	NUM
finefocus-3492	68	13	μm	μm	NOUN
finefocus-3492	68	14	scytonemin	scytonemin	NOUN
finefocus-3492	68	15	dilution	dilution	NOUN
finefocus-3492	68	16	without	without	ADP
finefocus-3492	68	17	con	con	PROPN
finefocus-3492	68	18	a	a	X
finefocus-3492	68	19	(	(	PUNCT
finefocus-3492	68	20	65.28	65.28	NUM
finefocus-3492	68	21	%	%	NOUN
finefocus-3492	68	22	±	±	NUM
finefocus-3492	68	23	5.34	5.34	NUM
finefocus-3492	68	24	)	)	PUNCT
finefocus-3492	68	25	,	,	PUNCT
finefocus-3492	68	26	the	the	DET
finefocus-3492	68	27	percentage	percentage	NOUN
finefocus-3492	68	28	proliferation	proliferation	NOUN
finefocus-3492	68	29	relative	relative	ADJ
finefocus-3492	68	30	to	to	ADP
finefocus-3492	68	31	the	the	DET
finefocus-3492	68	32	control	control	NOUN
finefocus-3492	68	33	was	be	AUX
finefocus-3492	68	34	over	over	ADP
finefocus-3492	68	35	100	100	NUM
finefocus-3492	68	36	%	%	NOUN
finefocus-3492	68	37	(	(	PUNCT
finefocus-3492	68	38	fig	fig	NOUN
finefocus-3492	68	39	.	.	PUNCT
finefocus-3492	69	1	3	3	NUM
finefocus-3492	69	2	)	)	PUNCT
finefocus-3492	69	3	.	.	PUNCT
finefocus-3492	70	1	for	for	ADP
finefocus-3492	70	2	the	the	DET
finefocus-3492	70	3	spleen	spleen	NOUN
finefocus-3492	70	4	cells	cell	NOUN
finefocus-3492	70	5	receiving	receive	VERB
finefocus-3492	70	6	the	the	DET
finefocus-3492	70	7	mitogen	mitogen	PROPN
finefocus-3492	70	8	con	con	PROPN
finefocus-3492	70	9	a	a	PROPN
finefocus-3492	70	10	,	,	PUNCT
finefocus-3492	70	11	the	the	DET
finefocus-3492	70	12	percentage	percentage	NOUN
finefocus-3492	70	13	proliferation	proliferation	NOUN
finefocus-3492	70	14	relative	relative	ADJ
finefocus-3492	70	15	to	to	ADP
finefocus-3492	70	16	the	the	DET
finefocus-3492	70	17	control	control	NOUN
finefocus-3492	70	18	was	be	AUX
finefocus-3492	70	19	211.14	211.14	NUM
finefocus-3492	70	20	%	%	NOUN
finefocus-3492	70	21	±	±	NUM
finefocus-3492	70	22	53.24	53.24	NUM
finefocus-3492	70	23	for	for	ADP
finefocus-3492	70	24	the	the	DET
finefocus-3492	70	25	most	most	ADV
finefocus-3492	70	26	dilute	dilute	ADJ
finefocus-3492	70	27	concentration	concentration	NOUN
finefocus-3492	70	28	of	of	ADP
finefocus-3492	70	29	scytonemin	scytonemin	NOUN
finefocus-3492	70	30	,	,	PUNCT
finefocus-3492	70	31	0.08	0.08	NUM
finefocus-3492	70	32	μm	μm	NOUN
finefocus-3492	70	33	,	,	PUNCT
finefocus-3492	70	34	peaking	peak	VERB
finefocus-3492	70	35	at	at	ADP
finefocus-3492	70	36	387.00	387.00	NUM
finefocus-3492	70	37	%	%	NOUN
finefocus-3492	70	38	±	±	NUM
finefocus-3492	70	39	79.34	79.34	NUM
finefocus-3492	70	40	with	with	ADP
finefocus-3492	70	41	2	2	NUM
finefocus-3492	70	42	μm	μm	NUM
finefocus-3492	70	43	scytonemin	scytonemin	NOUN
finefocus-3492	70	44	.	.	PUNCT
finefocus-3492	71	1	the	the	DET
finefocus-3492	71	2	percent	percent	NOUN
finefocus-3492	71	3	stimulation	stimulation	NOUN
finefocus-3492	71	4	compared	compare	VERB
finefocus-3492	71	5	to	to	ADP
finefocus-3492	71	6	the	the	DET
finefocus-3492	71	7	control	control	NOUN
finefocus-3492	71	8	was	be	AUX
finefocus-3492	71	9	significant	significant	ADJ
finefocus-3492	71	10	only	only	ADV
finefocus-3492	71	11	at	at	ADP
finefocus-3492	71	12	2	2	NUM
finefocus-3492	71	13	μm	μm	NOUN
finefocus-3492	71	14	scytonemin	scytonemin	NOUN
finefocus-3492	71	15	,	,	PUNCT
finefocus-3492	71	16	with	with	ADP
finefocus-3492	71	17	p	p	NOUN
finefocus-3492	71	18	=	=	PROPN
finefocus-3492	71	19	0.0012	0.0012	NUM
finefocus-3492	71	20	regardless	regardless	ADV
finefocus-3492	71	21	of	of	ADP
finefocus-3492	71	22	whether	whether	SCONJ
finefocus-3492	71	23	con	con	PROPN
finefocus-3492	71	24	a	a	PRON
finefocus-3492	71	25	was	be	AUX
finefocus-3492	71	26	used	use	VERB
finefocus-3492	71	27	.	.	PUNCT
finefocus-3492	72	1	the	the	DET
finefocus-3492	72	2	results	result	NOUN
finefocus-3492	72	3	of	of	ADP
finefocus-3492	72	4	the	the	DET
finefocus-3492	72	5	assays	assay	NOUN
finefocus-3492	72	6	with	with	ADP
finefocus-3492	72	7	and	and	CCONJ
finefocus-3492	72	8	without	without	ADP
finefocus-3492	72	9	con	con	PROPN
finefocus-3492	72	10	a	a	DET
finefocus-3492	72	11	display	display	NOUN
finefocus-3492	72	12	the	the	DET
finefocus-3492	72	13	same	same	ADJ
finefocus-3492	72	14	general	general	ADJ
finefocus-3492	72	15	trends	trend	NOUN
finefocus-3492	72	16	,	,	PUNCT
finefocus-3492	72	17	suggesting	suggest	VERB
finefocus-3492	72	18	that	that	SCONJ
finefocus-3492	72	19	the	the	DET
finefocus-3492	72	20	presence	presence	NOUN
finefocus-3492	72	21	of	of	ADP
finefocus-3492	72	22	the	the	DET
finefocus-3492	72	23	mitogen	mitogen	NOUN
finefocus-3492	72	24	was	be	AUX
finefocus-3492	72	25	not	not	PART
finefocus-3492	72	26	a	a	DET
finefocus-3492	72	27	confounding	confound	VERB
finefocus-3492	72	28	variable	variable	NOUN
finefocus-3492	72	29	.	.	PUNCT
finefocus-3492	73	1	scytonemin	scytonemin	NOUN
finefocus-3492	73	2	did	do	AUX
finefocus-3492	73	3	not	not	PART
finefocus-3492	73	4	demonstrate	demonstrate	VERB
finefocus-3492	73	5	any	any	DET
finefocus-3492	73	6	inhibition	inhibition	NOUN
finefocus-3492	73	7	of	of	ADP
finefocus-3492	73	8	these	these	DET
finefocus-3492	73	9	spleen	spleen	ADJ
finefocus-3492	73	10	tissue	tissue	NOUN
finefocus-3492	73	11	cultures	culture	NOUN
finefocus-3492	73	12	while	while	SCONJ
finefocus-3492	73	13	the	the	DET
finefocus-3492	73	14	2	2	NUM
finefocus-3492	73	15	μm	μm	NUM
finefocus-3492	73	16	and	and	CCONJ
finefocus-3492	73	17	10	10	NUM
finefocus-3492	73	18	μm	μm	NOUN
finefocus-3492	73	19	levels	level	NOUN
finefocus-3492	73	20	showed	show	VERB
finefocus-3492	73	21	significant	significant	ADJ
finefocus-3492	73	22	inhibition	inhibition	NOUN
finefocus-3492	73	23	of	of	ADP
finefocus-3492	73	24	melanoma	melanoma	NOUN
finefocus-3492	73	25	cell	cell	NOUN
finefocus-3492	73	26	growth	growth	NOUN
finefocus-3492	73	27	.	.	PUNCT
finefocus-3492	74	1	in	in	ADP
finefocus-3492	74	2	vivo	vivo	ADJ
finefocus-3492	74	3	assays	assay	NOUN
finefocus-3492	74	4	after	after	ADP
finefocus-3492	74	5	treatment	treatment	NOUN
finefocus-3492	74	6	,	,	PUNCT
finefocus-3492	74	7	there	there	PRON
finefocus-3492	74	8	was	be	VERB
finefocus-3492	74	9	no	no	DET
finefocus-3492	74	10	significant	significant	ADJ
finefocus-3492	74	11	difference	difference	NOUN
finefocus-3492	74	12	in	in	ADP
finefocus-3492	74	13	the	the	DET
finefocus-3492	74	14	weights	weight	NOUN
finefocus-3492	74	15	of	of	ADP
finefocus-3492	74	16	untreated	untreated	ADJ
finefocus-3492	74	17	mice	mouse	NOUN
finefocus-3492	74	18	(	(	PUNCT
finefocus-3492	74	19	28.44	28.44	NUM
finefocus-3492	74	20	±	±	NUM
finefocus-3492	74	21	0.49	0.49	NUM
finefocus-3492	74	22	g	g	NOUN
finefocus-3492	74	23	)	)	PUNCT
finefocus-3492	74	24	and	and	CCONJ
finefocus-3492	74	25	those	those	PRON
finefocus-3492	74	26	treated	treat	VERB
finefocus-3492	74	27	with	with	ADP
finefocus-3492	74	28	scytonemin	scytonemin	NOUN
finefocus-3492	74	29	(	(	PUNCT
finefocus-3492	74	30	29.63	29.63	NUM
finefocus-3492	74	31	±	±	NUM
finefocus-3492	74	32	0.48	0.48	NUM
finefocus-3492	74	33	g	g	NOUN
finefocus-3492	74	34	)	)	PUNCT
finefocus-3492	74	35	.	.	PUNCT
finefocus-3492	75	1	there	there	PRON
finefocus-3492	75	2	were	be	VERB
finefocus-3492	75	3	also	also	ADV
finefocus-3492	75	4	no	no	DET
finefocus-3492	75	5	significant	significant	ADJ
finefocus-3492	75	6	differences	difference	NOUN
finefocus-3492	75	7	in	in	ADP
finefocus-3492	75	8	the	the	DET
finefocus-3492	75	9	number	number	NOUN
finefocus-3492	75	10	of	of	ADP
finefocus-3492	75	11	melanoma	melanoma	NOUN
finefocus-3492	75	12	tumors	tumor	NOUN
finefocus-3492	75	13	in	in	ADP
finefocus-3492	75	14	untreated	untreated	ADJ
finefocus-3492	75	15	mice	mouse	NOUN
finefocus-3492	75	16	(	(	PUNCT
finefocus-3492	75	17	205.5	205.5	NUM
finefocus-3492	75	18	±	±	NUM
finefocus-3492	75	19	51.29	51.29	NUM
finefocus-3492	75	20	)	)	PUNCT
finefocus-3492	75	21	versus	versus	ADP
finefocus-3492	75	22	those	those	PRON
finefocus-3492	75	23	treated	treat	VERB
finefocus-3492	75	24	with	with	ADP
finefocus-3492	75	25	scytonemin	scytonemin	NOUN
finefocus-3492	75	26	(	(	PUNCT
finefocus-3492	75	27	142.50	142.50	NUM
finefocus-3492	75	28	±	±	NUM
finefocus-3492	75	29	30.65	30.65	NUM
finefocus-3492	75	30	)	)	PUNCT
finefocus-3492	75	31	.	.	PUNCT
finefocus-3492	76	1	discussion	discussion	NOUN
finefocus-3492	76	2	mechanistically	mechanistically	ADV
finefocus-3492	76	3	,	,	PUNCT
finefocus-3492	76	4	scytonemin	scytonemin	NOUN
finefocus-3492	76	5	inhibits	inhibit	VERB
finefocus-3492	76	6	the	the	DET
finefocus-3492	76	7	hyperproliferation	hyperproliferation	NOUN
finefocus-3492	76	8	of	of	ADP
finefocus-3492	76	9	cells	cell	NOUN
finefocus-3492	76	10	by	by	ADP
finefocus-3492	76	11	targeting	target	VERB
finefocus-3492	76	12	multiple	multiple	ADJ
finefocus-3492	76	13	enzymes	enzyme	NOUN
finefocus-3492	76	14	implicated	implicate	VERB
finefocus-3492	76	15	primarily	primarily	ADV
finefocus-3492	76	16	in	in	ADP
finefocus-3492	76	17	cell	cell	NOUN
finefocus-3492	76	18	cycle	cycle	NOUN
finefocus-3492	76	19	regulation	regulation	NOUN
finefocus-3492	76	20	.	.	PUNCT
finefocus-3492	77	1	for	for	ADP
finefocus-3492	77	2	instance	instance	NOUN
finefocus-3492	77	3	,	,	PUNCT
finefocus-3492	77	4	one	one	NUM
finefocus-3492	77	5	study	study	NOUN
finefocus-3492	77	6	examined	examine	VERB
finefocus-3492	77	7	the	the	DET
finefocus-3492	77	8	effect	effect	NOUN
finefocus-3492	77	9	on	on	ADP
finefocus-3492	77	10	several	several	ADJ
finefocus-3492	77	11	kinases	kinase	NOUN
finefocus-3492	77	12	,	,	PUNCT
finefocus-3492	77	13	including	include	VERB
finefocus-3492	77	14	plk1	plk1	PROPN
finefocus-3492	77	15	,	,	PUNCT
finefocus-3492	77	16	cdk1	cdk1	PROPN
finefocus-3492	77	17	/	/	SYM
finefocus-3492	77	18	cyclin	cyclin	PROPN
finefocus-3492	77	19	b	b	PROPN
finefocus-3492	77	20	,	,	PUNCT
finefocus-3492	77	21	checkpoint	checkpoint	NOUN
finefocus-3492	77	22	kinase	kinase	NOUN
finefocus-3492	77	23	1	1	NUM
finefocus-3492	77	24	,	,	PUNCT
finefocus-3492	77	25	protein	protein	NOUN
finefocus-3492	77	26	kinase	kinase	NOUN
finefocus-3492	77	27	a	a	X
finefocus-3492	77	28	,	,	PUNCT
finefocus-3492	77	29	protein	protein	NOUN
finefocus-3492	77	30	kinase	kinase	NOUN
finefocus-3492	77	31	c	c	X
finefocus-3492	77	32	,	,	PUNCT
finefocus-3492	77	33	myt1	myt1	PROPN
finefocus-3492	77	34	kinase	kinase	PROPN
finefocus-3492	77	35	,	,	PUNCT
finefocus-3492	77	36	and	and	CCONJ
finefocus-3492	77	37	tie2	tie2	PROPN
finefocus-3492	77	38	kinase	kinase	PROPN
finefocus-3492	77	39	(	(	PUNCT
finefocus-3492	77	40	16	16	NUM
finefocus-3492	77	41	)	)	PUNCT
finefocus-3492	77	42	.	.	PUNCT
finefocus-3492	78	1	of	of	ADP
finefocus-3492	78	2	these	these	DET
finefocus-3492	78	3	enzymes	enzyme	NOUN
finefocus-3492	78	4	,	,	PUNCT
finefocus-3492	78	5	it	it	PRON
finefocus-3492	78	6	was	be	AUX
finefocus-3492	78	7	determined	determine	VERB
finefocus-3492	78	8	that	that	SCONJ
finefocus-3492	78	9	scytonemin	scytonemin	NOUN
finefocus-3492	78	10	acted	act	VERB
finefocus-3492	78	11	as	as	ADP
finefocus-3492	78	12	an	an	DET
finefocus-3492	78	13	inhibitor	inhibitor	NOUN
finefocus-3492	78	14	for	for	ADP
finefocus-3492	78	15	plk1	plk1	NOUN
finefocus-3492	78	16	,	,	PUNCT
finefocus-3492	78	17	cdk1	cdk1	PROPN
finefocus-3492	78	18	/	/	SYM
finefocus-3492	78	19	cyclin	cyclin	PROPN
finefocus-3492	78	20	b	b	PROPN
finefocus-3492	78	21	,	,	PUNCT
finefocus-3492	78	22	checkpoint	checkpoint	NOUN
finefocus-3492	78	23	kinase	kinase	NOUN
finefocus-3492	78	24	1	1	NUM
finefocus-3492	78	25	,	,	PUNCT
finefocus-3492	78	26	protein	protein	NOUN
finefocus-3492	78	27	kinase	kinase	NOUN
finefocus-3492	78	28	c	c	X
finefocus-3492	78	29	,	,	PUNCT
finefocus-3492	78	30	and	and	CCONJ
finefocus-3492	78	31	myt1	myt1	PROPN
finefocus-3492	78	32	kinase	kinase	PROPN
finefocus-3492	78	33	,	,	PUNCT
finefocus-3492	78	34	but	but	CCONJ
finefocus-3492	78	35	did	do	AUX
finefocus-3492	78	36	not	not	PART
finefocus-3492	78	37	inhibit	inhibit	VERB
finefocus-3492	78	38	protein	protein	NOUN
finefocus-3492	78	39	kinase	kinase	NOUN
finefocus-3492	78	40	a	a	DET
finefocus-3492	78	41	or	or	CCONJ
finefocus-3492	78	42	tie2	tie2	PROPN
finefocus-3492	78	43	kinase	kinase	PROPN
finefocus-3492	78	44	(	(	PUNCT
finefocus-3492	78	45	16	16	NUM
finefocus-3492	78	46	)	)	PUNCT
finefocus-3492	78	47	.	.	PUNCT
finefocus-3492	79	1	these	these	DET
finefocus-3492	79	2	results	result	NOUN
finefocus-3492	79	3	suggest	suggest	VERB
finefocus-3492	79	4	that	that	SCONJ
finefocus-3492	79	5	scytonemin	scytonemin	NOUN
finefocus-3492	79	6	binds	bind	VERB
finefocus-3492	79	7	nonspecifically	nonspecifically	ADV
finefocus-3492	79	8	to	to	ADP
finefocus-3492	79	9	a	a	DET
finefocus-3492	79	10	variety	variety	NOUN
finefocus-3492	79	11	of	of	ADP
finefocus-3492	79	12	enzymes	enzyme	NOUN
finefocus-3492	79	13	to	to	PART
finefocus-3492	79	14	prevent	prevent	VERB
finefocus-3492	79	15	phosphorylation	phosphorylation	NOUN
finefocus-3492	79	16	steps	step	NOUN
finefocus-3492	79	17	critical	critical	ADJ
finefocus-3492	79	18	to	to	ADP
finefocus-3492	79	19	cell	cell	NOUN
finefocus-3492	79	20	cycle	cycle	NOUN
finefocus-3492	79	21	progression	progression	NOUN
finefocus-3492	79	22	.	.	PUNCT
finefocus-3492	80	1	other	other	ADJ
finefocus-3492	80	2	experiments	experiment	NOUN
finefocus-3492	80	3	explored	explore	VERB
finefocus-3492	80	4	the	the	DET
finefocus-3492	80	5	relationship	relationship	NOUN
finefocus-3492	80	6	between	between	ADP
finefocus-3492	80	7	scytonemin	scytonemin	NOUN
finefocus-3492	80	8	and	and	CCONJ
finefocus-3492	80	9	plk1	plk1	PROPN
finefocus-3492	80	10	,	,	PUNCT
finefocus-3492	80	11	finding	find	VERB
finefocus-3492	80	12	that	that	SCONJ
finefocus-3492	80	13	scytonemin	scytonemin	NOUN
finefocus-3492	80	14	acts	act	VERB
finefocus-3492	80	15	as	as	ADP
finefocus-3492	80	16	a	a	DET
finefocus-3492	80	17	mixed	mixed	ADJ
finefocus-3492	80	18	inhibitor	inhibitor	NOUN
finefocus-3492	80	19	for	for	ADP
finefocus-3492	80	20	plk1	plk1	NOUN
finefocus-3492	80	21	and	and	CCONJ
finefocus-3492	80	22	functions	function	NOUN
finefocus-3492	80	23	in	in	ADP
finefocus-3492	80	24	a	a	DET
finefocus-3492	80	25	concentration	concentration	NOUN
finefocus-3492	80	26	-	-	PUNCT
finefocus-3492	80	27	dependent	dependent	ADJ
finefocus-3492	80	28	,	,	PUNCT
finefocus-3492	80	29	time	time	NOUN
finefocus-3492	80	30	-	-	PUNCT
finefocus-3492	80	31	independent	independent	ADJ
finefocus-3492	80	32	manner	manner	NOUN
finefocus-3492	80	33	to	to	PART
finefocus-3492	80	34	induce	induce	VERB
finefocus-3492	80	35	cell	cell	NOUN
finefocus-3492	80	36	cycle	cycle	NOUN
finefocus-3492	80	37	arrest	arrest	NOUN
finefocus-3492	80	38	(	(	PUNCT
finefocus-3492	80	39	15	15	NUM
finefocus-3492	80	40	,	,	PUNCT
finefocus-3492	80	41	16	16	NUM
finefocus-3492	80	42	,	,	PUNCT
finefocus-3492	80	43	18	18	NUM
finefocus-3492	80	44	)	)	PUNCT
finefocus-3492	80	45	.	.	PUNCT
finefocus-3492	81	1	by	by	ADP
finefocus-3492	81	2	looking	look	VERB
finefocus-3492	81	3	at	at	ADP
finefocus-3492	81	4	molecular	molecular	ADJ
finefocus-3492	81	5	signals	signal	NOUN
finefocus-3492	81	6	in	in	ADP
finefocus-3492	81	7	the	the	DET
finefocus-3492	81	8	cell	cell	NOUN
finefocus-3492	81	9	,	,	PUNCT
finefocus-3492	81	10	the	the	DET
finefocus-3492	81	11	specific	specific	ADJ
finefocus-3492	81	12	mechanism	mechanism	NOUN
finefocus-3492	81	13	of	of	ADP
finefocus-3492	81	14	action	action	NOUN
finefocus-3492	81	15	of	of	ADP
finefocus-3492	81	16	scytonemin	scytonemin	NOUN
finefocus-3492	81	17	appears	appear	VERB
finefocus-3492	81	18	to	to	PART
finefocus-3492	81	19	be	be	AUX
finefocus-3492	81	20	g2	g2	PROPN
finefocus-3492	81	21	to	to	ADP
finefocus-3492	81	22	m	m	PROPN
finefocus-3492	81	23	phase	phase	NOUN
finefocus-3492	81	24	cell	cell	NOUN
finefocus-3492	81	25	cycle	cycle	NOUN
finefocus-3492	81	26	arrest	arrest	NOUN
finefocus-3492	81	27	(	(	PUNCT
finefocus-3492	81	28	15	15	NUM
finefocus-3492	81	29	,	,	PUNCT
finefocus-3492	81	30	19	19	NUM
finefocus-3492	81	31	)	)	PUNCT
finefocus-3492	81	32	.	.	PUNCT
finefocus-3492	82	1	in	in	ADP
finefocus-3492	82	2	light	light	NOUN
finefocus-3492	82	3	of	of	ADP
finefocus-3492	82	4	these	these	DET
finefocus-3492	82	5	prior	prior	ADJ
finefocus-3492	82	6	findings	finding	NOUN
finefocus-3492	82	7	,	,	PUNCT
finefocus-3492	82	8	the	the	DET
finefocus-3492	82	9	results	result	NOUN
finefocus-3492	82	10	of	of	ADP
finefocus-3492	82	11	this	this	DET
finefocus-3492	82	12	study	study	NOUN
finefocus-3492	82	13	support	support	VERB
finefocus-3492	82	14	the	the	DET
finefocus-3492	82	15	anti	anti	ADJ
finefocus-3492	82	16	-	-	ADJ
finefocus-3492	82	17	proliferative	proliferative	ADJ
finefocus-3492	82	18	potential	potential	NOUN
finefocus-3492	82	19	of	of	ADP
finefocus-3492	82	20	scytonemin	scytonemin	NOUN
finefocus-3492	82	21	as	as	ADP
finefocus-3492	82	22	an	an	DET
finefocus-3492	82	23	inhibitor	inhibitor	NOUN
finefocus-3492	82	24	of	of	ADP
finefocus-3492	82	25	important	important	ADJ
finefocus-3492	82	26	cell	cell	NOUN
finefocus-3492	82	27	cycle	cycle	NOUN
finefocus-3492	82	28	enzymes	enzyme	NOUN
finefocus-3492	82	29	implicated	implicate	VERB
finefocus-3492	82	30	in	in	ADP
finefocus-3492	82	31	cancer	cancer	NOUN
finefocus-3492	82	32	growth	growth	NOUN
finefocus-3492	82	33	.	.	PUNCT
finefocus-3492	83	1	scytonemin	scytonemin	NOUN
finefocus-3492	83	2	at	at	ADP
finefocus-3492	83	3	2	2	NUM
finefocus-3492	83	4	μm	μm	NUM
finefocus-3492	83	5	and	and	CCONJ
finefocus-3492	83	6	10	10	NUM
finefocus-3492	83	7	μm	μm	NOUN
finefocus-3492	83	8	significantly	significantly	ADV
finefocus-3492	83	9	inhibited	inhibit	VERB
finefocus-3492	83	10	melanoma	melanoma	NOUN
finefocus-3492	83	11	cell	cell	NOUN
finefocus-3492	83	12	proliferation	proliferation	NOUN
finefocus-3492	83	13	by	by	ADP
finefocus-3492	83	14	greater	great	ADJ
finefocus-3492	83	15	than	than	ADP
finefocus-3492	83	16	50	50	NUM
finefocus-3492	83	17	%	%	NOUN
finefocus-3492	83	18	compared	compare	VERB
finefocus-3492	83	19	to	to	ADP
finefocus-3492	83	20	controls	control	NOUN
finefocus-3492	83	21	in	in	ADP
finefocus-3492	83	22	a	a	DET
finefocus-3492	83	23	somewhat	somewhat	ADV
finefocus-3492	83	24	concentration	concentration	NOUN
finefocus-3492	83	25	dependent	dependent	ADJ
finefocus-3492	83	26	manner	manner	NOUN
finefocus-3492	83	27	.	.	PUNCT
finefocus-3492	84	1	this	this	PRON
finefocus-3492	84	2	is	be	AUX
finefocus-3492	84	3	consistent	consistent	ADJ
finefocus-3492	84	4	with	with	ADP
finefocus-3492	84	5	other	other	ADJ
finefocus-3492	84	6	studies	study	NOUN
finefocus-3492	84	7	that	that	PRON
finefocus-3492	84	8	explore	explore	VERB
finefocus-3492	84	9	the	the	DET
finefocus-3492	84	10	effect	effect	NOUN
finefocus-3492	84	11	of	of	ADP
finefocus-3492	84	12	scytonemin	scytonemin	NOUN
finefocus-3492	84	13	on	on	ADP
finefocus-3492	84	14	malignant	malignant	ADJ
finefocus-3492	84	15	cells	cell	NOUN
finefocus-3492	84	16	(	(	PUNCT
finefocus-3492	84	17	15	15	NUM
finefocus-3492	84	18	,	,	PUNCT
finefocus-3492	84	19	18	18	NUM
finefocus-3492	84	20	,	,	PUNCT
finefocus-3492	84	21	19	19	NUM
finefocus-3492	84	22	)	)	PUNCT
finefocus-3492	84	23	.	.	PUNCT
finefocus-3492	85	1	in	in	ADP
finefocus-3492	85	2	addition	addition	NOUN
finefocus-3492	85	3	,	,	PUNCT
finefocus-3492	85	4	the	the	DET
finefocus-3492	85	5	results	result	NOUN
finefocus-3492	85	6	of	of	ADP
finefocus-3492	85	7	the	the	DET
finefocus-3492	85	8	spleen	spleen	NOUN
finefocus-3492	85	9	cell	cell	NOUN
finefocus-3492	85	10	assay	assay	NOUN
finefocus-3492	85	11	demonstrates	demonstrate	VERB
finefocus-3492	85	12	that	that	SCONJ
finefocus-3492	85	13	2	2	NUM
finefocus-3492	85	14	μm	μm	NOUN
finefocus-3492	85	15	scytonemin	scytonemin	NOUN
finefocus-3492	85	16	significantly	significantly	ADV
finefocus-3492	85	17	stimulated	stimulate	VERB
finefocus-3492	85	18	proliferation	proliferation	NOUN
finefocus-3492	85	19	volume	volume	NOUN
finefocus-3492	85	20	seven	seven	NUM
finefocus-3492	85	21	|	|	ADV
finefocus-3492	85	22	59	59	NUM
finefocus-3492	85	23	compared	compare	VERB
finefocus-3492	85	24	to	to	ADP
finefocus-3492	85	25	the	the	DET
finefocus-3492	85	26	controls	control	NOUN
finefocus-3492	85	27	,	,	PUNCT
finefocus-3492	85	28	which	which	PRON
finefocus-3492	85	29	was	be	AUX
finefocus-3492	85	30	an	an	DET
finefocus-3492	85	31	unexpected	unexpected	ADJ
finefocus-3492	85	32	outcome	outcome	NOUN
finefocus-3492	85	33	.	.	PUNCT
finefocus-3492	86	1	since	since	SCONJ
finefocus-3492	86	2	scytonemin	scytonemin	NOUN
finefocus-3492	86	3	typically	typically	ADV
finefocus-3492	86	4	inhibits	inhibit	VERB
finefocus-3492	86	5	actively	actively	ADV
finefocus-3492	86	6	proliferating	proliferate	VERB
finefocus-3492	86	7	cell	cell	NOUN
finefocus-3492	86	8	types	type	NOUN
finefocus-3492	86	9	(	(	PUNCT
finefocus-3492	86	10	15	15	NUM
finefocus-3492	86	11	)	)	PUNCT
finefocus-3492	86	12	,	,	PUNCT
finefocus-3492	86	13	there	there	PRON
finefocus-3492	86	14	was	be	VERB
finefocus-3492	86	15	some	some	DET
finefocus-3492	86	16	concern	concern	NOUN
finefocus-3492	86	17	that	that	SCONJ
finefocus-3492	86	18	it	it	PRON
finefocus-3492	86	19	would	would	AUX
finefocus-3492	86	20	inhibit	inhibit	VERB
finefocus-3492	86	21	spleen	spleen	NOUN
finefocus-3492	86	22	and	and	CCONJ
finefocus-3492	86	23	melanoma	melanoma	NOUN
finefocus-3492	86	24	cell	cell	NOUN
finefocus-3492	86	25	growth	growth	NOUN
finefocus-3492	86	26	alike	alike	ADV
finefocus-3492	86	27	.	.	PUNCT
finefocus-3492	87	1	however	however	ADV
finefocus-3492	87	2	,	,	PUNCT
finefocus-3492	87	3	this	this	PRON
finefocus-3492	87	4	was	be	AUX
finefocus-3492	87	5	not	not	PART
finefocus-3492	87	6	the	the	DET
finefocus-3492	87	7	case	case	NOUN
finefocus-3492	87	8	,	,	PUNCT
finefocus-3492	87	9	and	and	CCONJ
finefocus-3492	87	10	was	be	AUX
finefocus-3492	87	11	especially	especially	ADV
finefocus-3492	87	12	true	true	ADJ
finefocus-3492	87	13	for	for	ADP
finefocus-3492	87	14	spleen	spleen	NOUN
finefocus-3492	87	15	cells	cell	NOUN
finefocus-3492	87	16	receiving	receive	VERB
finefocus-3492	87	17	con	con	NOUN
finefocus-3492	87	18	a.	a.	NOUN
finefocus-3492	87	19	in	in	ADP
finefocus-3492	87	20	these	these	DET
finefocus-3492	87	21	cells	cell	NOUN
finefocus-3492	87	22	scytonemin	scytonemin	NOUN
finefocus-3492	87	23	appears	appear	VERB
finefocus-3492	87	24	to	to	PART
finefocus-3492	87	25	have	have	VERB
finefocus-3492	87	26	enhanced	enhance	VERB
finefocus-3492	87	27	proliferation	proliferation	NOUN
finefocus-3492	87	28	,	,	PUNCT
finefocus-3492	87	29	ranging	range	VERB
finefocus-3492	87	30	from	from	ADP
finefocus-3492	87	31	164.79	164.79	NUM
finefocus-3492	87	32	%	%	NOUN
finefocus-3492	87	33	to	to	ADP
finefocus-3492	87	34	387.00	387.00	NUM
finefocus-3492	87	35	%	%	NOUN
finefocus-3492	87	36	relative	relative	ADJ
finefocus-3492	87	37	to	to	ADP
finefocus-3492	87	38	the	the	DET
finefocus-3492	87	39	control	control	NOUN
finefocus-3492	87	40	group	group	NOUN
finefocus-3492	87	41	.	.	PUNCT
finefocus-3492	88	1	however	however	ADV
finefocus-3492	88	2	,	,	PUNCT
finefocus-3492	88	3	unlike	unlike	ADP
finefocus-3492	88	4	the	the	DET
finefocus-3492	88	5	melanoma	melanoma	NOUN
finefocus-3492	88	6	cell	cell	NOUN
finefocus-3492	88	7	assays	assay	NOUN
finefocus-3492	88	8	,	,	PUNCT
finefocus-3492	88	9	the	the	DET
finefocus-3492	88	10	spleen	spleen	NOUN
finefocus-3492	88	11	cells	cell	NOUN
finefocus-3492	88	12	were	be	AUX
finefocus-3492	88	13	not	not	PART
finefocus-3492	88	14	affected	affect	VERB
finefocus-3492	88	15	by	by	ADP
finefocus-3492	88	16	scytonemin	scytonemin	NOUN
finefocus-3492	88	17	in	in	ADP
finefocus-3492	88	18	a	a	DET
finefocus-3492	88	19	concentration	concentration	NOUN
finefocus-3492	88	20	-	-	PUNCT
finefocus-3492	88	21	dependent	dependent	ADJ
finefocus-3492	88	22	manner	manner	NOUN
finefocus-3492	88	23	through	through	ADP
finefocus-3492	88	24	10	10	NUM
finefocus-3492	88	25	μm	μm	NOUN
finefocus-3492	88	26	of	of	ADP
finefocus-3492	88	27	scytonemin	scytonemin	NOUN
finefocus-3492	88	28	.	.	PUNCT
finefocus-3492	89	1	this	this	DET
finefocus-3492	89	2	result	result	NOUN
finefocus-3492	89	3	could	could	AUX
finefocus-3492	89	4	be	be	AUX
finefocus-3492	89	5	due	due	ADJ
finefocus-3492	89	6	to	to	ADP
finefocus-3492	89	7	high	high	ADJ
finefocus-3492	89	8	standard	standard	ADJ
finefocus-3492	89	9	errors	error	NOUN
finefocus-3492	89	10	or	or	CCONJ
finefocus-3492	89	11	data	datum	NOUN
finefocus-3492	89	12	resolution	resolution	NOUN
finefocus-3492	89	13	,	,	PUNCT
finefocus-3492	89	14	which	which	PRON
finefocus-3492	89	15	does	do	AUX
finefocus-3492	89	16	not	not	PART
finefocus-3492	89	17	show	show	VERB
finefocus-3492	89	18	the	the	DET
finefocus-3492	89	19	trend	trend	NOUN
finefocus-3492	89	20	between	between	ADP
finefocus-3492	89	21	0.4	0.4	NUM
finefocus-3492	89	22	to	to	PART
finefocus-3492	89	23	2	2	NUM
finefocus-3492	89	24	μm	μm	NOUN
finefocus-3492	89	25	of	of	ADP
finefocus-3492	89	26	scytonemin	scytonemin	NOUN
finefocus-3492	89	27	.	.	PUNCT
finefocus-3492	90	1	nonetheless	nonetheless	ADV
finefocus-3492	90	2	,	,	PUNCT
finefocus-3492	90	3	the	the	DET
finefocus-3492	90	4	data	data	NOUN
finefocus-3492	90	5	suggests	suggest	VERB
finefocus-3492	90	6	that	that	SCONJ
finefocus-3492	90	7	scytonemin	scytonemin	NOUN
finefocus-3492	90	8	inhibits	inhibit	VERB
finefocus-3492	90	9	melanoma	melanoma	NOUN
finefocus-3492	90	10	cells	cell	NOUN
finefocus-3492	90	11	without	without	ADP
finefocus-3492	90	12	hindering	hinder	VERB
finefocus-3492	90	13	spleen	spleen	NOUN
finefocus-3492	90	14	cell	cell	NOUN
finefocus-3492	90	15	proliferation	proliferation	NOUN
finefocus-3492	90	16	.	.	PUNCT
finefocus-3492	91	1	given	give	VERB
finefocus-3492	91	2	that	that	SCONJ
finefocus-3492	91	3	scytonemin	scytonemin	NOUN
finefocus-3492	91	4	inhibits	inhibit	VERB
finefocus-3492	91	5	melanoma	melanoma	NOUN
finefocus-3492	91	6	cell	cell	NOUN
finefocus-3492	91	7	proliferation	proliferation	NOUN
finefocus-3492	91	8	and	and	CCONJ
finefocus-3492	91	9	potentially	potentially	ADV
finefocus-3492	91	10	increases	increase	VERB
finefocus-3492	91	11	spleen	spleen	NOUN
finefocus-3492	91	12	cell	cell	NOUN
finefocus-3492	91	13	proliferation	proliferation	NOUN
finefocus-3492	91	14	,	,	PUNCT
finefocus-3492	91	15	it	it	PRON
finefocus-3492	91	16	is	be	AUX
finefocus-3492	91	17	a	a	DET
finefocus-3492	91	18	promising	promising	ADJ
finefocus-3492	91	19	therapeutic	therapeutic	ADJ
finefocus-3492	91	20	agent	agent	NOUN
finefocus-3492	91	21	for	for	ADP
finefocus-3492	91	22	melanoma	melanoma	NOUN
finefocus-3492	91	23	treatment	treatment	NOUN
finefocus-3492	91	24	because	because	SCONJ
finefocus-3492	91	25	it	it	PRON
finefocus-3492	91	26	can	can	AUX
finefocus-3492	91	27	slow	slow	VERB
finefocus-3492	91	28	cell	cell	NOUN
finefocus-3492	91	29	growth	growth	NOUN
finefocus-3492	91	30	while	while	SCONJ
finefocus-3492	91	31	figure	figure	NOUN
finefocus-3492	91	32	2	2	NUM
finefocus-3492	91	33	.	.	PUNCT
finefocus-3492	91	34	figure	figure	NOUN
finefocus-3492	91	35	2	2	NUM
finefocus-3492	91	36	.	.	PUNCT
finefocus-3492	91	37	percent	percent	NOUN
finefocus-3492	91	38	inhibition	inhibition	NOUN
finefocus-3492	91	39	of	of	ADP
finefocus-3492	91	40	melanoma	melanoma	NOUN
finefocus-3492	91	41	cells	cell	NOUN
finefocus-3492	91	42	compared	compare	VERB
finefocus-3492	91	43	to	to	ADP
finefocus-3492	91	44	the	the	DET
finefocus-3492	91	45	untreated	untreated	ADJ
finefocus-3492	91	46	control	control	NOUN
finefocus-3492	91	47	for	for	ADP
finefocus-3492	91	48	various	various	ADJ
finefocus-3492	91	49	concentrations	concentration	NOUN
finefocus-3492	91	50	of	of	ADP
finefocus-3492	91	51	scytonemin	scytonemin	PROPN
finefocus-3492	91	52	.	.	PUNCT
finefocus-3492	91	53	error	error	NOUN
finefocus-3492	91	54	bars	bar	NOUN
finefocus-3492	91	55	represent	represent	VERB
finefocus-3492	91	56	the	the	DET
finefocus-3492	91	57	standard	standard	ADJ
finefocus-3492	91	58	error	error	NOUN
finefocus-3492	91	59	of	of	ADP
finefocus-3492	91	60	nine	nine	NUM
finefocus-3492	91	61	replicates	replicate	NOUN
finefocus-3492	91	62	.	.	PUNCT
finefocus-3492	92	1	significant	significant	ADJ
finefocus-3492	92	2	inhibition	inhibition	NOUN
finefocus-3492	92	3	compared	compare	VERB
finefocus-3492	92	4	to	to	ADP
finefocus-3492	92	5	the	the	DET
finefocus-3492	92	6	control	control	NOUN
finefocus-3492	92	7	is	be	AUX
finefocus-3492	92	8	marked	mark	VERB
finefocus-3492	92	9	with	with	ADP
finefocus-3492	92	10	an	an	DET
finefocus-3492	92	11	asterisk	asterisk	NOUN
finefocus-3492	92	12	,	,	PUNCT
finefocus-3492	92	13	for	for	ADP
finefocus-3492	92	14	both	both	CCONJ
finefocus-3492	92	15	the	the	DET
finefocus-3492	92	16	2	2	NUM
finefocus-3492	92	17	µm	µm	NOUN
finefocus-3492	92	18	and	and	CCONJ
finefocus-3492	92	19	10	10	NUM
finefocus-3492	92	20	µm	µm	NOUN
finefocus-3492	92	21	samples	sample	NOUN
finefocus-3492	92	22	,	,	PUNCT
finefocus-3492	92	23	p	p	X
finefocus-3492	92	24	<	<	X
finefocus-3492	92	25	0.0001	0.0001	NUM
finefocus-3492	92	26	.	.	PUNCT
finefocus-3492	93	1	figure	figure	NOUN
finefocus-3492	93	2	4	4	NUM
finefocus-3492	93	3	.	.	NOUN
finefocus-3492	93	4	60	60	NUM
finefocus-3492	94	1	|	|	ADV
finefocus-3492	94	2	fine	fine	ADJ
finefocus-3492	94	3	focus	focus	NOUN
finefocus-3492	94	4	simultaneously	simultaneously	ADV
finefocus-3492	94	5	augmenting	augment	VERB
finefocus-3492	94	6	the	the	DET
finefocus-3492	94	7	immune	immune	ADJ
finefocus-3492	94	8	system	system	NOUN
finefocus-3492	94	9	.	.	PUNCT
finefocus-3492	95	1	the	the	DET
finefocus-3492	95	2	in	in	ADP
finefocus-3492	95	3	vivo	vivo	ADJ
finefocus-3492	95	4	experiments	experiment	NOUN
finefocus-3492	95	5	on	on	ADP
finefocus-3492	95	6	mice	mouse	NOUN
finefocus-3492	95	7	evaluating	evaluate	VERB
finefocus-3492	95	8	the	the	DET
finefocus-3492	95	9	number	number	NOUN
finefocus-3492	95	10	of	of	ADP
finefocus-3492	95	11	tumors	tumor	NOUN
finefocus-3492	95	12	formed	form	VERB
finefocus-3492	95	13	with	with	ADP
finefocus-3492	95	14	and	and	CCONJ
finefocus-3492	95	15	without	without	ADP
finefocus-3492	95	16	the	the	DET
finefocus-3492	95	17	presence	presence	NOUN
finefocus-3492	95	18	of	of	ADP
finefocus-3492	95	19	scytonemin	scytonemin	NOUN
finefocus-3492	95	20	favored	favor	VERB
finefocus-3492	95	21	the	the	DET
finefocus-3492	95	22	inhibitory	inhibitory	ADJ
finefocus-3492	95	23	effects	effect	NOUN
finefocus-3492	95	24	of	of	ADP
finefocus-3492	95	25	scytonemin	scytonemin	NOUN
finefocus-3492	95	26	.	.	PUNCT
finefocus-3492	96	1	even	even	ADV
finefocus-3492	96	2	though	though	SCONJ
finefocus-3492	96	3	there	there	PRON
finefocus-3492	96	4	were	be	VERB
finefocus-3492	96	5	no	no	DET
finefocus-3492	96	6	significant	significant	ADJ
finefocus-3492	96	7	differences	difference	NOUN
finefocus-3492	96	8	in	in	ADP
finefocus-3492	96	9	the	the	DET
finefocus-3492	96	10	number	number	NOUN
finefocus-3492	96	11	of	of	ADP
finefocus-3492	96	12	melanoma	melanoma	NOUN
finefocus-3492	96	13	tumors	tumor	NOUN
finefocus-3492	96	14	in	in	ADP
finefocus-3492	96	15	untreated	untreated	ADJ
finefocus-3492	96	16	mice	mouse	NOUN
finefocus-3492	96	17	versus	versus	ADP
finefocus-3492	96	18	those	those	PRON
finefocus-3492	96	19	treated	treat	VERB
finefocus-3492	96	20	with	with	ADP
finefocus-3492	96	21	scytonemin	scytonemin	NOUN
finefocus-3492	96	22	,	,	PUNCT
finefocus-3492	96	23	the	the	DET
finefocus-3492	96	24	averages	average	NOUN
finefocus-3492	96	25	themselves	themselves	PRON
finefocus-3492	96	26	indicate	indicate	VERB
finefocus-3492	96	27	that	that	SCONJ
finefocus-3492	96	28	with	with	ADP
finefocus-3492	96	29	additional	additional	ADJ
finefocus-3492	96	30	studies	study	NOUN
finefocus-3492	96	31	there	there	PRON
finefocus-3492	96	32	may	may	AUX
finefocus-3492	96	33	be	be	AUX
finefocus-3492	96	34	some	some	DET
finefocus-3492	96	35	inhibitory	inhibitory	ADJ
finefocus-3492	96	36	effect	effect	NOUN
finefocus-3492	96	37	of	of	ADP
finefocus-3492	96	38	scytonemin	scytonemin	NOUN
finefocus-3492	96	39	on	on	ADP
finefocus-3492	96	40	melanoma	melanoma	NOUN
finefocus-3492	96	41	tumor	tumor	NOUN
finefocus-3492	96	42	cells	cell	NOUN
finefocus-3492	96	43	.	.	PUNCT
finefocus-3492	97	1	these	these	DET
finefocus-3492	97	2	studies	study	NOUN
finefocus-3492	97	3	could	could	AUX
finefocus-3492	97	4	benefit	benefit	VERB
finefocus-3492	97	5	by	by	ADP
finefocus-3492	97	6	a	a	DET
finefocus-3492	97	7	dose	dose	NOUN
finefocus-3492	97	8	-	-	PUNCT
finefocus-3492	97	9	dependent	dependent	ADJ
finefocus-3492	97	10	analysis	analysis	NOUN
finefocus-3492	97	11	.	.	PUNCT
finefocus-3492	98	1	the	the	DET
finefocus-3492	98	2	concentration	concentration	NOUN
finefocus-3492	98	3	of	of	ADP
finefocus-3492	98	4	scytonemin	scytonemin	NOUN
finefocus-3492	98	5	used	use	VERB
finefocus-3492	98	6	was	be	AUX
finefocus-3492	98	7	based	base	VERB
finefocus-3492	98	8	on	on	ADP
finefocus-3492	98	9	a	a	DET
finefocus-3492	98	10	study	study	NOUN
finefocus-3492	98	11	using	use	VERB
finefocus-3492	98	12	jurkat	jurkat	PROPN
finefocus-3492	98	13	t	t	PROPN
finefocus-3492	98	14	cells	cell	NOUN
finefocus-3492	98	15	(	(	PUNCT
finefocus-3492	98	16	15	15	NUM
finefocus-3492	98	17	)	)	PUNCT
finefocus-3492	98	18	and	and	CCONJ
finefocus-3492	98	19	it	it	PRON
finefocus-3492	98	20	may	may	AUX
finefocus-3492	98	21	have	have	AUX
finefocus-3492	98	22	not	not	PART
finefocus-3492	98	23	been	be	AUX
finefocus-3492	98	24	ideal	ideal	ADJ
finefocus-3492	98	25	to	to	PART
finefocus-3492	98	26	use	use	VERB
finefocus-3492	98	27	the	the	DET
finefocus-3492	98	28	same	same	ADJ
finefocus-3492	98	29	concentration	concentration	NOUN
finefocus-3492	98	30	in	in	ADP
finefocus-3492	98	31	a	a	DET
finefocus-3492	98	32	study	study	NOUN
finefocus-3492	98	33	on	on	ADP
finefocus-3492	98	34	melanoma	melanoma	PROPN
finefocus-3492	98	35	tumor	tumor	NOUN
finefocus-3492	98	36	development	development	NOUN
finefocus-3492	98	37	.	.	PUNCT
finefocus-3492	99	1	to	to	PART
finefocus-3492	99	2	better	well	ADV
finefocus-3492	99	3	compare	compare	VERB
finefocus-3492	99	4	the	the	DET
finefocus-3492	99	5	inhibitory	inhibitory	ADJ
finefocus-3492	99	6	effects	effect	NOUN
finefocus-3492	99	7	of	of	ADP
finefocus-3492	99	8	scytonemin	scytonemin	NOUN
finefocus-3492	99	9	with	with	ADP
finefocus-3492	99	10	the	the	DET
finefocus-3492	99	11	previous	previous	ADJ
finefocus-3492	99	12	body	body	NOUN
finefocus-3492	99	13	of	of	ADP
finefocus-3492	99	14	knowledge	knowledge	NOUN
finefocus-3492	99	15	,	,	PUNCT
finefocus-3492	99	16	the	the	DET
finefocus-3492	99	17	inhibitory	inhibitory	ADJ
finefocus-3492	99	18	concentration	concentration	NOUN
finefocus-3492	99	19	at	at	ADP
finefocus-3492	99	20	50	50	NUM
finefocus-3492	99	21	%	%	NOUN
finefocus-3492	99	22	inhibition	inhibition	NOUN
finefocus-3492	99	23	(	(	PUNCT
finefocus-3492	99	24	ic50	ic50	PROPN
finefocus-3492	99	25	)	)	PUNCT
finefocus-3492	99	26	was	be	AUX
finefocus-3492	99	27	determined	determine	VERB
finefocus-3492	99	28	.	.	PUNCT
finefocus-3492	100	1	this	this	DET
finefocus-3492	100	2	value	value	NOUN
finefocus-3492	100	3	represents	represent	VERB
finefocus-3492	100	4	the	the	DET
finefocus-3492	100	5	concentration	concentration	NOUN
finefocus-3492	100	6	of	of	ADP
finefocus-3492	100	7	scytonemin	scytonemin	NOUN
finefocus-3492	100	8	at	at	ADP
finefocus-3492	100	9	which	which	PRON
finefocus-3492	100	10	cell	cell	NOUN
finefocus-3492	100	11	proliferation	proliferation	NOUN
finefocus-3492	100	12	is	be	AUX
finefocus-3492	100	13	stunted	stunt	VERB
finefocus-3492	100	14	by	by	ADP
finefocus-3492	100	15	50	50	NUM
finefocus-3492	100	16	%	%	NOUN
finefocus-3492	100	17	relative	relative	ADJ
finefocus-3492	100	18	to	to	ADP
finefocus-3492	100	19	the	the	DET
finefocus-3492	100	20	control	control	NOUN
finefocus-3492	100	21	.	.	PUNCT
finefocus-3492	101	1	in	in	ADP
finefocus-3492	101	2	a	a	DET
finefocus-3492	101	3	regression	regression	NOUN
finefocus-3492	101	4	analysis	analysis	NOUN
finefocus-3492	101	5	of	of	ADP
finefocus-3492	101	6	scytonemin	scytonemin	ADJ
finefocus-3492	101	7	concentration	concentration	NOUN
finefocus-3492	101	8	versus	versus	ADP
finefocus-3492	101	9	percent	percent	NOUN
finefocus-3492	101	10	inhibition	inhibition	NOUN
finefocus-3492	101	11	of	of	ADP
finefocus-3492	101	12	melanoma	melanoma	ADJ
finefocus-3492	101	13	proliferation	proliferation	NOUN
finefocus-3492	101	14	,	,	PUNCT
finefocus-3492	101	15	a	a	DET
finefocus-3492	101	16	positive	positive	ADJ
finefocus-3492	101	17	correlation	correlation	NOUN
finefocus-3492	101	18	(	(	PUNCT
finefocus-3492	101	19	r2	r2	NOUN
finefocus-3492	101	20	=	=	NOUN
finefocus-3492	101	21	0.89	0.89	NUM
finefocus-3492	101	22	)	)	PUNCT
finefocus-3492	101	23	was	be	AUX
finefocus-3492	101	24	identified	identify	VERB
finefocus-3492	101	25	(	(	PUNCT
finefocus-3492	101	26	fig	fig	NOUN
finefocus-3492	101	27	.	.	PUNCT
finefocus-3492	101	28	4	4	NUM
finefocus-3492	101	29	)	)	PUNCT
finefocus-3492	101	30	.	.	PUNCT
finefocus-3492	102	1	using	use	VERB
finefocus-3492	102	2	this	this	DET
finefocus-3492	102	3	regression	regression	NOUN
finefocus-3492	102	4	plot	plot	NOUN
finefocus-3492	102	5	,	,	PUNCT
finefocus-3492	102	6	the	the	DET
finefocus-3492	102	7	ic50	ic50	PROPN
finefocus-3492	102	8	for	for	ADP
finefocus-3492	102	9	scytonemin	scytonemin	NOUN
finefocus-3492	102	10	on	on	ADP
finefocus-3492	102	11	melanoma	melanoma	NOUN
finefocus-3492	102	12	cells	cell	NOUN
finefocus-3492	102	13	was	be	AUX
finefocus-3492	102	14	determined	determine	VERB
finefocus-3492	102	15	to	to	PART
finefocus-3492	102	16	be	be	AUX
finefocus-3492	102	17	approximately	approximately	ADV
finefocus-3492	102	18	1.66	1.66	NUM
finefocus-3492	102	19	±	±	NUM
finefocus-3492	102	20	0.34	0.34	NUM
finefocus-3492	102	21	μm	μm	NOUN
finefocus-3492	102	22	.	.	PUNCT
finefocus-3492	103	1	in	in	ADP
finefocus-3492	103	2	a	a	DET
finefocus-3492	103	3	similar	similar	ADJ
finefocus-3492	103	4	study	study	NOUN
finefocus-3492	103	5	measuring	measure	VERB
finefocus-3492	103	6	the	the	DET
finefocus-3492	103	7	effects	effect	NOUN
finefocus-3492	103	8	of	of	ADP
finefocus-3492	103	9	scytonemin	scytonemin	NOUN
finefocus-3492	103	10	on	on	ADP
finefocus-3492	103	11	the	the	DET
finefocus-3492	103	12	cancerous	cancerous	ADJ
finefocus-3492	103	13	jurkat	jurkat	NOUN
finefocus-3492	103	14	t	t	PROPN
finefocus-3492	103	15	cell	cell	NOUN
finefocus-3492	103	16	line	line	NOUN
finefocus-3492	103	17	,	,	PUNCT
finefocus-3492	103	18	the	the	DET
finefocus-3492	103	19	ic50	ic50	PROPN
finefocus-3492	103	20	was	be	AUX
finefocus-3492	103	21	determined	determined	ADJ
finefocus-3492	103	22	to	to	PART
finefocus-3492	103	23	be	be	AUX
finefocus-3492	103	24	2.5	2.5	NUM
finefocus-3492	103	25	±	±	NUM
finefocus-3492	103	26	0.6	0.6	NUM
finefocus-3492	103	27	μm	μm	NOUN
finefocus-3492	103	28	(	(	PUNCT
finefocus-3492	103	29	15	15	NUM
finefocus-3492	103	30	)	)	PUNCT
finefocus-3492	103	31	.	.	PUNCT
finefocus-3492	104	1	these	these	DET
finefocus-3492	104	2	relatively	relatively	ADV
finefocus-3492	104	3	close	close	ADJ
finefocus-3492	104	4	values	value	NOUN
finefocus-3492	104	5	could	could	AUX
finefocus-3492	104	6	help	help	VERB
finefocus-3492	104	7	inform	inform	VERB
finefocus-3492	104	8	future	future	ADJ
finefocus-3492	104	9	research	research	NOUN
finefocus-3492	104	10	studies	study	NOUN
finefocus-3492	104	11	exploring	explore	VERB
finefocus-3492	104	12	the	the	DET
finefocus-3492	104	13	benefits	benefit	NOUN
finefocus-3492	104	14	of	of	ADP
finefocus-3492	104	15	scytonemin	scytonemin	NOUN
finefocus-3492	104	16	as	as	ADP
finefocus-3492	104	17	an	an	DET
finefocus-3492	104	18	antiproliferative	antiproliferative	NOUN
finefocus-3492	104	19	therapeutic	therapeutic	ADJ
finefocus-3492	104	20	.	.	PUNCT
finefocus-3492	105	1	the	the	DET
finefocus-3492	105	2	results	result	NOUN
finefocus-3492	105	3	of	of	ADP
finefocus-3492	105	4	this	this	DET
finefocus-3492	105	5	study	study	NOUN
finefocus-3492	105	6	support	support	NOUN
finefocus-3492	105	7	that	that	PRON
finefocus-3492	105	8	scytonemin	scytonemin	NOUN
finefocus-3492	105	9	inhibits	inhibit	VERB
finefocus-3492	105	10	melanoma	melanoma	NOUN
finefocus-3492	105	11	cell	cell	NOUN
finefocus-3492	105	12	proliferation	proliferation	NOUN
finefocus-3492	105	13	and	and	CCONJ
finefocus-3492	105	14	enhances	enhance	VERB
finefocus-3492	105	15	the	the	DET
finefocus-3492	105	16	immune	immune	ADJ
finefocus-3492	105	17	response	response	NOUN
finefocus-3492	105	18	via	via	ADP
finefocus-3492	105	19	spleen	spleen	NOUN
finefocus-3492	105	20	cell	cell	NOUN
finefocus-3492	105	21	proliferation	proliferation	NOUN
finefocus-3492	105	22	.	.	PUNCT
finefocus-3492	106	1	as	as	ADP
finefocus-3492	106	2	a	a	DET
finefocus-3492	106	3	result	result	NOUN
finefocus-3492	106	4	,	,	PUNCT
finefocus-3492	106	5	future	future	ADJ
finefocus-3492	106	6	research	research	NOUN
finefocus-3492	106	7	should	should	AUX
finefocus-3492	106	8	examine	examine	VERB
finefocus-3492	106	9	the	the	DET
finefocus-3492	106	10	role	role	NOUN
finefocus-3492	106	11	of	of	ADP
finefocus-3492	106	12	scytonemin	scytonemin	NOUN
finefocus-3492	106	13	on	on	ADP
finefocus-3492	106	14	in	in	ADP
finefocus-3492	106	15	vivo	vivo	ADJ
finefocus-3492	106	16	tumor	tumor	NOUN
finefocus-3492	106	17	growth	growth	NOUN
finefocus-3492	106	18	beyond	beyond	ADP
finefocus-3492	106	19	our	our	PRON
finefocus-3492	106	20	studies	study	NOUN
finefocus-3492	106	21	to	to	PART
finefocus-3492	106	22	determine	determine	VERB
finefocus-3492	106	23	whether	whether	SCONJ
finefocus-3492	106	24	scytonemin	scytonemin	NOUN
finefocus-3492	106	25	functionally	functionally	ADV
finefocus-3492	106	26	inhibits	inhibit	VERB
finefocus-3492	106	27	malignant	malignant	ADJ
finefocus-3492	106	28	growth	growth	NOUN
finefocus-3492	106	29	in	in	ADP
finefocus-3492	106	30	body	body	NOUN
finefocus-3492	106	31	systems	system	NOUN
finefocus-3492	106	32	without	without	ADP
finefocus-3492	106	33	cytotoxicity	cytotoxicity	NOUN
finefocus-3492	106	34	to	to	ADP
finefocus-3492	106	35	healthy	healthy	ADJ
finefocus-3492	106	36	cells	cell	NOUN
finefocus-3492	106	37	.	.	PUNCT
finefocus-3492	107	1	further	far	ADV
finefocus-3492	107	2	,	,	PUNCT
finefocus-3492	107	3	in	in	ADP
finefocus-3492	107	4	vivo	vivo	ADJ
finefocus-3492	107	5	systems	system	NOUN
finefocus-3492	107	6	can	can	AUX
finefocus-3492	107	7	be	be	AUX
finefocus-3492	107	8	used	use	VERB
finefocus-3492	107	9	to	to	PART
finefocus-3492	107	10	examine	examine	VERB
finefocus-3492	107	11	the	the	DET
finefocus-3492	107	12	response	response	NOUN
finefocus-3492	107	13	of	of	ADP
finefocus-3492	107	14	the	the	DET
finefocus-3492	107	15	immune	immune	ADJ
finefocus-3492	107	16	system	system	NOUN
finefocus-3492	107	17	to	to	PART
finefocus-3492	107	18	scytonemin	scytonemin	VERB
finefocus-3492	107	19	,	,	PUNCT
finefocus-3492	107	20	to	to	ADP
finefocus-3492	107	21	potentially	potentially	ADV
finefocus-3492	107	22	affirm	affirm	ADJ
finefocus-3492	107	23	enhanced	enhance	VERB
finefocus-3492	107	24	spleen	spleen	NOUN
finefocus-3492	107	25	cell	cell	NOUN
finefocus-3492	107	26	proliferation	proliferation	NOUN
finefocus-3492	107	27	and	and	CCONJ
finefocus-3492	107	28	examine	examine	VERB
finefocus-3492	107	29	other	other	ADJ
finefocus-3492	107	30	cytokines	cytokine	NOUN
finefocus-3492	107	31	and	and	CCONJ
finefocus-3492	107	32	immune	immune	ADJ
finefocus-3492	107	33	figure	figure	NOUN
finefocus-3492	107	34	3	3	NUM
finefocus-3492	107	35	.	.	PUNCT
finefocus-3492	107	36	figure	figure	VERB
finefocus-3492	107	37	3	3	NUM
finefocus-3492	107	38	.	.	NOUN
finefocus-3492	107	39	percent	percent	NOUN
finefocus-3492	107	40	proliferation	proliferation	NOUN
finefocus-3492	107	41	of	of	ADP
finefocus-3492	107	42	spleen	spleen	NOUN
finefocus-3492	107	43	cells	cell	NOUN
finefocus-3492	107	44	compared	compare	VERB
finefocus-3492	107	45	to	to	ADP
finefocus-3492	107	46	the	the	DET
finefocus-3492	107	47	control	control	NOUN
finefocus-3492	107	48	for	for	ADP
finefocus-3492	107	49	various	various	ADJ
finefocus-3492	107	50	concentrations	concentration	NOUN
finefocus-3492	107	51	of	of	ADP
finefocus-3492	107	52	scytonemin	scytonemin	NOUN
finefocus-3492	107	53	in	in	ADP
finefocus-3492	107	54	the	the	DET
finefocus-3492	107	55	absence	absence	NOUN
finefocus-3492	107	56	(	(	PUNCT
finefocus-3492	107	57	white	white	ADJ
finefocus-3492	107	58	bars	bar	NOUN
finefocus-3492	107	59	)	)	PUNCT
finefocus-3492	107	60	and	and	CCONJ
finefocus-3492	107	61	presence	presence	NOUN
finefocus-3492	107	62	(	(	PUNCT
finefocus-3492	107	63	black	black	ADJ
finefocus-3492	107	64	bars	bar	NOUN
finefocus-3492	107	65	)	)	PUNCT
finefocus-3492	107	66	of	of	ADP
finefocus-3492	107	67	con	con	PROPN
finefocus-3492	107	68	a.	a.	NOUN
finefocus-3492	107	69	error	error	NOUN
finefocus-3492	107	70	bars	bar	NOUN
finefocus-3492	107	71	represent	represent	VERB
finefocus-3492	107	72	the	the	DET
finefocus-3492	107	73	standard	standard	ADJ
finefocus-3492	107	74	error	error	NOUN
finefocus-3492	107	75	of	of	ADP
finefocus-3492	107	76	nine	nine	NUM
finefocus-3492	107	77	replicates	replicate	NOUN
finefocus-3492	107	78	.	.	PUNCT
finefocus-3492	108	1	significant	significant	ADJ
finefocus-3492	108	2	inhibition	inhibition	NOUN
finefocus-3492	108	3	compared	compare	VERB
finefocus-3492	108	4	to	to	ADP
finefocus-3492	108	5	the	the	DET
finefocus-3492	108	6	control	control	NOUN
finefocus-3492	108	7	is	be	AUX
finefocus-3492	108	8	marked	mark	VERB
finefocus-3492	108	9	with	with	ADP
finefocus-3492	108	10	an	an	DET
finefocus-3492	108	11	asterisk	asterisk	NOUN
finefocus-3492	108	12	,	,	PUNCT
finefocus-3492	108	13	at	at	ADP
finefocus-3492	108	14	2	2	NUM
finefocus-3492	108	15	µm	µm	ADP
finefocus-3492	108	16	scytonemin	scytonemin	NOUN
finefocus-3492	108	17	,	,	PUNCT
finefocus-3492	108	18	p	p	NOUN
finefocus-3492	108	19	=	=	NOUN
finefocus-3492	108	20	0.0012	0.0012	NUM
finefocus-3492	108	21	for	for	ADP
finefocus-3492	108	22	cells	cell	NOUN
finefocus-3492	108	23	with	with	ADP
finefocus-3492	108	24	and	and	CCONJ
finefocus-3492	108	25	without	without	ADP
finefocus-3492	108	26	con	con	PROPN
finefocus-3492	108	27	a.	a.	NOUN
finefocus-3492	108	28	biorender.com	biorender.com	PROPN
finefocus-3492	108	29	.	.	PUNCT
finefocus-3492	109	1	volume	volume	NOUN
finefocus-3492	109	2	seven	seven	NUM
finefocus-3492	109	3	|	|	ADV
finefocus-3492	109	4	61	61	NUM
finefocus-3492	109	5	cells	cell	NOUN
finefocus-3492	109	6	.	.	PUNCT
finefocus-3492	110	1	research	research	NOUN
finefocus-3492	110	2	could	could	AUX
finefocus-3492	110	3	also	also	ADV
finefocus-3492	110	4	focus	focus	VERB
finefocus-3492	110	5	on	on	ADP
finefocus-3492	110	6	experimental	experimental	ADJ
finefocus-3492	110	7	cancer	cancer	NOUN
finefocus-3492	110	8	therapies	therapy	NOUN
finefocus-3492	110	9	using	use	VERB
finefocus-3492	110	10	scytonemin	scytonemin	NOUN
finefocus-3492	110	11	to	to	PART
finefocus-3492	110	12	prevent	prevent	VERB
finefocus-3492	110	13	tumors	tumor	NOUN
finefocus-3492	110	14	from	from	ADP
finefocus-3492	110	15	growing	grow	VERB
finefocus-3492	110	16	and	and	CCONJ
finefocus-3492	110	17	metastasizing	metastasizing	NOUN
finefocus-3492	110	18	.	.	PUNCT
finefocus-3492	111	1	since	since	SCONJ
finefocus-3492	111	2	a	a	DET
finefocus-3492	111	3	growing	grow	VERB
finefocus-3492	111	4	body	body	NOUN
finefocus-3492	111	5	of	of	ADP
finefocus-3492	111	6	literature	literature	NOUN
finefocus-3492	111	7	suggests	suggest	VERB
finefocus-3492	111	8	that	that	SCONJ
finefocus-3492	111	9	scytonemin	scytonemin	NOUN
finefocus-3492	111	10	acts	act	VERB
finefocus-3492	111	11	as	as	ADP
finefocus-3492	111	12	an	an	DET
finefocus-3492	111	13	inhibitor	inhibitor	NOUN
finefocus-3492	111	14	for	for	ADP
finefocus-3492	111	15	plk1	plk1	NOUN
finefocus-3492	111	16	(	(	PUNCT
finefocus-3492	111	17	15	15	NUM
finefocus-3492	111	18	,	,	PUNCT
finefocus-3492	111	19	16	16	NUM
finefocus-3492	111	20	,	,	PUNCT
finefocus-3492	111	21	18	18	NUM
finefocus-3492	111	22	,	,	PUNCT
finefocus-3492	111	23	19	19	NUM
finefocus-3492	111	24	)	)	PUNCT
finefocus-3492	111	25	,	,	PUNCT
finefocus-3492	111	26	the	the	DET
finefocus-3492	111	27	role	role	NOUN
finefocus-3492	111	28	of	of	ADP
finefocus-3492	111	29	plk1	plk1	NOUN
finefocus-3492	111	30	in	in	ADP
finefocus-3492	111	31	melanoma	melanoma	NOUN
finefocus-3492	111	32	and	and	CCONJ
finefocus-3492	111	33	spleen	spleen	NOUN
finefocus-3492	111	34	cell	cell	NOUN
finefocus-3492	111	35	proliferation	proliferation	NOUN
finefocus-3492	111	36	should	should	AUX
finefocus-3492	111	37	be	be	AUX
finefocus-3492	111	38	further	far	ADV
finefocus-3492	111	39	studied	study	VERB
finefocus-3492	111	40	.	.	PUNCT
finefocus-3492	112	1	in	in	ADP
finefocus-3492	112	2	addition	addition	NOUN
finefocus-3492	112	3	,	,	PUNCT
finefocus-3492	112	4	since	since	SCONJ
finefocus-3492	112	5	dimethoxyscytonemin	dimethoxyscytonemin	NOUN
finefocus-3492	112	6	binds	bind	VERB
finefocus-3492	112	7	to	to	ADP
finefocus-3492	112	8	plk1	plk1	NOUN
finefocus-3492	112	9	with	with	ADP
finefocus-3492	112	10	high	high	ADJ
finefocus-3492	112	11	affinity	affinity	NOUN
finefocus-3492	112	12	(	(	PUNCT
finefocus-3492	112	13	9	9	NUM
finefocus-3492	112	14	)	)	PUNCT
finefocus-3492	112	15	,	,	PUNCT
finefocus-3492	112	16	it	it	PRON
finefocus-3492	112	17	would	would	AUX
finefocus-3492	112	18	be	be	AUX
finefocus-3492	112	19	interesting	interesting	ADJ
finefocus-3492	112	20	to	to	PART
finefocus-3492	112	21	study	study	VERB
finefocus-3492	112	22	how	how	SCONJ
finefocus-3492	112	23	this	this	DET
finefocus-3492	112	24	scytonemin	scytonemin	ADJ
finefocus-3492	112	25	derivative	derivative	NOUN
finefocus-3492	112	26	affects	affect	VERB
finefocus-3492	112	27	proliferation	proliferation	NOUN
finefocus-3492	112	28	in	in	ADP
finefocus-3492	112	29	melanoma	melanoma	NOUN
finefocus-3492	112	30	and	and	CCONJ
finefocus-3492	112	31	spleen	spleen	NOUN
finefocus-3492	112	32	cell	cell	NOUN
finefocus-3492	112	33	assays	assay	NOUN
finefocus-3492	112	34	compared	compare	VERB
finefocus-3492	112	35	to	to	ADP
finefocus-3492	112	36	purified	purified	ADJ
finefocus-3492	112	37	scytonemin	scytonemin	NOUN
finefocus-3492	112	38	.	.	PUNCT
finefocus-3492	113	1	overall	overall	ADJ
finefocus-3492	113	2	this	this	DET
finefocus-3492	113	3	study	study	NOUN
finefocus-3492	113	4	,	,	PUNCT
finefocus-3492	113	5	along	along	ADP
finefocus-3492	113	6	with	with	ADP
finefocus-3492	113	7	prior	prior	ADJ
finefocus-3492	113	8	research	research	NOUN
finefocus-3492	113	9	,	,	PUNCT
finefocus-3492	113	10	provides	provide	VERB
finefocus-3492	113	11	evidence	evidence	NOUN
finefocus-3492	113	12	that	that	SCONJ
finefocus-3492	113	13	the	the	DET
finefocus-3492	113	14	therapeutic	therapeutic	ADJ
finefocus-3492	113	15	potential	potential	NOUN
finefocus-3492	113	16	of	of	ADP
finefocus-3492	113	17	scytonemin	scytonemin	NOUN
finefocus-3492	113	18	should	should	AUX
finefocus-3492	113	19	be	be	AUX
finefocus-3492	113	20	further	far	ADV
finefocus-3492	113	21	explored	explore	VERB
finefocus-3492	113	22	.	.	PUNCT
finefocus-3492	114	1	acknowledgements	acknowledgement	NOUN
finefocus-3492	114	2	we	we	PRON
finefocus-3492	114	3	wish	wish	VERB
finefocus-3492	114	4	to	to	PART
finefocus-3492	114	5	thank	thank	VERB
finefocus-3492	114	6	dr	dr	PROPN
finefocus-3492	114	7	.	.	PROPN
finefocus-3492	114	8	benjamin	benjamin	PROPN
finefocus-3492	114	9	philmus	philmus	PROPN
finefocus-3492	114	10	for	for	ADP
finefocus-3492	114	11	the	the	DET
finefocus-3492	114	12	purified	purify	VERB
finefocus-3492	114	13	scytonemin	scytonemin	NOUN
finefocus-3492	114	14	extract	extract	NOUN
finefocus-3492	114	15	used	use	VERB
finefocus-3492	114	16	in	in	ADP
finefocus-3492	114	17	this	this	DET
finefocus-3492	114	18	study	study	NOUN
finefocus-3492	114	19	.	.	PUNCT
finefocus-3492	115	1	we	we	PRON
finefocus-3492	115	2	also	also	ADV
finefocus-3492	115	3	thank	thank	VERB
finefocus-3492	115	4	the	the	DET
finefocus-3492	115	5	purdue	purdue	PROPN
finefocus-3492	115	6	fort	fort	PROPN
finefocus-3492	115	7	wayne	wayne	PROPN
finefocus-3492	115	8	office	office	PROPN
finefocus-3492	115	9	of	of	ADP
finefocus-3492	115	10	university	university	NOUN
finefocus-3492	115	11	research	research	NOUN
finefocus-3492	115	12	and	and	CCONJ
finefocus-3492	115	13	innovation	innovation	NOUN
finefocus-3492	115	14	for	for	ADP
finefocus-3492	115	15	support	support	NOUN
finefocus-3492	115	16	through	through	ADP
finefocus-3492	115	17	the	the	DET
finefocus-3492	115	18	undergraduate	undergraduate	NOUN
finefocus-3492	115	19	summer	summer	NOUN
finefocus-3492	115	20	research	research	NOUN
finefocus-3492	115	21	support	support	NOUN
finefocus-3492	115	22	program	program	NOUN
finefocus-3492	115	23	.	.	PUNCT
finefocus-3492	116	1	this	this	DET
finefocus-3492	116	2	research	research	NOUN
finefocus-3492	116	3	is	be	AUX
finefocus-3492	116	4	in	in	ADP
finefocus-3492	116	5	compliance	compliance	NOUN
finefocus-3492	116	6	with	with	ADP
finefocus-3492	116	7	federal	federal	ADJ
finefocus-3492	116	8	regulations	regulation	NOUN
finefocus-3492	116	9	and	and	CCONJ
finefocus-3492	116	10	institutional	institutional	ADJ
finefocus-3492	116	11	policies	policy	NOUN
finefocus-3492	116	12	relating	relate	VERB
finefocus-3492	116	13	to	to	ADP
finefocus-3492	116	14	animal	animal	NOUN
finefocus-3492	116	15	care	care	NOUN
finefocus-3492	116	16	and	and	CCONJ
finefocus-3492	116	17	use	use	NOUN
finefocus-3492	116	18	according	accord	VERB
finefocus-3492	116	19	to	to	ADP
finefocus-3492	116	20	iacuc	iacuc	PROPN
finefocus-3492	116	21	protocol	protocol	NOUN
finefocus-3492	116	22	#	#	SYM
finefocus-3492	116	23	1111000244	1111000244	NUM
finefocus-3492	116	24	.	.	PUNCT
finefocus-3492	117	1	references	reference	NOUN
finefocus-3492	117	2	1	1	NUM
finefocus-3492	117	3	.	.	PUNCT
finefocus-3492	117	4	bebout	bebout	PROPN
finefocus-3492	117	5	bm	bm	PROPN
finefocus-3492	117	6	,	,	PUNCT
finefocus-3492	117	7	garcia	garcia	PROPN
finefocus-3492	117	8	-	-	PUNCT
finefocus-3492	117	9	pichel	pichel	PROPN
finefocus-3492	117	10	f.	f.	PROPN
finefocus-3492	117	11	1995	1995	NUM
finefocus-3492	117	12	.	.	PUNCT
finefocus-3492	118	1	uv	uv	NOUN
finefocus-3492	118	2	-	-	PUNCT
finefocus-3492	118	3	b	b	NOUN
finefocus-3492	118	4	-	-	PUNCT
finefocus-3492	118	5	induced	induce	VERB
finefocus-3492	118	6	vertical	vertical	ADJ
finefocus-3492	118	7	migrations	migration	NOUN
finefocus-3492	118	8	of	of	ADP
finefocus-3492	118	9	cyanobacteria	cyanobacteria	NOUN
finefocus-3492	118	10	in	in	ADP
finefocus-3492	118	11	a	a	DET
finefocus-3492	118	12	microbial	microbial	ADJ
finefocus-3492	118	13	mat	mat	NOUN
finefocus-3492	118	14	.	.	PUNCT
finefocus-3492	118	15	appl	appl	PROPN
finefocus-3492	118	16	environ	environ	PROPN
finefocus-3492	118	17	microbiol	microbiol	PROPN
finefocus-3492	118	18	61:4215	61:4215	PROPN
finefocus-3492	118	19	-	-	PUNCT
finefocus-3492	118	20	4222	4222	NUM
finefocus-3492	118	21	.	.	PUNCT
finefocus-3492	119	1	2	2	X
finefocus-3492	119	2	.	.	X
finefocus-3492	119	3	briles	briles	PROPN
finefocus-3492	119	4	eb	eb	PROPN
finefocus-3492	119	5	,	,	PUNCT
finefocus-3492	119	6	kornfeld	kornfeld	PROPN
finefocus-3492	119	7	s.	s.	PROPN
finefocus-3492	119	8	1978	1978	NUM
finefocus-3492	119	9	.	.	PUNCT
finefocus-3492	120	1	isolation	isolation	NOUN
finefocus-3492	120	2	and	and	CCONJ
finefocus-3492	120	3	metastatic	metastatic	ADJ
finefocus-3492	120	4	properties	property	NOUN
finefocus-3492	120	5	of	of	ADP
finefocus-3492	120	6	detachment	detachment	NOUN
finefocus-3492	120	7	variants	variant	NOUN
finefocus-3492	120	8	of	of	ADP
finefocus-3492	120	9	b16	b16	PROPN
finefocus-3492	120	10	melanoma	melanoma	NOUN
finefocus-3492	120	11	cells	cell	NOUN
finefocus-3492	120	12	.	.	PUNCT
finefocus-3492	121	1	j	j	PROPN
finefocus-3492	121	2	natl	natl	PROPN
finefocus-3492	121	3	cancer	cancer	PROPN
finefocus-3492	121	4	inst	inst	PROPN
finefocus-3492	121	5	60:1217	60:1217	NOUN
finefocus-3492	121	6	-	-	NOUN
finefocus-3492	121	7	1222	1222	NUM
finefocus-3492	121	8	.	.	PUNCT
finefocus-3492	122	1	3	3	X
finefocus-3492	122	2	.	.	X
finefocus-3492	122	3	cdc	cdc	PROPN
finefocus-3492	122	4	.	.	PUNCT
finefocus-3492	122	5	2020	2020	NUM
finefocus-3492	122	6	.	.	PUNCT
finefocus-3492	123	1	skin	skin	NOUN
finefocus-3492	123	2	cancer	cancer	NOUN
finefocus-3492	123	3	.	.	PUNCT
finefocus-3492	124	1	https://www.cdc.gov/cancer/skin/statistics/index.htm	https://www.cdc.gov/cancer/skin/statistics/index.htm	PROPN
finefocus-3492	124	2	.	.	PROPN
finefocus-3492	124	3	accessed	access	VERB
finefocus-3492	124	4	4	4	NUM
finefocus-3492	124	5	.	.	PUNCT
finefocus-3492	124	6	ehling	ehling	PROPN
finefocus-3492	124	7	-	-	PUNCT
finefocus-3492	124	8	schulz	schulz	PROPN
finefocus-3492	124	9	m	m	PROPN
finefocus-3492	124	10	,	,	PUNCT
finefocus-3492	124	11	bilger	bilger	PROPN
finefocus-3492	124	12	w	w	PROPN
finefocus-3492	124	13	,	,	PUNCT
finefocus-3492	124	14	scherer	scherer	PROPN
finefocus-3492	124	15	s.	s.	PROPN
finefocus-3492	124	16	1997	1997	NUM
finefocus-3492	124	17	.	.	PUNCT
finefocus-3492	125	1	uv	uv	NOUN
finefocus-3492	125	2	-	-	PUNCT
finefocus-3492	125	3	b	b	NOUN
finefocus-3492	125	4	-	-	PUNCT
finefocus-3492	125	5	induced	induced	ADJ
finefocus-3492	125	6	synthesis	synthesis	NOUN
finefocus-3492	125	7	of	of	ADP
finefocus-3492	125	8	photoprotective	photoprotective	ADJ
finefocus-3492	125	9	pigments	pigment	NOUN
finefocus-3492	125	10	and	and	CCONJ
finefocus-3492	125	11	extracellular	extracellular	ADJ
finefocus-3492	125	12	polysaccharides	polysaccharide	NOUN
finefocus-3492	125	13	in	in	ADP
finefocus-3492	125	14	the	the	DET
finefocus-3492	125	15	terrestrial	terrestrial	ADJ
finefocus-3492	125	16	cyanobacterium	cyanobacterium	NOUN
finefocus-3492	125	17	nostoc	nostoc	NOUN
finefocus-3492	125	18	commune	commune	NOUN
finefocus-3492	125	19	.	.	PUNCT
finefocus-3492	126	1	j	j	PROPN
finefocus-3492	126	2	bacteriol	bacteriol	PROPN
finefocus-3492	126	3	179:1940	179:1940	PROPN
finefocus-3492	126	4	-	-	SYM
finefocus-3492	126	5	1945	1945	NUM
finefocus-3492	126	6	.	.	PUNCT
finefocus-3492	127	1	5	5	NUM
finefocus-3492	127	2	.	.	X
finefocus-3492	127	3	garcia	garcia	PROPN
finefocus-3492	127	4	-	-	PUNCT
finefocus-3492	127	5	pichel	pichel	PROPN
finefocus-3492	127	6	f	f	X
finefocus-3492	127	7	,	,	PUNCT
finefocus-3492	127	8	castenholz	castenholz	ADJ
finefocus-3492	127	9	rw	rw	NOUN
finefocus-3492	127	10	.	.	PROPN
finefocus-3492	127	11	1991	1991	NUM
finefocus-3492	127	12	.	.	PUNCT
finefocus-3492	128	1	characterization	characterization	NOUN
finefocus-3492	128	2	and	and	CCONJ
finefocus-3492	128	3	biological	biological	ADJ
finefocus-3492	128	4	implications	implication	NOUN
finefocus-3492	128	5	of	of	ADP
finefocus-3492	128	6	scytonemin	scytonemin	NOUN
finefocus-3492	128	7	,	,	PUNCT
finefocus-3492	128	8	a	a	DET
finefocus-3492	128	9	cyanobacterial	cyanobacterial	ADJ
finefocus-3492	128	10	sheath	sheath	NOUN
finefocus-3492	128	11	pigment	pigment	NOUN
finefocus-3492	128	12	.	.	PUNCT
finefocus-3492	129	1	j	j	PROPN
finefocus-3492	129	2	phycol	phycol	VERB
finefocus-3492	129	3	27:395	27:395	PROPN
finefocus-3492	129	4	-	-	SYM
finefocus-3492	129	5	409	409	NUM
finefocus-3492	129	6	.	.	NOUN
finefocus-3492	130	1	6	6	NUM
finefocus-3492	130	2	.	.	X
finefocus-3492	130	3	garcia	garcia	PROPN
finefocus-3492	130	4	-	-	PUNCT
finefocus-3492	130	5	pichel	pichel	PROPN
finefocus-3492	130	6	f	f	PROPN
finefocus-3492	130	7	,	,	PUNCT
finefocus-3492	130	8	sherry	sherry	PROPN
finefocus-3492	130	9	nd	nd	PROPN
finefocus-3492	130	10	,	,	PUNCT
finefocus-3492	130	11	castenholz	castenholz	ADJ
finefocus-3492	130	12	rw	rw	NOUN
finefocus-3492	130	13	.	.	PROPN
finefocus-3492	130	14	1992	1992	NUM
finefocus-3492	130	15	.	.	PUNCT
finefocus-3492	131	1	evidence	evidence	NOUN
finefocus-3492	131	2	for	for	ADP
finefocus-3492	131	3	an	an	DET
finefocus-3492	131	4	ultraviolet	ultraviolet	ADJ
finefocus-3492	131	5	sunscreen	sunscreen	ADJ
finefocus-3492	131	6	role	role	NOUN
finefocus-3492	131	7	of	of	ADP
finefocus-3492	131	8	the	the	DET
finefocus-3492	131	9	extracellular	extracellular	ADJ
finefocus-3492	131	10	pigment	pigment	NOUN
finefocus-3492	131	11	scytonemin	scytonemin	NOUN
finefocus-3492	131	12	in	in	ADP
finefocus-3492	131	13	the	the	DET
finefocus-3492	131	14	terrestrial	terrestrial	ADJ
finefocus-3492	131	15	cyanobacterium	cyanobacterium	NOUN
finefocus-3492	131	16	chlorogloeopsis	chlorogloeopsis	NOUN
finefocus-3492	131	17	sp	sp	PROPN
finefocus-3492	131	18	.	.	PROPN
finefocus-3492	131	19	photochem	photochem	PROPN
finefocus-3492	131	20	photobiol	photobiol	PROPN
finefocus-3492	131	21	56:17	56:17	NUM
finefocus-3492	131	22	-	-	SYM
finefocus-3492	131	23	23	23	NUM
finefocus-3492	131	24	.	.	PUNCT
finefocus-3492	132	1	7	7	X
finefocus-3492	132	2	.	.	PUNCT
finefocus-3492	132	3	huang	huang	PROPN
finefocus-3492	132	4	l	l	PROPN
finefocus-3492	132	5	,	,	PUNCT
finefocus-3492	132	6	mccluskey	mccluskey	PROPN
finefocus-3492	132	7	mp	mp	PROPN
finefocus-3492	132	8	,	,	PUNCT
finefocus-3492	132	9	ni	ni	PROPN
finefocus-3492	132	10	h	h	PROPN
finefocus-3492	132	11	,	,	PUNCT
finefocus-3492	132	12	larossa	larossa	PROPN
finefocus-3492	132	13	ra	ra	PROPN
finefocus-3492	132	14	.	.	PROPN
finefocus-3492	132	15	2002	2002	NUM
finefocus-3492	132	16	.	.	PUNCT
finefocus-3492	133	1	global	global	ADJ
finefocus-3492	133	2	gene	gene	NOUN
finefocus-3492	133	3	expression	expression	NOUN
finefocus-3492	133	4	profiles	profile	NOUN
finefocus-3492	133	5	of	of	ADP
finefocus-3492	133	6	the	the	DET
finefocus-3492	133	7	cyanobacterium	cyanobacterium	NOUN
finefocus-3492	133	8	synechocystis	synechocystis	NOUN
finefocus-3492	133	9	sp	sp	PROPN
finefocus-3492	133	10	.	.	PROPN
finefocus-3492	133	11	strain	strain	PROPN
finefocus-3492	133	12	pcc	pcc	PROPN
finefocus-3492	133	13	6803	6803	NUM
finefocus-3492	133	14	in	in	ADP
finefocus-3492	133	15	response	response	NOUN
finefocus-3492	133	16	to	to	ADP
finefocus-3492	133	17	irradiation	irradiation	NOUN
finefocus-3492	133	18	with	with	ADP
finefocus-3492	133	19	uv	uv	NOUN
finefocus-3492	133	20	-	-	PUNCT
finefocus-3492	133	21	b	b	NOUN
finefocus-3492	133	22	and	and	CCONJ
finefocus-3492	133	23	white	white	ADJ
finefocus-3492	133	24	light	light	NOUN
finefocus-3492	133	25	.	.	PUNCT
finefocus-3492	134	1	j	j	PROPN
finefocus-3492	134	2	bacteriol	bacteriol	PROPN
finefocus-3492	134	3	184:6845	184:6845	PROPN
finefocus-3492	134	4	-	-	SYM
finefocus-3492	134	5	6858	6858	NUM
finefocus-3492	134	6	.	.	PUNCT
finefocus-3492	135	1	8	8	X
finefocus-3492	135	2	.	.	X
finefocus-3492	135	3	jagger	jagger	PROPN
finefocus-3492	135	4	j.	j.	PROPN
finefocus-3492	135	5	1985	1985	NUM
finefocus-3492	135	6	.	.	PUNCT
finefocus-3492	136	1	solar	solar	ADJ
finefocus-3492	136	2	-	-	PUNCT
finefocus-3492	136	3	uv	uv	NOUN
finefocus-3492	136	4	actions	action	NOUN
finefocus-3492	136	5	on	on	ADP
finefocus-3492	136	6	living	living	NOUN
finefocus-3492	136	7	cells	cell	NOUN
finefocus-3492	136	8	.	.	PUNCT
finefocus-3492	137	1	praeger	praeger	NOUN
finefocus-3492	137	2	,	,	PUNCT
finefocus-3492	137	3	new	new	PROPN
finefocus-3492	137	4	york	york	PROPN
finefocus-3492	137	5	.	.	PUNCT
finefocus-3492	138	1	9	9	X
finefocus-3492	138	2	.	.	X
finefocus-3492	138	3	pathak	pathak	PROPN
finefocus-3492	138	4	j	j	PROPN
finefocus-3492	138	5	,	,	PUNCT
finefocus-3492	138	6	mondal	mondal	PROPN
finefocus-3492	138	7	s	s	PROPN
finefocus-3492	138	8	,	,	PUNCT
finefocus-3492	138	9	ahmed	ahmed	PROPN
finefocus-3492	138	10	h	h	PROPN
finefocus-3492	138	11	,	,	PUNCT
finefocus-3492	138	12	rajneesh	rajneesh	PROPN
finefocus-3492	138	13	,	,	PUNCT
finefocus-3492	138	14	singh	singh	PROPN
finefocus-3492	138	15	sp	sp	PROPN
finefocus-3492	138	16	,	,	PUNCT
finefocus-3492	138	17	rp	rp	NOUN
finefocus-3492	138	18	s.	s.	PROPN
finefocus-3492	138	19	2019	2019	NUM
finefocus-3492	138	20	.	.	PUNCT
finefocus-3492	139	1	in	in	ADP
finefocus-3492	139	2	silico	silico	NOUN
finefocus-3492	139	3	study	study	NOUN
finefocus-3492	139	4	on	on	ADP
finefocus-3492	139	5	interaction	interaction	NOUN
finefocus-3492	139	6	between	between	ADP
finefocus-3492	139	7	human	human	ADJ
finefocus-3492	139	8	polo	polo	NOUN
finefocus-3492	139	9	-	-	PUNCT
finefocus-3492	139	10	like	like	ADJ
finefocus-3492	139	11	kinase	kinase	NOUN
finefocus-3492	139	12	1	1	NUM
finefocus-3492	139	13	and	and	CCONJ
finefocus-3492	139	14	cyanobacterial	cyanobacterial	ADJ
finefocus-3492	139	15	sheath	sheath	NOUN
finefocus-3492	139	16	pigment	pigment	NOUN
finefocus-3492	139	17	scytonemin	scytonemin	NOUN
finefocus-3492	139	18	by	by	ADP
finefocus-3492	139	19	molecular	molecular	ADJ
finefocus-3492	139	20	docking	docking	NOUN
finefocus-3492	139	21	approach	approach	NOUN
finefocus-3492	139	22	.	.	PUNCT
finefocus-3492	140	1	biointerface	biointerface	NOUN
finefocus-3492	140	2	res	re	NOUN
finefocus-3492	140	3	appl	appl	PROPN
finefocus-3492	140	4	chem	chem	NOUN
finefocus-3492	140	5	9:4374	9:4374	NOUN
finefocus-3492	140	6	-	-	SYM
finefocus-3492	140	7	4378	4378	NUM
finefocus-3492	140	8	.	.	PUNCT
finefocus-3492	141	1	10	10	NUM
finefocus-3492	141	2	.	.	X
finefocus-3492	141	3	proteau	proteau	PROPN
finefocus-3492	141	4	pj	pj	PROPN
finefocus-3492	141	5	,	,	PUNCT
finefocus-3492	141	6	gerwick	gerwick	VERB
finefocus-3492	141	7	wh	wh	PROPN
finefocus-3492	141	8	,	,	PUNCT
finefocus-3492	141	9	garcia	garcia	PROPN
finefocus-3492	141	10	-	-	PUNCT
finefocus-3492	141	11	pichel	pichel	PROPN
finefocus-3492	141	12	f	f	X
finefocus-3492	141	13	,	,	PUNCT
finefocus-3492	141	14	castenholz	castenholz	ADJ
finefocus-3492	141	15	rw	rw	NOUN
finefocus-3492	141	16	.	.	PROPN
finefocus-3492	141	17	1993	1993	NUM
finefocus-3492	141	18	.	.	PUNCT
finefocus-3492	142	1	the	the	DET
finefocus-3492	142	2	structure	structure	NOUN
finefocus-3492	142	3	of	of	ADP
finefocus-3492	142	4	scytonemin	scytonemin	NOUN
finefocus-3492	142	5	,	,	PUNCT
finefocus-3492	142	6	an	an	DET
finefocus-3492	142	7	ultraviolet	ultraviolet	NOUN
finefocus-3492	142	8	sunscreen	sunscreen	NOUN
finefocus-3492	142	9	pigment	pigment	NOUN
finefocus-3492	142	10	from	from	ADP
finefocus-3492	142	11	the	the	DET
finefocus-3492	142	12	sheaths	sheath	NOUN
finefocus-3492	142	13	of	of	ADP
finefocus-3492	142	14	cyanobacteria	cyanobacteria	NOUN
finefocus-3492	142	15	.	.	PUNCT
finefocus-3492	143	1	experientia	experientia	PROPN
finefocus-3492	143	2	49:825829	49:825829	NUM
finefocus-3492	143	3	.	.	PUNCT
finefocus-3492	144	1	11	11	NUM
finefocus-3492	144	2	.	.	PUNCT
finefocus-3492	145	1	rastogi	rastogi	NOUN
finefocus-3492	145	2	r	r	NOUN
finefocus-3492	145	3	,	,	PUNCT
finefocus-3492	145	4	sonani	sonani	ADJ
finefocus-3492	145	5	r	r	NOUN
finefocus-3492	145	6	,	,	PUNCT
finefocus-3492	145	7	madamwar	madamwar	PROPN
finefocus-3492	145	8	d.	d.	PROPN
finefocus-3492	145	9	2015	2015	NUM
finefocus-3492	145	10	.	.	PUNCT
finefocus-3492	146	1	cyanobacterial	cyanobacterial	ADJ
finefocus-3492	146	2	sunscreen	sunscreen	NOUN
finefocus-3492	146	3	scytonemin	scytonemin	NOUN
finefocus-3492	146	4	:	:	PUNCT
finefocus-3492	146	5	role	role	NOUN
finefocus-3492	146	6	in	in	ADP
finefocus-3492	146	7	photoprotection	photoprotection	NOUN
finefocus-3492	146	8	and	and	CCONJ
finefocus-3492	146	9	biomedical	biomedical	ADJ
finefocus-3492	146	10	research	research	NOUN
finefocus-3492	146	11	.	.	PUNCT
finefocus-3492	147	1	appl	appl	PROPN
finefocus-3492	147	2	biochem	biochem	PROPN
finefocus-3492	147	3	biotechnol	biotechnol	VERB
finefocus-3492	147	4	176:1551	176:1551	NUM
finefocus-3492	147	5	-	-	SYM
finefocus-3492	147	6	1563	1563	NUM
finefocus-3492	147	7	.	.	PUNCT
finefocus-3492	148	1	62	62	NUM
finefocus-3492	148	2	|	|	ADV
finefocus-3492	148	3	fine	fine	ADJ
finefocus-3492	148	4	focus	focus	NOUN
finefocus-3492	148	5	12	12	NUM
finefocus-3492	148	6	.	.	PUNCT
finefocus-3492	149	1	reeke	reeke	PROPN
finefocus-3492	149	2	gn	gn	PROPN
finefocus-3492	149	3	,	,	PUNCT
finefocus-3492	149	4	jr	jr	PROPN
finefocus-3492	149	5	.	.	PROPN
finefocus-3492	149	6	,	,	PUNCT
finefocus-3492	149	7	becker	becker	PROPN
finefocus-3492	149	8	jw	jw	PROPN
finefocus-3492	149	9	,	,	PUNCT
finefocus-3492	149	10	cunningham	cunningham	PROPN
finefocus-3492	149	11	ba	ba	PROPN
finefocus-3492	149	12	,	,	PUNCT
finefocus-3492	149	13	wang	wang	PROPN
finefocus-3492	149	14	jl	jl	PROPN
finefocus-3492	149	15	,	,	PUNCT
finefocus-3492	149	16	yahara	yahara	NOUN
finefocus-3492	150	1	i	i	PRON
finefocus-3492	150	2	,	,	PUNCT
finefocus-3492	150	3	edelman	edelman	PROPN
finefocus-3492	150	4	gm	gm	PROPN
finefocus-3492	150	5	.	.	PROPN
finefocus-3492	150	6	1975	1975	NUM
finefocus-3492	150	7	.	.	PUNCT
finefocus-3492	151	1	structure	structure	NOUN
finefocus-3492	151	2	and	and	CCONJ
finefocus-3492	151	3	function	function	NOUN
finefocus-3492	151	4	of	of	ADP
finefocus-3492	151	5	concanavalin	concanavalin	PROPN
finefocus-3492	151	6	a.	a.	PROPN
finefocus-3492	151	7	adv	adv	PROPN
finefocus-3492	151	8	exp	exp	NOUN
finefocus-3492	151	9	med	med	ADJ
finefocus-3492	151	10	biol	biol	NOUN
finefocus-3492	151	11	55:13	55:13	NUM
finefocus-3492	151	12	-	-	SYM
finefocus-3492	151	13	33	33	NUM
finefocus-3492	151	14	.	.	NOUN
finefocus-3492	151	15	13	13	NUM
finefocus-3492	151	16	.	.	PUNCT
finefocus-3492	151	17	rstudio	rstudio	NOUN
finefocus-3492	151	18	.	.	PUNCT
finefocus-3492	151	19	2018	2018	NUM
finefocus-3492	151	20	.	.	PUNCT
finefocus-3492	152	1	rstudio	rstudio	NOUN
finefocus-3492	152	2	:	:	PUNCT
finefocus-3492	152	3	integrated	integrate	VERB
finefocus-3492	152	4	development	development	NOUN
finefocus-3492	152	5	for	for	ADP
finefocus-3492	152	6	r.	r.	PROPN
finefocus-3492	152	7	rstudio	rstudio	PROPN
finefocus-3492	152	8	,	,	PUNCT
finefocus-3492	152	9	inc	inc	PROPN
finefocus-3492	152	10	.	.	PROPN
finefocus-3492	152	11	,	,	PUNCT
finefocus-3492	152	12	boston	boston	PROPN
finefocus-3492	152	13	,	,	PUNCT
finefocus-3492	152	14	ma	ma	PROPN
finefocus-3492	152	15	.	.	PROPN
finefocus-3492	153	1	http://	http://	PROPN
finefocus-3492	153	2	www.rstudio.com/.	www.rstudio.com/.	PROPN
finefocus-3492	153	3	14	14	NUM
finefocus-3492	153	4	.	.	PUNCT
finefocus-3492	154	1	shibata	shibata	PROPN
finefocus-3492	154	2	h	h	PROPN
finefocus-3492	154	3	,	,	PUNCT
finefocus-3492	154	4	baba	baba	PROPN
finefocus-3492	154	5	k	k	PROPN
finefocus-3492	154	6	,	,	PUNCT
finefocus-3492	154	7	ochiai	ochiai	PROPN
finefocus-3492	154	8	h.	h.	PROPN
finefocus-3492	154	9	1991	1991	NUM
finefocus-3492	154	10	.	.	PUNCT
finefocus-3492	155	1	near	near	ADP
finefocus-3492	155	2	-	-	PUNCT
finefocus-3492	155	3	uv	uv	NOUN
finefocus-3492	155	4	induces	induce	VERB
finefocus-3492	155	5	shock	shock	NOUN
finefocus-3492	155	6	proteins	protein	NOUN
finefocus-3492	155	7	in	in	ADP
finefocus-3492	155	8	anacystis	anacystis	PROPN
finefocus-3492	155	9	nidulans	nidulan	VERB
finefocus-3492	155	10	r-2	r-2	PROPN
finefocus-3492	155	11	,	,	PUNCT
finefocus-3492	155	12	possible	possible	ADJ
finefocus-3492	155	13	role	role	NOUN
finefocus-3492	155	14	of	of	ADP
finefocus-3492	155	15	active	active	ADJ
finefocus-3492	155	16	oxygen	oxygen	NOUN
finefocus-3492	155	17	.	.	PUNCT
finefocus-3492	156	1	plant	plant	NOUN
finefocus-3492	156	2	cell	cell	NOUN
finefocus-3492	156	3	physiol	physiol	PROPN
finefocus-3492	156	4	32:771	32:771	NUM
finefocus-3492	156	5	-	-	SYM
finefocus-3492	156	6	776	776	NUM
finefocus-3492	156	7	.	.	PUNCT
finefocus-3492	156	8	15	15	NUM
finefocus-3492	156	9	.	.	PUNCT
finefocus-3492	157	1	stevenson	stevenson	PROPN
finefocus-3492	157	2	cs	cs	PROPN
finefocus-3492	157	3	,	,	PUNCT
finefocus-3492	157	4	capper	capper	NOUN
finefocus-3492	157	5	ea	ea	NOUN
finefocus-3492	157	6	,	,	PUNCT
finefocus-3492	157	7	roshak	roshak	PROPN
finefocus-3492	157	8	ak	ak	PROPN
finefocus-3492	157	9	,	,	PUNCT
finefocus-3492	157	10	marquez	marquez	PROPN
finefocus-3492	157	11	b	b	PROPN
finefocus-3492	157	12	,	,	PUNCT
finefocus-3492	157	13	eichman	eichman	NOUN
finefocus-3492	157	14	c	c	PROPN
finefocus-3492	157	15	,	,	PUNCT
finefocus-3492	157	16	jackson	jackson	PROPN
finefocus-3492	157	17	jr	jr	PROPN
finefocus-3492	157	18	,	,	PUNCT
finefocus-3492	157	19	mattern	mattern	PROPN
finefocus-3492	157	20	m	m	PROPN
finefocus-3492	157	21	,	,	PUNCT
finefocus-3492	157	22	gerwick	gerwick	PROPN
finefocus-3492	157	23	wh	wh	PROPN
finefocus-3492	157	24	,	,	PUNCT
finefocus-3492	157	25	jacobs	jacobs	PROPN
finefocus-3492	157	26	rs	rs	PROPN
finefocus-3492	157	27	,	,	PUNCT
finefocus-3492	157	28	marshall	marshall	PROPN
finefocus-3492	157	29	la	la	PROPN
finefocus-3492	157	30	.	.	PROPN
finefocus-3492	157	31	2002	2002	NUM
finefocus-3492	157	32	.	.	PUNCT
finefocus-3492	158	1	the	the	DET
finefocus-3492	158	2	identification	identification	NOUN
finefocus-3492	158	3	and	and	CCONJ
finefocus-3492	158	4	characterization	characterization	NOUN
finefocus-3492	158	5	of	of	ADP
finefocus-3492	158	6	the	the	DET
finefocus-3492	158	7	marine	marine	ADJ
finefocus-3492	158	8	natural	natural	ADJ
finefocus-3492	158	9	product	product	NOUN
finefocus-3492	158	10	scytonemin	scytonemin	NOUN
finefocus-3492	158	11	as	as	ADP
finefocus-3492	158	12	a	a	DET
finefocus-3492	158	13	novel	novel	ADJ
finefocus-3492	158	14	antiproliferative	antiproliferative	NOUN
finefocus-3492	158	15	pharmacophore	pharmacophore	NOUN
finefocus-3492	158	16	.	.	PUNCT
finefocus-3492	159	1	j	j	PROPN
finefocus-3492	159	2	pharmacol	pharmacol	PROPN
finefocus-3492	159	3	exp	exp	NOUN
finefocus-3492	159	4	ther	ther	ADV
finefocus-3492	159	5	303:858	303:858	NUM
finefocus-3492	159	6	-	-	SYM
finefocus-3492	159	7	866	866	NUM
finefocus-3492	159	8	.	.	PUNCT
finefocus-3492	160	1	16	16	NUM
finefocus-3492	160	2	.	.	PUNCT
finefocus-3492	161	1	stevenson	stevenson	PROPN
finefocus-3492	161	2	cs	cs	PROPN
finefocus-3492	161	3	,	,	PUNCT
finefocus-3492	161	4	capper	capper	NOUN
finefocus-3492	161	5	ea	ea	NOUN
finefocus-3492	161	6	,	,	PUNCT
finefocus-3492	161	7	roshak	roshak	PROPN
finefocus-3492	161	8	ak	ak	PROPN
finefocus-3492	161	9	,	,	PUNCT
finefocus-3492	161	10	marquez	marquez	PROPN
finefocus-3492	161	11	b	b	PROPN
finefocus-3492	161	12	,	,	PUNCT
finefocus-3492	161	13	grace	grace	NOUN
finefocus-3492	161	14	k	k	NOUN
finefocus-3492	161	15	,	,	PUNCT
finefocus-3492	161	16	gerwick	gerwick	PROPN
finefocus-3492	161	17	wh	wh	PROPN
finefocus-3492	161	18	,	,	PUNCT
finefocus-3492	161	19	jacobs	jacobs	PROPN
finefocus-3492	161	20	rs	rs	PROPN
finefocus-3492	161	21	,	,	PUNCT
finefocus-3492	161	22	marshall	marshall	PROPN
finefocus-3492	161	23	la	la	PROPN
finefocus-3492	161	24	.	.	PROPN
finefocus-3492	161	25	2002	2002	NUM
finefocus-3492	161	26	.	.	PUNCT
finefocus-3492	162	1	scytonemin	scytonemin	NOUN
finefocus-3492	162	2	,	,	PUNCT
finefocus-3492	162	3	a	a	DET
finefocus-3492	162	4	marine	marine	ADJ
finefocus-3492	162	5	natural	natural	ADJ
finefocus-3492	162	6	product	product	NOUN
finefocus-3492	162	7	inhibitor	inhibitor	NOUN
finefocus-3492	162	8	of	of	ADP
finefocus-3492	162	9	kinases	kinase	NOUN
finefocus-3492	162	10	key	key	ADJ
finefocus-3492	162	11	in	in	ADP
finefocus-3492	162	12	hyperproliferative	hyperproliferative	ADJ
finefocus-3492	162	13	inflammatory	inflammatory	ADJ
finefocus-3492	162	14	diseases	disease	NOUN
finefocus-3492	162	15	.	.	PUNCT
finefocus-3492	163	1	inflammation	inflammation	NOUN
finefocus-3492	163	2	res	re	NOUN
finefocus-3492	163	3	51:112114	51:112114	PRON
finefocus-3492	163	4	.	.	PROPN
finefocus-3492	163	5	17	17	NUM
finefocus-3492	163	6	.	.	PUNCT
finefocus-3492	164	1	urbach	urbach	PROPN
finefocus-3492	164	2	f.	f.	PROPN
finefocus-3492	164	3	1997	1997	NUM
finefocus-3492	164	4	.	.	PUNCT
finefocus-3492	165	1	ultraviolet	ultraviolet	ADJ
finefocus-3492	165	2	radiation	radiation	NOUN
finefocus-3492	165	3	and	and	CCONJ
finefocus-3492	165	4	skin	skin	NOUN
finefocus-3492	165	5	cancer	cancer	NOUN
finefocus-3492	165	6	of	of	ADP
finefocus-3492	165	7	humans	human	NOUN
finefocus-3492	165	8	.	.	PUNCT
finefocus-3492	166	1	j	j	PROPN
finefocus-3492	166	2	photochem	photochem	PROPN
finefocus-3492	166	3	photobiol	photobiol	PROPN
finefocus-3492	166	4	b	b	PROPN
finefocus-3492	166	5	:	:	PUNCT
finefocus-3492	166	6	biology	biology	NOUN
finefocus-3492	166	7	40:3	40:3	NUM
finefocus-3492	166	8	-	-	SYM
finefocus-3492	166	9	7	7	NUM
finefocus-3492	166	10	.	.	NOUN
finefocus-3492	166	11	18	18	NUM
finefocus-3492	166	12	.	.	PUNCT
finefocus-3492	167	1	zhang	zhang	PROPN
finefocus-3492	167	2	g	g	PROPN
finefocus-3492	167	3	,	,	PUNCT
finefocus-3492	167	4	zhang	zhang	PROPN
finefocus-3492	167	5	z	z	PROPN
finefocus-3492	167	6	,	,	PUNCT
finefocus-3492	167	7	liu	liu	PROPN
finefocus-3492	167	8	z.	z.	PROPN
finefocus-3492	167	9	2013	2013	NUM
finefocus-3492	167	10	.	.	PUNCT
finefocus-3492	168	1	polo	polo	NOUN
finefocus-3492	168	2	-	-	PUNCT
finefocus-3492	168	3	like	like	ADJ
finefocus-3492	168	4	kinase	kinase	NOUN
finefocus-3492	168	5	1	1	NUM
finefocus-3492	168	6	is	be	AUX
finefocus-3492	168	7	overexpressed	overexpresse	VERB
finefocus-3492	168	8	in	in	ADP
finefocus-3492	168	9	renal	renal	ADJ
finefocus-3492	168	10	cancer	cancer	NOUN
finefocus-3492	168	11	and	and	CCONJ
finefocus-3492	168	12	participates	participate	VERB
finefocus-3492	168	13	in	in	ADP
finefocus-3492	168	14	the	the	DET
finefocus-3492	168	15	proliferation	proliferation	NOUN
finefocus-3492	168	16	and	and	CCONJ
finefocus-3492	168	17	invasion	invasion	NOUN
finefocus-3492	168	18	of	of	ADP
finefocus-3492	168	19	renal	renal	ADJ
finefocus-3492	168	20	cancer	cancer	NOUN
finefocus-3492	168	21	cells	cell	NOUN
finefocus-3492	168	22	.	.	PUNCT
finefocus-3492	169	1	tumor	tumor	NOUN
finefocus-3492	169	2	biol	biol	PROPN
finefocus-3492	169	3	34:1887	34:1887	PROPN
finefocus-3492	169	4	-	-	SYM
finefocus-3492	169	5	1894	1894	NUM
finefocus-3492	169	6	.	.	PUNCT
finefocus-3492	170	1	19	19	NUM
finefocus-3492	170	2	.	.	X
finefocus-3492	171	1	zhang	zhang	PROPN
finefocus-3492	171	2	g	g	PROPN
finefocus-3492	171	3	,	,	PUNCT
finefocus-3492	171	4	zhang	zhang	PROPN
finefocus-3492	171	5	z	z	PROPN
finefocus-3492	171	6	,	,	PUNCT
finefocus-3492	171	7	liu	liu	PROPN
finefocus-3492	171	8	z.	z.	PROPN
finefocus-3492	171	9	2013	2013	NUM
finefocus-3492	171	10	.	.	PUNCT
finefocus-3492	172	1	scytonemin	scytonemin	NOUN
finefocus-3492	172	2	inhibits	inhibit	VERB
finefocus-3492	172	3	cell	cell	NOUN
finefocus-3492	172	4	proliferation	proliferation	NOUN
finefocus-3492	172	5	and	and	CCONJ
finefocus-3492	172	6	arrests	arrest	NOUN
finefocus-3492	172	7	cell	cell	NOUN
finefocus-3492	172	8	cycle	cycle	NOUN
finefocus-3492	172	9	through	through	ADP
finefocus-3492	172	10	downregulating	downregulating	NOUN
finefocus-3492	172	11	plk1	plk1	NOUN
finefocus-3492	172	12	activity	activity	NOUN
finefocus-3492	172	13	in	in	ADP
finefocus-3492	172	14	multiple	multiple	ADJ
finefocus-3492	172	15	myeloma	myeloma	NOUN
finefocus-3492	172	16	cells	cell	NOUN
finefocus-3492	172	17	.	.	PUNCT
finefocus-3492	173	1	tumor	tumor	NOUN
finefocus-3492	173	2	biol	biol	PROPN
finefocus-3492	173	3	34:2241	34:2241	PROPN
finefocus-3492	173	4	-	-	SYM
finefocus-3492	173	5	2247	2247	NUM
finefocus-3492	173	6	.	.	PUNCT
finefocus-3492	174	1	volume	volume	NOUN
finefocus-3492	174	2	seven	seven	NUM
finefocus-3492	174	3	|	|	ADV
finefocus-3492	174	4	63	63	NUM
finefocus-3492	174	5	’	'	PUNCT